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ABSTRACT 
 
 
 
THE ROLE OF CALCINEURIN IN DENDRITIC REMODELING AND 
EPILEPTOGENESIS IN A RAT MODEL OF TRAUMATIC BRAIN INJURY 
 
By John N. Campbell 
 
A dissertation submitted in partial fulfillment of the requirements for the degree of Doctor 
of Philosophy at Virginia Commonwealth University 
 
Virginia Commonwealth University, 2012 
 
Director: Severn B. Churn, Ph.D. 
Associate Professor, Departments of Neurology,  
Anatomy & Neurobiology, Pharmacology & Toxicology,  
and Physiology & Biophysics 
 
 
 Traumatic brain injury (TBI), a leading cause of death and disability in the United 
States, causes potentially preventable damage in part through the dysregulation of 
neural calcium levels.  This dysregulation likely affects the activity of the calcium-
sensitive phosphatase, calcineurin, with serious implications for neural function.  To test 
this possibility, the present study characterized the role of calcineurin in a rat model of 
brain trauma, the lateral fluid percussion injury model.  Golgi-Cox histochemistry 
revealed an acute post-TBI loss and delayed overgrowth of dendritic spines on principal 
cortical cells.  The spine loss appeared to require calcineurin activity, since 
administering a calcineurin inhibitor, FK506, 1 hour after TBI prevented the spine loss.  
x 
 
Additional experiments showed how calcineurin activity might be related to the spine 
loss.  Specifically, Western blots and enzyme activity assays revealed an acute 
increase in the cortical activity of calcineurin and its downstream effector, the actin-
depolymerizing protein, cofilin.  The cofilin activation was blocked by the same FK506 
treatment that prevented spine loss, suggesting a relationship between cofilin 
activation and spine loss.  To investigate long-term consequences of calcineurin 
activation after TBI, rats were administered FK506 (Tacrolimus) 1 hour after TBI and 
then monitored for spontaneous seizure activity months later.  Acute post-TBI treatment 
with FK506 reduced the frequency of late non-convulsive seizures but did not prevent 
late convulsive seizures, cortical atrophy, or thalamic damage.  The results of the 
present study implicate calcineurin in the acute dendritic remodeling and late non-
convulsive seizures that occur after TBI.  Importantly, these findings reveal calcineurin 
as a potential therapeutic target in the treatment of TBI and its sequalae.   
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INTRODUCTION 
 
The Exciting but Risky Lives of Dendritic Spines 
 Experience leaves a trace in the adult brain through the formation and 
elimination, strengthening and weakening of individual synapses [1,2].  In vertebrates 
this plasticity depends largely on tiny protuberances of neuronal membrane, known as 
dendritic spines [3].  Dendritic spines abound in forebrain regions where memories are 
formed and stored [4], regions in which nearly all excitatory synapses are formed on 
dendritic spines [5] and in which nearly all spines bear at least one excitatory synapse 
[6].  The importance of these spines to synaptic plasticity is further evidenced by their 
composition: each spine is equipped with a diverse complement of signaling proteins 
which work together to not only transduce synaptic communication, but to regulate 
synaptic efficacy in an activity-dependent and synapse-specific manner [7,8,9].  Such 
plasticity may, however, be risky business for the dendritic spine.  Excitatory signaling 
can occur to toxic excess in many forms of brain injury and disease [10].  This 
excitotoxicity can trigger the rapid retraction of spines into the parent dendrite [11], 
potentially coinciding with a breakdown of the post-synaptic machinery [12,13] and 
separating the pre- and post-synaptic membranes.  The collapse of a spine could 
therefore mean the loss of its synapse.  However, this may be neuroprotective under 
certain circumstances.  For example, by weakening or disconnecting an overactive 
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synapse, the collapse of a dendritic spine may help to prevent further excitotoxic 
damage to the parent neuron.  Spine collapse could therefore act like a circuit-breaker.  
On the other hand, the collapse of a dendritic spine may entail risks for neuronal 
networks, especially if spine collapse disconnects synaptic partners or impairs synaptic 
communication.  The resulting decrease in network activity may be temporary if the 
synaptic partners are able to re-connect.  Still, a decrease in network activity lasting a 
day or longer can trigger homeostatic increases in the sensitivity of remaining excitatory 
synapses [14], or provoke the formation of new excitatory synapses [15].  Dendritic 
spines are a therefore a likely substrate for injury-induced and potentially pathological 
changes in brain circuitry.  A better understanding of the mechanisms of dendritic spine 
collapse may reveal therapeutic targets for the treatment of brain injury and its 
sequelae. 
This introduction considers potential mechanisms of dendritic spine collapse.  
The terms “spine loss” and “spine collapse” are used interchangeably herein to describe 
the retraction of a spine into the parent dendrite.  Many mechanisms of spine loss have 
been demonstrated experimentally, including some which are pre-synaptic (e.g., [16]), 
and others which are extra-synaptic, such as the removal of synapses by microglia 
[17,18,19,20].  Other studies have identified mechanisms which appear to be contained 
within the post-synaptic neuron.  These post-synaptic mechanisms of spine loss are the 
focus of this introduction.   
Since much of spine plasticity depends on intracellular Ca2+ ions, the first part of 
this introduction considers Ca2+ signaling within the dendritic spine and how this 
signaling affects spine structure and function.  
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Calcium in Dendritic Spine Plasticity 
Intracellular Ca2+ signaling is integral to many cellular functions, including 
synaptic plasticity.  Normally, excitatory signaling at the spine synapse causes an 
accumulation of Ca2+ ions within the dendritic spine.  These ions relay the excitatory 
signal from the synaptic surface to Ca2+-sensitive proteins within the dendritic spine.  
The Ca2+-sensitive proteins then act on divergent biochemical pathways which 
ultimately determine post-synaptic structure and function.  Some pathways alter the 
number or sensitivity of receptors at the spine synapse, thereby adjusting its response 
to subsequent signals [21,22].  Other pathways expand, lengthen, or shrink the spine by 
remodeling its cytoskeleton [23,24], morphological changes which can influence the 
spread of electrical and molecular signals [25,26,27].  Because antagonistic pathways 
compete for Ca2+ binding, the outcome of this competition depends on their relative 
Ca2+ sensitivity as well as on the magnitude and duration of the Ca2+ signal [28].  Likely 
for this reason, Ca2+ dynamics are tightly controlled in the dendritic spine.  Indeed, Ca2+ 
dynamics are subject to a host of locally-regulated processes, including Ca2+ influx 
through gated channels and efflux through ion pumps, Ca2+ sequestration in organelles 
and binding of proteins, even the geometry of the dendritic spine [29,30,31].  However, 
many of these regulatory processes can be disrupted or over-activated by brain injury 
[32,33,34,35].  The resulting dysregulation of Ca2+-sensitive pathways may have 
substantial consequences for the structure and function of the dendritic spine. 
A major trigger for Ca2+ accumulation in the dendritic spine is glutamate. 
Glutamate, the predominant excitatory neurotransmitter in the mammalian brain, binds 
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metabotropic and ionotropic glutamate receptors expressed on the surface of the 
dendritic spine [30].  The interaction of glutamate with any type of glutamate receptor 
can affect the Ca2+ content of a dendritic spine.  For example, metabotropic glutamate 
receptors (mGluRs) are coupled to G proteins that mediate, among other things, the 
release of intracellular stores of Ca2+ [36].  But while mGluRs do mediate some forms of 
spine plasticity [37,38,39], the role of these receptors under pathological conditions is 
not well understood.  Some in vitro studies suggest that mGluR activation during 
excitotoxicity limits the post-synaptic influx of Ca2+ and the related neuronal 
degeneration [40,41]; other studies report evidence to the contrary [42].  A more recent 
in vivo study found that the truncation of mGluRs by calpain is a critical step in neuronal 
excitotoxicity [43].  Still, it is unclear to what extent mGluRs participate in Ca2+-
dependent mechanisms of dendritic spine collapse.  
Ionotropic glutamate receptors open channels which make the cell membrane 
permeable to cations.  All three known subtypes of ionotropic glutamate receptors can 
be expressed by dendritic spines: the 2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl) 
proprionate (AMPA) receptor, the kainate receptor, and the N-methyl-D-aspartate 
(NMDA) receptor.  These receptor subtypes differentially affect the Ca2+ content of a 
dendritic spine and so are described separately below.   
 
AMPA Receptors 
The AMPA receptor (AMPAR) is the primary route of fast synaptic input at the 
dendritic spine.  The expression of AMPARs at the spine synapse is activity-dependent, 
which is integral to long-term plasticity of the post-synapse [44]. Upon binding 
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glutamate, the AMPAR opens a pore in the spine membrane through which ions travel 
along their concentration gradient.  Due to the charge profile of this pore [45], AMPARs 
mostly conduct Na+ and K+, resulting in the rapid depolarization of the dendritic spine 
membrane.  However, the ion permeability of the AMPAR is a function of its subunit 
composition. One subunit in particular, GluR2, confers impermeability to divalent 
cations, due to the presence of a polar arginine residue at a key site along the GluR2 
pore-forming domain [46].  Therefore, AMPARs can be permeable to divalent cations 
such as Ca2+ and Zn2+ when formed without a GluR2 subunit, or when formed with a 
GluR2 in which a non-polar glutamine was substituted for the key arginine [47].  
Normally in the adult brain, GluR2-lacking, Ca2+-permeable AMPARs are expressed 
stably by interneurons but only transiently by principal cells of the neocortex and 
hippocampus [47,48].  The transient expression of Ca2+-permeable AMPARs by 
principal cells is thought to be a mechanism of synaptic scaling – in this case, a 
sensitization of the post-synapse in response to a loss of synaptic activity [47].  
Synaptic scaling by Ca2+-permeable AMPARs can also occur pathologically.  For 
example, hippocampal pyramidal neurons that are vulnerable to either ischemic or 
epileptogenic injury show an increased proportion of GluR2-lacking AMPARs in 
response to that particular injury [49].  This change in AMPAR composition may help to 
explain the pattern of neuronal death following ischemia [48].  However, it is unclear to 
what extent the cell death involves Ca2+ permeability, Zn2+ permeability, or other GluR2-
related issues [50,51].  In fact, studies of transgenic mice have suggested that the Ca2+ 
conducted by Ca2+-permeable AMPARs may not be directly toxic [52,53].  Instead, 
Ca2+-permeable AMPARs may cause problems by facilitating the long-term potentiation 
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(LTP) of excitatory synapses [52].  Such synaptic scaling could promote 
hyperexcitability in neuronal networks and so indirectly contribute to pathology [54]. 
 
Kainate Receptors 
Similar to the AMPAR, the post-synaptic kainate receptor contributes to 
membrane depolarization and exhibits subunit-dependent Ca2+ permeability [55]. 
However, at least in the hippocampus, the composition and function of post-synaptic 
kainate receptors appear to be region-specific [55,56].  Furthermore, kainate receptors 
appear to be expressed at specific types of synapses within these regions.  For 
example,  pyramidal neurons in hippocampal CA3 express post-synaptic kainate 
receptors almost exclusively on thorny excrescences [56], multi-lobed spines found at 
the synapses between mossy fibers and CA3 pyramidals [57].   
Both kainate receptors and AMPARs can indirectly generate an influx of Ca2+ into 
the dendritic spine in a number of ways.  First, membrane depolarization by AMPARs 
and/or kainate receptors is essential to the activation of NMDA receptors, a principal 
source of spine Ca2+ (see below).  This depolarization may also open local voltage-
sensitive Ca2+ channels (VSCCs) [58].  These VSCCs appear to enhance or support 
plasticity at hippocampal synapses [58], though the role of VSCCs in the pathological 
plasticity of dendritic spines is not yet known.  Finally, kainate receptors and AMPARs 
may conduct enough Na+ to reverse the flow of local Na+/Ca2+ transporters, resulting in 
an inward Ca2+ current across those transporters [59].  However, there is conflicting 
evidence over the role of Na+/Ca2+ transporters in neuronal excitotoxicity [59,60].   
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NMDA Receptors 
The NMDA receptor (NMDAR) is a major conduit of Ca2+ into dendritic spines 
throughout the neocortex and hippocampus [30].  Like the AMPAR and the kainate 
receptor, the NMDAR exhibits activity-dependent permeability to Na+ and K+ and 
subunit-dependent permeability to Ca2+ [61].  However, the Ca2+ permeability of the 
NMDAR can be 20 times greater than that of the other ionotropic glutamate receptors 
[62] and is far less dependent on subunit composition [63].  The subunit composition of 
the NMDAR does, however, determine its inactivation time and other functional 
properties that affect the size of its Ca2+ current [63,64].  Also unique among the 
ionotropic glutamate receptors, activation of the NMDAR requires the co-incidence of 
multiple events: binding of glutamate; binding of a co-agonist, such as glycine or D-
serine; and a depolarization of the local membrane sufficient to dislodge the Mg2+ ion 
which normally occludes the NMDAR ion channel.  
NMDARs play a central, well-characterized role in neuronal excitotoxicity [65].  
Selective agonists of NMDARs can cause excitotoxicity in vitro, and glutamate-induced 
excitotoxicity is mostly blocked by NMDAR-selective antagonists (e.g., [66]).  Similarly, 
NMDAR antagonists have proven to be neuroprotective in models of stroke and 
traumatic brain injury in vivo [67,68], suggesting that NMDAR activity can be neurotoxic.  
This NMDAR toxicity appears to be largely Ca2+-dependent, as cell-permeable Ca2+ 
chelators are neuroprotective during excitotoxicity in vitro and in vivo [69].  
Many studies have demonstrated that high intracellular Ca2+ concentrations are 
neurotoxic [32,70].  Yet, the amount of Ca2+ does not solely determine its toxicity. For 
instance, excitotoxic NMDAR activity can generate high intracellular concentrations of 
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Ca2+, but an equivalent concentration of Ca2+ achieved with ionophores is not toxic to 
neurons in vitro [71].  The particular toxicity of NMDAR-mediated Ca2+ may be explained 
in a number of ways.  One possibility is that NMDARs conduct Ca2+ into a diffusion-
limited space, the head of the dendritic spine, thereby creating toxic foci of highly 
concentrated Ca2+.  However, this seems unlikely to explain the toxicity of NMDAR-
mediated Ca2+: excitotoxicity can still occur by NMDA receptors expressed on the 
dendritic shaft, a space which is less diffusion-limited [72].  Another, more likely 
possibility is that the toxicity relates to the special environment of the NMDAR, e.g., its 
neighboring clusters of Ca2+-sensitive proteins and their effector pathways.   
 
Calcium Nanodomains 
The NMDAR-mediated Ca2+ current is a principal determinant of dendritic spine 
plasticity.  This Ca2+ activates pathways which antagonistically control the size and 
shape of the dendritic spine as well as the expression and sensitivity of post-synaptic 
glutamate receptors [28].  The underlying pathways are mediated by Ca2+-sensitive 
proteins anchored near NMDARs at the post-synaptic density [73], which suggests a 
competition among these pathways for the Ca2+ signal [7].  Yet, the size of the Ca2+ 
influx does not alone determine which Ca2+ sensitive proteins are activated [39].  Other 
important variables may be involved, including the Ca2+ sensitivity of the protein, its 
proximity to the Ca2+ signal, and any post-translational modifications of the protein due 
to cross-talk with other pathways.  These variables are part of the “nanodomain,” the 
nano-scale environment in which a Ca2+ influx becomes an intracellular signaling event.  
In the dendritic spine, Ca2+ nanodomains may decide the outcome in the competition 
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between Ca2+-sensitive pathways [74], ultimately determining whether LTP or LTD 
occurs, whether the spine grows or shrinks, and so on. 
Ca2+ nanodomains may also influence the neuronal response to excitotoxicity 
[75].  For example, in vitro studies have demonstrated that toxicity of Ca2+ depends 
more on the source than on the amount of Ca2+ [71,76].  This “source specificity” of Ca2+ 
toxicity [75] may be related to proximity of Ca2+-sensitive elements, such as 
mitochondria and apoptotic signaling pathways [77].  
Other Ca2+-sensitive elements of the nanodomain may determine different 
neuronal responses to excitotoxicity.  One response in particular, the collapse of 
dendritic spines, is associated with a variety of excitotoxic brain injuries in humans and 
the relevant animal models [78,79].  But the collapse of dendritic spines may be more 
than a symptom of neuronal excitotoxicity; spine collapse potentially could contribute to 
injury-related pathology, such as cognitive impairment or epilepsy [78].  For this reason, 
a better understanding of dendritic spine collapse can be instructive in the treatment of 
brain injury.  Research over the past decade has revealed a variety of biochemical 
mechanisms to explain dendritic spine collapse following brain injury.  The following 
section is a review of four such mechanisms.  
 
Post-Synaptic Mechanisms of Dendritic Spine Collapse 
Dendritic Beading 
In the late 1970’s, James Olney and colleagues reported kainic acid caused 
spherical swellings in neuronal dendrites [80].  Similar swellings had been described by 
Santiago Ramon y Cajal in 1909, but their etiology remained unknown for nearly a 
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century.  The formation of these varicosities, known as dendritic beading [78], is now 
generally regarded as an early and reversible sign of neuronal excitotoxicity [81].  
Dendritic beading is commonly observed following brain injuries, especially those in 
which excitotoxicity is involved, such as epilepsy [78,82], stroke [83,84], and traumatic 
brain injury [85,86,87].  Dendritic beading can be induced by a variety of experimental 
conditions, including treatment with ionotropic glutamate receptor agonists 
[84,88,89,90], ischemia [91,92,93,94], activation of microglia [95], or by cooling [96,97].  
Interestingly, neuronal degeneration is worsened when experimental conditions prevent 
dendritic beading, suggesting that the beading may be a neuroprotective response [90] 
(but see also [98]).  
Two mechanisms are independently sufficient to induce dendritic beading: an 
osmotic shift involving ligand-gated and voltage-sensitive ion channels, and a Ca2+-
dependent disruption of dendritic cytoskeleton.  The osmotic shift begins with an influx 
of ions into the dendrite, first through ionotropic glutamate receptors [80,84,89,90,94] 
and then through voltage-sensitive sodium [99,100,101] and chloride channels [98].  
Eventually, the influx of ions outstrips their efflux through the Na+/K+ pump [102] and 
other means of extrusion, resulting in hyperosmotic foci within the dendrite.  These foci 
draw fluid from neighboring segments of dendrite and/or from the extracellular 
environment [93], producing the characteristic appearance of spherical swellings 
separated by narrowed segments of dendrite [96,102].  
Interestingly, the NMDAR-mediated Ca2+ current does not contribute substantially 
to the osmotic shift [89,99,102].  This may be due to Ca2+ uptake and buffering within 
the dendrite, which would minimize the effect of Ca2+ on osmolarity.  However, the Ca2+ 
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influx does induce a different mechanism of dendritic beading, one in which Ca2+-
sensitive enzymes lead to the disruption the dendrite cytoskeleton.  Evidence for this 
mechanism comes from reports of fragmented microtubules in electron micrographs of 
dendritic beads [96] and in neurons during excitotoxicity [103].  These microtubules are 
normally stabilized by the binding of microtubule associated protein 2 (MAP2) [104,105].  
However, a dramatic loss of MAP2 occurs with excitotoxicity in vivo [106] and is 
attributed to Ca2+ signaling [103,107].  The loss of MAP2 and dendritic beading can both 
be prevented by the microtubule-stabilizing drug, taxol, in an acute hippocampal slice 
model of excitotoxicity [103].  Conversely, beading is induced when microtubules are 
destabilized by various agents, including nocodazole, platelet activating factor, or 
methyl-carbamyl platelet activating factor [108].  
Microtubule disruption may explain the Ca2+-dependent form of dendritic beading 
observed in the literature [96,103,107,109].  Unlike the beading induced by the osmotic 
shift, these Ca2+-dependent beads are smaller in diameter [96] and more irregular in 
form [107].  Since Ca2+-dependent and -independent (i.e., osmotic shift) forms have 
both been reported, the literature contains some disagreement over the etiology of 
dendritic beading.  However, at least some conflicting reports may be explained by 
differences in experimental design.  For example, dendritic beading tends to be Ca2+-
dependent when induced by NMDAR agonists [96,103,107] and Ca2+-independent 
when induced by agonists of other, less Ca2+-permeable glutamate receptors 
[80,89,99,101,106].  The Ca2+-dependent form of dendritic beading has also been 
observed in kainic acid-treated Purkinje neurons [109].  Because mature Purkinje cells 
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lack NMDARs [110], this beading likely involves voltage-sensitive Ca2+ channels 
opened upon membrane depolarization by kainate receptors/AMPARs.  
Though both Ca2+-dependent and -independent mechanisms can be induced 
experimentally, both likely contribute to the dendritic beading observed in injured brains.  
In fact, their effects appear to be complementary: Ca2+-dependent dendritic beads have 
an irregular, oblong shape [96,107], similar to Ca2+-independent beads induced in the 
presence of a voltage-gated calcium channel blocker [101].  Therefore, the spherical 
shape of dendritic beads observed in vivo seems to require both Ca2+-dependent and -
independent mechanisms.  
Dendritic beading is associated with a significant loss of dendritic spines, up to 
50% on affected segments of dendrite [88].  Yet, most of this spine loss is only an 
apparent loss. Just as the fingers of a rubber glove are absorbed upon its inflation, 
dendritic spines may be engulfed by the swelling dendrite.  However, within a few hours 
of a brief excitotoxic challenge, the dendritic beads gradually resolve and most of their 
spines re-emerge [84,88,97].  Importantly, this temporary spine loss does not appear to 
disrupt spine synapses.  In vitro and slice culture studies have found that, while some 
synapses are lost in the process, most retracted spines re-emerge at their original sites 
[88,97].  Time-lapse imaging of mouse cortical neurons in vitro shows that pre- and 
post-synaptic components remain apposed during NMDA-induced spine collapse [88].  
Therefore, synapses on collapsed spines may remain intact during brief excitotoxic 
challenges.  
While the loss of dendritic spines during beading may be superficial and 
temporary, other mechanisms underlie more chronic spine loss as well as the 
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elimination of spine synapses.  These mechanisms are all Ca2+-dependent and their 
actions may be complementary.  Interestingly, at least two of these mechanisms are 
mediated by the Ca2+-sensitive phosphatase, calcineurin. 
 
Calcineurin-Mediated Cofilin Activation 
Calcineurin is a neurally-enriched, serine/threonine phosphatase which is 
stimulated upon its binding Ca2+/calmodulin [111,112,113].  Calcineurin is expressed by 
every cell type in the brain, though its role in neurons has been particularly well-
characterized.  In fact, neuronal calcineurin appears to play a variety of roles in synaptic 
plasticity [114].  Notably, calcineurin is essential for the induction of long-term 
depression (LTD) at synapses in some hippocampal regions [115,116], where it 
regulates functional aspects of LTD, including the desensitization and endocytosis of 
post-synaptic AMPA receptors [21,117].  Furthermore, calcineurin is involved in the 
structural plasticity of dendritic spines: it is responsible for the shrinkage of dendritic 
spines associated with the induction of LTD [23], and for the collapse of dendritic spines 
following excitotoxic injury [11,118].  Though many details are still under investigation, a 
number of candidate pathways linking calcineurin activity to dendritic spine collapse 
have been identified.  One such pathway involves proteins of the actin depolymerizing 
factor (ADF)/cofilin family (cofilin).  
Cofilin binds and severs actin filaments (F-actin) and accelerates their 
depolymerization [119].  Since actin filaments are the major cytoskeletal element in the 
dendritic spine [120,121], actin breakdown by cofilin can destabilize the spine 
cytoskeleton, resulting in spine shrinkage [23] or even collapse.  Indeed, the distribution 
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of cofilin fits with its role in the remodeling of dendritic spines.  Cofilin is distributed 
heterogeneously in the dendritic spine, found abundantly in the PSD and the spine 
periphery but is mostly absent from the spine core [122].  This distribution overlaps the 
outer edges of the spine’s more dynamic actin network, a pool of F-actin that rapidly 
responds to glutamate stimulation [123].  Therefore, the co-localization of cofilin with 
this dynamic pool of actin is consistent with the role of cofilin in spine remodeling. 
Like many proteins in the dendritic spine, the activity of cofilin is regulated by 
phosphorylation.  In the case of cofilin, its activity depends on the phosphorylation state 
of a key amino acid residue, serine 3 (ser3).  Phosphorylation of ser3 decreases the 
ability of cofilin to bind (and therefore sever) actin filaments [119].  Ser3 phosphorylation 
is catalyzed by LIM kinases [124,125,126,127,128].  In turn, LIM kinase activity depends 
on the signaling cascades of the Rho, Rac and Cdc42 family of small GTPases 
[129,130], some of which are influenced by Ca2+-sensitive pathways that begin at the 
NMDA receptors.  Therefore, NMDA receptors may be linked to cofilin inactivation by 
Ca2+-dependent pathways involving the small GTPases (e.g., Rac1 and Ras) and LIM 
kinase.  
NMDA receptors are also linked to cofilin activation by a different Ca2+-sensitive 
pathway, one mediated by calcineurin.  This is because calcineurin dephosphorylates 
and thereby activates Slingshot [131], a family of cofilin phosphatases [132,133] which 
are enriched in neurons [134] and which localize to dendritic spines [135].  Slingshot 
then dephosphorylates the cofilin ser3 residue [132], which increases the binding and 
breakdown of F-actin by cofilin [119].  Thus, NMDA receptor activity can stimulate cofilin 
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via a calcineurin-Slingshot pathway, or inactivate cofilin via a small GTPase-LIMK 
pathway. 
The calcineurin-Slingshot pathway is one mechanism which couples NMDAR 
activity with cofilin activity.  Indeed, cofilin activation is associated with spine shrinkage 
following low frequency stimulation of NMDARs (i.e., LTD) [23] and with spine collapse 
following excessive stimulation of NMDARs (i.e., excitotoxicity) [118].  Yet, frequencies 
of NMDAR activation that induce long-term potentiation (LTP) also cause cofilin 
inactivation and spine growth [24,136].  So, how could LTP-inducing frequencies 
inactivate cofilin, while lower and higher frequencies have just the opposite effect? One 
possibility is that there are multiple, cofilin-activating pathways which differ in Ca2+ 
sensitivity.  For example, cofilin activating pathways may be either very sensitive or very 
insensitive to Ca2+, such that only excitotoxic levels of Ca2+ could induce both types of 
pathways, which together overwhelm the opposing pathways, resulting in cofilin 
activation. 
An alternative but not exclusive possibility is that cofilin does not work alone in 
the collapse of dendritic spines.  In fact, the effect of cofilin on F-actin can be simulated 
with latrunculin A, a drug which inhibits actin polymerization [137].  Yet, treating cultured 
neurons with latrunculin A does not entirely reproduce the spine collapse associated 
with NMDA excitotoxicity [72,138].  Wispy, filopodia-like structures remain.  These 
structures, termed “spine remnants” [138,139,140], have been offered as evidence that 
the dendritic spine is bolstered by the proteins contained within, not just by the spine’s 
cytoskeleton [140].  Indeed, each dendritic spine contains a dense network of proteins 
[9] which may suffice to stabilize the spine in vitro.  However, it remains to be seen 
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whether this protein netowrk is enough to prevent collapse in the more densely packed 
in vivo environment, where the spine is likely subject to greater external pressures.  
Nonetheless, recently published in vitro studies have demonstrated the critical role of 
two proteins in dendritic spine stability, and in doing so, identified novel mechanisms of 
dendritic spine collapse.  These mechanisms involve intracellular pathways that extend 
far beyond the dendritic spine, even one that reaches to the cell nucleus and back. 
 
Snk-Mediated SPAR Proteolysis 
Another intracellular event associated with spine collapse is the proteolysis of 
SPAR, the spine-associated Rap guanosine triphosphatase activating protein 
[12,141,142].  SPAR is a 190kDa protein with separate binding sites for actin and post-
synaptic density (PSD) proteins, and a guanosine triphosphatase activating protein 
(GAP)-like domain [12].  SPAR is localized to the dendritic spine, where the binding and 
catalytic domains of SPAR suggest its involvement in cytoskeletal regulation.  For 
example, its binding domains may allow SPAR to physically bridge the post-synaptic 
density to the spine cytoskeleton [141], which could stabilize the spine.  Additionally, its 
catalytic domain allows SPAR to inactivate two functionally distinct [143] cytoskeletal 
regulating members of the Ras family of small GTPases [144]: Rap2 and, to a lesser 
extent, Rap1 [141]. 
Clues to the role of SPAR in the dendritic spine have emerged from experiments 
which altered SPAR protein expression.  One study found that SPAR re-organizes 
cytoskeletal actin when expressed in COS-7 cells, and that SPAR over-expression 
induces spine growth in cultured hippocampal neurons [141].  Another study reported 
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that RNAi knockdown of SPAR weakened post-synaptic responsiveness to glutamate in 
cultured hippocampal neurons [145].  These studies suggest that SPAR stabilizes both 
structural and functional aspects of the dendritic spine. 
Excitotoxic insult causes a loss of SPAR in vitro, which correlates with a loss of 
dendritic spines and of the major PSD scaffold protein, PSD-95 [12,142].  This 
excitotoxic depletion of SPAR requires the following: a Ca2+ influx mediated by NMDA 
receptors and/or voltage gated Ca2+ channels; the activation of calcineurin; and a 
downstream increase in the transcription of serum inducible kinase, Snk (also known as 
polo-like kinase 2) which upregulates Snk protein expression [12].  Snk then 
phosphorylates SPAR, targeting it for ubiquitination and subsequent proteolysis 
[12,145,146]; the proteolysis likely occurs by proteosomes transported into the spine in 
response to NMDA receptor activity [147].  Despite its dependence on nuclear events, 
SPAR depletion can be detected within a few hours of excitotoxic insult.  For example, 
in cultured hippocampal neurons, a significant loss of SPAR protein is observed from 3 
hours to over 72 hours after exposure to glutamate [142].  This degradation of SPAR is 
matched in timing and magnitude by an increase in Snk protein levels [142].  
Loss of SPAR also corresponds to a decrease in miniature excitatory post-
synaptic currents (mEPSCs) [145].  This post-synaptic desensitization has led to the 
hypothesis that SPAR proteolysis is a mechanism of synaptic scaling (for review, see 
[148]) – in this case, a homeostatic reduction of synaptic activity in response to 
excessive synaptic activity [145].  This synaptic scaling may be a neuroprotective 
mechanism deployed in response to excitotoxicity.  However, it is not yet understood 
how SPAR proteolysis is able to downscale post-synaptic activity.  One possibility is that 
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the related loss of PSD-95, an important scaffold protein of the post-synaptic density, 
disrupts the clustering of NMDA receptors at the post-synaptic density.  The dispersal of 
synaptic NMDARs does correspond to increased resistance to excitotoxicity in another 
in vitro model [72]. 
Another possibility is that the collapse of the dendritic spine physically separates 
the pre- and post-synaptic components.  This spine collapse may be due to the loss of 
SPAR as either a structural protein or as a negative regulator of the GTPase Rap2.  
Constitutively active Rap2 causes a loss of dendritic spines and spine synapses in 
cultured neurons [143]; a similar outcome may occur when proteolysis of SPAR 
releases Rap2 from negative regulation.  Future studies could test this hypothesis by 
transfecting neurons with a mutant SPAR lacking an inactive RapGAP domain.  More 
investigation is needed to appreciate the relationship between the Snk-SPAR pathway 
and excitotoxic spine collapse.  
 
MARCKS Proteolysis 
SPAR degradation is not the only proteolytic event associated with the 
excitotoxic collapse of dendritic spines.  The targeted degradation of another spine 
protein, myristoylated alanine-rich C-kinase substrate (MARCKS), is also activity-
dependent and linked to dendritic spine collapse [138].  MARCKS is expressed 
heterogeneously across the neocortex and subcortical structures, and enriched in 
neuronal processes [149].  MARCKS is also found in some dendritic spines [149], 
though its function there is not completely understood.  Yet, recent evidence implicates 
MARCKS in the activity-dependent plasticity of dendritic spines [150,151,152,153], 
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where it is thought to integrate converging signals from protein kinase C (PKC) and 
Ca2+/calmodulin [154].  When neither phosphorylated by PKC nor bound by calmodulin, 
MARCKS adheres to the cell membrane and promotes the growth of the actin network, 
potentially by sequestering phospholipids which affect actin dynamics [155].  
Furthermore, by physically anchoring the cytoskeleton to the cell membrane, MARCKS 
may stabilize dendritic structure [156].  Therefore, the loss of MARCKS can limit the 
growth and anchorage of the actin cytoskeleton, which may destabilize dendritic spines. 
Experimental depletion of MARCKS in vitro has revealed its importance to the 
stability of dendritic spines.  For example, spine density and size are significantly 
decreased following RNA interference of MARCKS protein expression in cultured 
hippocampal cells [150].  MARCKS protein levels and spine density are also reduced 
following exogenous activation of PKC [150], suggesting that PKC phosphorylation may 
target MARCKS for proteolysis.  PKC is active during NMDA-induced excitotoxicity 
[157,158], which may explain the extensive proteolysis of MARCKS under those 
conditions.  Indeed, within 10 minutes of a 30 second treatment with 50μM NMDA, 
MARCKS protein is reduced by nearly 50% and spine density by roughly 75% in 
cultured hippocampal neurons [138].  Strikingly, all of the MARCKS proteolysis and 
nearly half of the spine loss were blocked by inhibitors of cathepsin B/L [138], cysteine 
proteases for which MARCKS is a known substrate [159].  Considered together, these 
observations support a mechanism of dendritic spine collapse as follows: excessive 
NMDA receptor activity leads to MARCKS phosphorylation by PKC and subsequent 
proteolysis by cathepsin B/L; the loss of MARCKS protein inhibits actin growth and/or 
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disconnects the cytoskeleton from the plasma membrane, which progressively 
destabilizes and ultimately collapses the dendritic spine.  
The Snk-SPAR pathway is one putative mechanism of synaptic scaling, could 
MARCKS proteolysis be another?  One recent publication found that MARCKS 
proteolysis is associated with the post-ischemic development of NMDA tolerance.  In 
this study, cultured neocortical neurons were deprived of glucose and oxygen for 30 
minutes.  One hour later, these neurons showed a 23% loss of MARCKS protein, a 
transient, 75% reduction in dendritic spine density, and a similarly transient tolerance to 
NMDA-induced excitotoxicity [151].  Treatment with the actin-stabilizing compound, 
jasplakinolide, blocked both the dendritic spine loss and NMDA tolerance, as did 
treatment with proteosome inhibitors that preserved MARCKS protein levels* [151].  
Therefore, the spine loss and NMDA tolerance required both proteolysis and the 
breakdown of the actin cytoskeleton.  Yet, it is unclear just how NMDA tolerance is 
related to these other phenomena.  One possibility is that proteolytic events (e.g., 
MARCKS) drive the breakdown of the spine cytoskeleton, which destabilizes the spine 
and disperses glutamate receptors and/or related signaling proteins from the post-
synaptic region.  If the dispersal of signaling proteins affected signal reception or 
processing, this could explain the decreased response of these post-ischemic neurons 
to NMDA treatment.  Consistent with this scenario, the authors reported that brief 
ischemia decreased the actin binding of two important post-synaptic proteins, the 
NMDA receptor subunit NR2B, and PSD-95, but did not affect their protein expression 
                                                 
*
Curiously, one of the proteosome inhibitors, MG132, was ineffective in blocking MARCKS proteolysis in 
the study by Graber et al. (2004). However, the Graber study induced excitotoxicity with NMDA, not 
ischemia. Therefore, the discrepancy between the two studies may be explained by differences in 
experimental design.   
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[151].  These observations suggest that post-synaptic proteins detach from the spine 
cytoskeleton following brief ischemia, which could disperse the signaling proteins and 
reduce their responsiveness to subsequent signals. 
Dendritic spine collapse may protect the parent neuron at the expense of the 
neuronal network.  The resulting disruptions in network activity or connectivity could 
contribute to the cognitive impairment which follows injury, and may even facilitate the 
development of epilepsy . The next section considers traumatic brain injury, a common 
form of brain injury which is associated with both dendritic spine loss and epilepsy. 
 
Traumatic Brain Injury and Post-Traumatic Epilepsy 
Traumatic brain injury (TBI) occurs when the brain is damaged by external 
forces, such as impact, penetration, blast, or a sudden change in velocity.  TBI occurs 
approximately every 19 seconds in the United States and is a leading cause of 
morbidity and mortality, resulting in more than 1.3 million hospitalizations and more than 
50,000 deaths in the U.S. each year [160].  Those that survive TBI often face lifelong 
impairments and other complications [161] which incur lifelong costs in quality of life, 
productivity, and medical care.  Indeed, the personal, financial, and societal costs of a 
single TBI can last for decades, since TBI predominantly affects children and young 
adults [160].  The high incidence and chronic costs make TBI one of the most expensive 
diseases in the U.S., estimated at $60 billion dollars in the year 2000 alone [162].   
One significant complication of TBI is post-traumatic epilepsy. This form of 
acquired epilepsy is characterized by spontaneous, recurrent seizures which begin 
weeks to years after TBI.  Epilepsy is a common consequence of TBI, diagnosed in 2-
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25% of TBI survivors [163,164].  Conversely, TBI is a common cause of epilepsy, 
accounting for about 5% of all cases of epilepsy in the general population [165].  Most 
post-traumatic epileptics exhibit partial seizures as the dominant seizure type (91% 
cases), originating in either the temporal lobe (54% cases) or in the frontal neocortex 
(33% cases) [166,167].  Though conventional anti-seizure drugs are indicated for its 
treatment, post-traumatic epilepsy is often refractory to drugs and surgery [168,169].  
Though difficult to treat, post-traumatic epilepsy may be preventable, as the latency 
between TBI and seizure onset suggests a wide window for therapeutic intervention.  
While efforts to prevent human post-traumatic epilepsy have so far been disappointing 
[170], hope has emerged from research in rodent models of the disease [171]. 
Several models of closed-head injury, the predominant form of human TBI, have 
been adapted for studying post-traumatic epilepsy.  In two of these models, the cortical 
contusion model and the fluid percussion model, rats and mice subjected to a laterally-
placed TBI develop spontaneous, recurrent seizures within weeks to months 
[172,173,174,175].  However, the mechanisms which lead from TBI to seizures in these 
models have not been identified.  Nor is it known when these mechanisms are initiated, 
though some studies of humans and rodent models suggest that epileptogenesis begins 
within minutes of TBI [176,177].  A better understanding of the mechanisms and timing 
of epileptogenesis are essential to developing prophylactic treatments for post-traumatic 
epilepsy. 
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CHAPTER I 
TRAUMATIC BRAIN INJURY CAUSES AN FK506-SENSITIVE LOSS AND AN 
OVERGROWTH OF DENDRITIC SPINES 
 
INTRODUCTION 
Survivors of traumatic brain injury (TBI), most of whom are young adults, often 
suffer lifelong disabilities. The devastating consequences of TBI derive in part from its 
progressive nature: the immediate, mechanical destruction of tissue can be followed by 
days to weeks of excitotoxic and inflammatory damage [178,179]. This cumulative injury 
can alter neural function well beyond the focally-damaged tissue and so may contribute 
to TBI-induced neuropathologies, such as cognitive impairment and post-traumatic 
epilepsy. Animal modeling of TBI has revealed that cognitive impairment can occur in 
the absence of cell death (e.g., [180]) and that the onset of PTE can be many months 
after TBI [181]. It is therefore likely that cognitive impairment and PTE develop from 
disruptions in neural circuitry beyond the acute loss of cells. A better understanding of 
how TBI disrupts neural circuitry should uncover novel therapeutic targets for treating 
TBI-induced neuropathologies. 
One potential mechanism of disrupted neural circuitry may be the loss of 
dendritic spines. Dendritic spines are specialized protuberances of dendritic membrane 
which form the post-synaptic component of most excitatory synapses in the brain [5]. 
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The stability of the dendritic spine depends on synaptic activity [182]. Indeed, the loss of 
its pre-synaptic partner can cause the spine to retract into the dendritic shaft [16], and 
spine collapse due to deafferentation is a well-characterized phenomenon. However, an 
excess of synaptic activity can also cause spine collapse, through the toxic excitation of 
glutamate receptors [84]. Multiple post-synaptic mechanisms linking excitotoxicity to 
dendritic spine loss have been proposed and demonstrated in vitro (reviewed in [183]). 
Interestingly, at least two of these mechanisms are mediated by the calcium-sensitive 
phosphatase, calcineurin (CaN) [11,12]. Since CaN is activated by glutamate signaling 
[184] and glutamate signaling occurs to excess after TBI [185], it is plausible that an 
increase in CaN activity leads to dendritic spine loss after TBI.   
Here we report an extensive analysis of dendritic spine density in the laterally 
injured brain. In addition, this study and its companion [186] present evidence of CaN-
dependent mechanisms by which TBI results in dendritic spine loss. In particular, this 
study describes a region-specific loss of dendritic spines which can be blocked by a 
single, post-injury injection of FK506, a pharmacological inhibitor of CaN. This spine 
loss coincides, temporally and regionally, with changes in cofilin activity observed by our 
companion study [186]. In addition, the spine loss is followed by an apparent 
overgrowth of dendritic spines in both hemispheres of hippocampus. Overall, these 
findings suggest that the rat forebrain undergoes an extensive turnover of dendritic 
spines during recovery from lateral brain injury, which may participate in the 
development of cognitive impairment and post-traumatic epilepsy. Furthermore, these 
findings identify CaN as a potential therapeutic target in the treatment of TBI. 
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MATERIALS AND METHODS 
Animal Use and Care 
Use of animal subjects was performed in strict accordance with the Guide for the 
Care and Use of Laboratory Animals, provided by the National Institutes of Health, and 
approved in advance by the Virginia Commonwealth University Institutional Animal Care 
and Use Committee. Animal subjects received ad libitum access to food and water and 
were maintained on 12hr light/dark cycles throughout the experiment.  
 
Surgical preparation and fluid percussion injury  
Adult male Sprague-Dawley rats (90 day old; 350-400g; n=21) were anesthetized 
with sodium pentobarbital (54 mg/kg intraperitoneally; i.p.) and placed into a stereotactic 
frame. A 4.8-mm hole was made over the left hemisphere using a trephine centered 
4mm caudal to bregma and -3mm lateral to the sagittal suture. A screw was inserted 
over the opposite hemisphere to anchor the skull attachments. A modified female Luer-
Loc syringe hub (2.6mm inside diameter) was placed over the exposed dura, affixed 
with a cyanoacrylate adhesive, and then secured with dental acrylic. On the following 
day, subjects were anesthetized (4% isoflurane in a carrier gas mixture of 26% N2O and 
70% O2) in a chamber, then removed from the chamber and immediately subjected to 
fluid percussion of the intact dura over their left parietal cortex. The fluid percussion 
device used in these experiments is identical to that described by Dixon and colleagues 
[187]. The Luer-Loc fitting, screw, and dental cement were removed from the skull 
immediately following injury. Subjects were then placed in a supine position and the 
time at which they righted themselves was recorded. Upon recovery of righting reflexes, 
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subjects were placed on a heating pad for at least 30 minutes (and up to 1 hour) until 
ambulatory, then returned to home cages and monitored daily. At 1hr post-injury, some 
subjects received a single intraperitoneal injection of FK506 (5mg/kg; Fujisawa 
Chemical Company, Osaka, Japan).  
 
Golgi-Cox histology and light microscopy 
At 1hr, 24hr, and 1wk after lateral fluid percussion injury, subjects were injected 
with a lethal dose of pentobarbital, perfused intracardially with saline (0.9%, 120mL, 
room temperature), and decapitated. Brains were quickly extracted and immersed into a 
Golgi-Cox staining solution prepared from a commercially-available kit (FD Rapid 
Golgistain Kit, FD Neurotechnologies, Inc., Baltimore, MD, U.S.A.). After 24hr of 
staining, brains were blocked to remove tissue rostral and caudal to the hippocampus, 
immersed in fresh staining solution, and stored at room temperature in the dark for a 
total of 2 weeks. The remainder of the staining procedure was performed according to 
the kit instructions.  
Following the staining procedure, brains were cut into 200μm thick coronal 
sections using a vibratome (Leica, Wetzler, Germany). Sections were mounted onto 
2%-gelatin coated slides and air-dried at room temperature in the dark overnight. Slide-
mounted sections were developed and dehydrated according to the kit instructions, and 
coverslipped with Permount.  
Three brain sections nearest the injury site were selected for further analysis. 
Golgi-impregnated principal cells from the following regions were assessed for dendritic 
spine density: layers II and III of parietal neocortex penumbral to the site of injury 
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(“ipsilateral neocortexII,III”) and an analogous area of the contralateral hemisphere 
(“contralateral neocortexII,III”); the pyramidal cell layer of the hippocampal subfields CA1 
and CA3 in each hemisphere; and the granule cell layer of the dorsal leaf of the dentate 
gyrus (dDG; Figure 1) in each hemisphere. Brain region identification was aided by a 
standard atlas of the rat brain [188]. Golgi-stained principal cells were then visualized by 
light microscope (Nikon Optiphot-2, Nikon Optiphot, Melville, NY, U.S.A.). Under a 40x 
objective lens, pyramidal and granule neurons were identified by their location within 
cell layers and by the shape of their soma and dendritic arbor. Dendrites were 
visualized using a 100x/oil-immersion lens for manual tracing and dendritic spine 
quantification. 
 
Dendrite tracing and dendritic spine quantification 
To ensure consistency of sampling, the following inclusion criteria were applied. 
The dendrite sampled had to be (1) a second- or third-order branch, (2) within 30μm-
150μm of the parent cell soma (as measured along the dendrite; “proximal”) (3) not 
obscured by other Golgi-stained tissue, (4) showing no signs of degeneration which 
would interfere with spine quantification (i.e., blebbing or beading of the proximal 
dendrite), and (5) connected to a soma which did not appear swollen or necrotic.   
For each group of animals, at least 10 neurons per brain region per hemisphere 
were included in the analysis (for n values, see Table 1). Fully-stained principal neurons 
within each region of interest were first selected under minimal magnification (4x 
objective). Under high magnification (100x oil-immersion objective), selected neurons 
were then screened according to the inclusion criteria described above. For each 
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neuron, one proximal branch of dendrite was traced to a minimum length of 20μm. With 
regard to granule cells of the dDG, only dendrites oriented dorsolaterally were analyzed. 
Dendrites were traced through the x-, y-, and z-planes using a digitizing microscope 
stage under control of Neurolucida (MicroBrightField, Inc., Williston, VT, U.S.A.). The 
lengths of tracings were computed by Neurolucida Explorer software (MicroBrightField, 
Inc.). Along each traced segment of dendrite, dendritic spines were counted according 
to their morphology [189,190]: thin spines and mushroom-shaped spines were counted 
together as “pedunculated spines,” whereas spines lacking a neck constriction (e.g., 
stubby spines and filopodia-like spines) were counted as “non-pedunculated spines” 
(Figure 2). Spine density was calculated as the number of spines visible along a traced 
segment of dendrite, divided by the length of the traced segment. No correction was 
made for spines not seen due to the angle or plane of section.  
 
Statistical analyses  
Mean spine densities in injured brains were statistically compared to those from 
the corresponding dendritic arbor and brain region of age- and drug treatment-matched 
control brains. Each mean was derived from a pool of spine densities obtained from 3 
identically-treated rats. Student’s t-tests were used to compare the FK506-treated 
injured group to the FK506-treated uninjured group, while one-way analysis of variance 
(ANOVA) with Tukey post hoc test was used for all other comparisons. Statistical 
analyses were performed with GraphPad Prism, version 5.0 (GraphPad Software, Inc., 
La Jolla, CA, U.S.A.). Comparisons generating p values less than 0.05 were considered 
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statistically significant. Data are presented as group mean ± standard error of the mean 
(SEM). 
 
RESULTS 
Lateral fluid percussion injury 
Adult male rats received a traumatic brain injury by fluid percussion of the dura 
overlying their left parietal cortex (mean pressure, 2.22 ± 0.02atm; between groups, p > 
0.05). A common correlate of injury severity is the length of time between injury and the 
recovery of righting reflexes (“righting time”) [191]. In the present study, the mean 
righting time was 8min 52sec ± 1min 31sec (n = 12)  and was not significantly different 
between groups (p > 0.05). Some subjects exhibited apnea immediately following injury 
(5 out of 12 subjects) and were mechanically ventilated as needed (mean duration of 
ventilation, 1min 32sec ± 52sec). All subjects survived the injury. 
 
Dendritic spine quantification in injured and uninjured forebrain  
To determine the effect of TBI on dendritic structure, brains were recovered 1hr, 
24hr, and 1wk after lateral fluid percussion injury (LFPI) and subjected to a modified 
Golgi-Cox procedure (see Materials and Methods). Proximal dendrites (within 30-150μm 
of soma) of Golgi-stained principal cells were manually traced (mean length of tracing ± 
standard deviation, 33.90 ± 9.43μm) and spine density was quantified, in the following 
forebrain regions: neocortexII,III penumbral to the LFPI site (“ipsilateral neocortexII,III”) 
and in an analogous region of the contralateral hemisphere (“contralateral 
neocortexII,III”); the hippocampal subfields, CA1 and CA3; and the dorsal leaf of the 
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dentate gyrus (dDG; Figure 1). Mean densities of pedunculated spines (thin spines and 
mushroom-shaped spines; Figure 2) and non-pedunculated spines (stubby spines and 
filopodia-like spines; Figure 2) are provided in a supplementary table (Table 1). Overall, 
1,264 dendrites were traced and 57,372 dendritic spines were counted. 
 
On apical dendrites in neocortexII,III, lateral fluid percussion injury caused a transient 
decrease in spine density 
Pyramidal cells in neocortexII,III receive excitatory synapses on spines throughout 
their apical and basilar dendritic arbors. To investigate the effect of traumatic brain 
injury on these dendritic spines, we began by assessing spine density on the apical 
dendrites of neocortexII,III pyramidal cells in control and laterally injured brains (Figure 
3). In control brains, neocortexII,III pyramidal cells (n=14) displayed an average of 1.20 ± 
0.08 spines/μm on proximal apical dendrites, consistent with previously published data 
[192]. This spine density included an average of 0.74 ± 0.05 pedunculated spines/μm 
and an average of 0.46 ± 0.04 non-pedunculated spines/μm. At 1hr post-LFPI, the total 
spine density of these dendrites did not differ significantly from that of controls, in 
ipsilateral or contralateral neocortexII,III (each vs. control, p > 0.05; Figure 4a). Nor was 
the pedunculated or non-pedunculated spine density of these dendrites appreciably 
different from control values, in ipsilateral or contralateral neocortexII,III (each vs. control, 
p > 0.05; Figure 4b,c).    
By 24hr post-LFPI however, apical dendrites in neocortexII,III showed a significant 
loss of spine density. Specifically, in ipsilateral neocortexII,III, the total spine density of 
these dendrites decreased by 21% relative to controls (vs. control, p < 0.05; Figure 4a). 
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Further analysis revealed an underlying change in the density of pedunculated spines: 
pedunculated spine density decreased 30% from control values (vs. control, p < 0.01; 
Figure 4b). Since the non-pedunculated spine density of these dendrites was relatively 
unchanged at this time (vs. control, p > 0.05; Figure 4c), it is likely that the loss of 
pedunculated spine density involved more than just a change in spine phenotype (i.e., 
from pedunculated to non-pedunculated). Furthermore, the effect on spine density 
appeared to be greater in the ipsilateral hemisphere. In contralateral neocortexII,III, the 
pedunculated spine density of apical dendrites decreased 14% relative to controls, a 
change which was not statistically significant (vs. control, p > 0.05; Figure 4b). Thus, the 
data indicate that by 24hr post-LFPI there is a selective loss of pedunculated spine 
density from apical dendrites in ipsilateral neocortexII,III. Because pedunculated spines 
are associated with stable synapses [193], a decrease in their density could indicate 
synaptic re-modeling in the injured brain. 
The decrease in pedunculated spine density was not permanent. By 1wk post-
LFPI in ipsilateral neocortexII,III, the pedunculated spine density of apical dendrites 
recovered to control levels (vs. control, p > 0.05; Figure 4b). Likewise in contralateral 
neocortexII,III, the pedunculated spine density of these dendrites did not differ 
significantly from control values (vs. control, p > 0.05; Figure 4b). Nor was the non-
pedunculated spine density altered relative to controls, in either hemisphere of 
neocortexII,III (vs. control, p > 0.05; Figure 4c). The data therefore describe a recovery in 
the pedunculated spine density of apical dendrites in neocortexII,III by 1wk post-LFPI.  
Overall, these results suggest that lateral TBI transiently decreased the 
pedunculated spine density of apical dendrites in ipsilateral neocortexII,III. This decrease 
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is not likely due to acute mechanical trauma, as it occurred by 24hr but not by 1hr post-
LFPI. The timing is more consistent with a secondary injury process, such as 
excitotoxicity. Importantly, these changes in post-synaptic structure could indicate 
extensive alterations of neocortexII,III circuitry in the injured brain. 
 
On basilar dendrites in neocortexII,III, spine density fluctuated during recovery from 
lateral fluid percussion injury 
Basilar dendrites in neocortexII,III were also studied in control and laterally injured 
brains. In control brains, the proximal basilar dendrites of neocortexII,III pyramidals 
(n=13) displayed 1.07 ± 0.04 spines/μm; a similar value has been reported previously 
[192]. This spine density included 0.65 ± 0.03 pedunculated spines/μm and 0.43 ± 0.02 
non-pedunculated spines/μm. Following LFPI, the spine density of these dendrites did 
not differ significantly from controls (p > 0.05). However, basilar spine density did 
change significantly across time points after LFPI, as summarized below. Micrographs 
of representative dendrites from ipsilateral neocortexII,III are also provided 
(Supplementary Figure 1). 
From 1hr to 24hr post-LFPI in ipsilateral neocortexII,III the total spine density of 
basilar dendrites decreased by 27% (1hr post-LFPI vs. 24hr post-LFPI, p < 0.001; 
Figure 5a). Further analysis revealed an underlying, 35% decrease in pedunculated 
spine density (1hr post-LFPI vs. 24hr post-LFPI, p < 0.01; Figure 5b) but no change in 
non-pedunculated spine density (1hr post-LFPI vs. 24hr post-LFPI, p > 0.05; Figure 5c), 
across these time points. In the contralateral hemisphere, a similar pattern was 
observed. From 1hr to 24hr post-LFPI in contralateral neocortexII,III, basilar dendrites 
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showed a 26% decrease in pedunculated spine density (1hr post-LFPI vs. 24hr post-
LFPI, p < 0.001; Figure 5b) while non-pedunculated spine density was relatively 
unchanged (vs. control, p > 0.05; Figure 5c). Thus, the data demonstrate that from 1hr 
to 24hr post-LFPI basilar dendrites undergo a selective loss of pedunculated spine 
density in the bilateral neocortexII,III. 
The decrease in basilar spine density was followed by an increase. From 24hr to 
1wk post-LFPI, basilar spine density increased by 35% in the ipsilateral neocortexII,III 
and by 26% in the contralateral neocortexII,III (24hr post-LFPI vs. 1wk post-LFPI, p < 
0.01; Figure 5a). Again, the underlying change was in pedunculated spine density, 
which increased by 46% in the ipsilateral neocortexII,III and by 32% in the contralateral 
neocortexII,III across these time points (24hr post-LFPI vs. 1wk post-LFPI, p < 0.001 and 
p < 0.01, respectively; Figure 5b). The non-pedunculated spine density of basilar 
dendrites did not change from 24hr to 1wk post-LFPI, however, but did increase 
significantly from 1hr to 1wk post-LFPI in the contralateral neocortexII,III (1hr post-LFPI 
vs. 1wk post-LFPI, p < 0.05; Figure 5c). The data suggest extensive remodeling of 
basilar dendritic structure in the bilateral neocortexII,III during recovery from LFPI. 
 
On apical dendrites in hippocampal CA1, lateral fluid percussion injury caused a 
delayed increase in spine density 
CA1 pyramidal cells have proximal dendrites which form spine synapses 
primarily with Shaffer collateral and commissural axons [194]. In the rat brain, these 
synapses occur throughout the proximal apical and basilar dendritic arbors of CA1 
pyramidal cells [194]. We investigated the effect of TBI on the spine density of these 
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dendrites, beginning with the apical dendrites. In control brains, the proximal apical 
dendrites of CA1 pyramidals (n=15) exhibited 1.56 ± 0.08 dendritic spines/μm, 
consistent with previously published studies [195,196]. This spine density consisted of 
0.83 ± 0.04 pedunculated spines/μm and 0.52 ± 0.05 non-pedunculated spines/μm. 
Similar to dendrites in neocortexII,III, apical dendritic spine density was not affected at 
1hr post-LFPI, in either hemisphere of CA1 (vs. control, p > 0.05; Figure 6a-c). Nor was 
there any appreciable change in spine density by 24hr post-LFPI (vs. control, p > 0.05; 
Figure 6a-c), in contrast to what was observed in neocortexII,III. However, there was a 
delayed increase in the spine density of CA1 apical dendrites, as described below. 
Micrographs of representative dendrites from ipsilateral CA1 are provided as a 
supplementary figure (Supplementary Figure 2).  
By 1wk post-LFPI, the spine density of proximal apical dendrites increased 
dramatically in both hemispheres of CA1. In ipsilateral CA1, for instance, the spine 
density of these dendrites rose by 32% relative to controls (vs. control, p < 0.001; Figure 
4a). Further analysis revealed underlying changes in pedunculated and non-
pedunculated spine density, which increased by 31% and 33% respectively, compared 
to controls (vs. control, p < 0.001 and 0.01, respectively; Figure 6b,c). Meanwhile, in the 
contralateral CA1, spine density increased by 22% relative to controls (vs. control, p < 
0.05; Figure 6a), though pedunculated and non-pedunculated spine density did not 
differ significantly from that of controls (each vs. control, p > 0.05; Figure 6b,c). Overall, 
the data indicate that LFPI causes a delayed, but substantial increase in the spine 
density of proximal apical dendrites in bilateral CA1. These changes are consistent with 
an increased density of excitatory synapses on CA1 dendrites, e.g., reactive 
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synaptogenesis [197,198], and so could have considerable implications for hippocampal 
circuitry in the injured brain.  
 
On basilar dendrites in hippocampal CA1, lateral fluid percussion injury caused a 
delayed increase in spine density 
Proximal basilar dendrites of CA1 pyramidals were also examined. In control 
brains, the proximal basilar dendrites of CA1 pyramidals (n=12) exhibited 1.48 ± 0.11 
spines/μm, similar to previously published data [196]. This total spine density included 
0.92 ± 0.08 pedunculated spines/μm and 0.56 ± 0.04 non-pedunculated spines/μm. As 
with CA1 apical dendrites, the spine density of CA1 basilar dendrites at 1hr or 24hr 
post-LFPI did not differ significantly from that of controls (ipsilateral or contralateral vs. 
control, p > 0.05; Figure 7a-c).  
By 1wk post-LFPI however, basilar dendrites in both hemispheres of CA1 
showed significant increases in spine density. In ipsilateral CA1 for example, spine 
density increased 23% relative to controls (1.82 ± 0.08 total spines/μm vs. control, p < 
0.01; Figure 7a), though neither pedunculated nor non-pedunculated spine density at 
1wk post-LFPI differed significantly from controls (each vs. control, p > 0.05; Figure 
7b,c). However, the pedunculated spine density at this time point was increased when 
compared to earlier time points, by 33% relative to 1hr post-LFPI and by 49% relative to 
24hr post-LFPI (1hr post-LFPI vs. 1wk post-LFPI, p < 0.01; 24hr post-LFPI vs. 1wk post-
LFPI, p < 0.001; Figure 7b).  
Meanwhile, in the contralateral CA1, a similar increase in spine density observed. 
Basilar dendrites in contralateral CA1 showed a 27% increase in total spine density (vs. 
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control, p < 0.05; Figure 7a), apparently driven by a 25% rise in pedunculated spine 
density (vs. control, p < 0.05; Figure 7b). Therefore, the data indicate that LFPI causes 
a delayed, but significant increase in basilar dendritic spine density bilaterally in CA1. 
As with the apical dendrites in CA1, this increase in spine density could signify the 
formation of novel excitatory circuits in the injured brain. 
 
On apical dendrites in hippocampal CA3, lateral fluid percussion injury caused a 
delayed increase in spine density 
Pyramidal cells of hippocampal CA3 form synapses with associational and 
commissural fibers on dendritic spines throughout their proximal apical and basilar 
arbors [194]. To understand the effect of LFPI on these spines, we compared apical 
dendritic spine density between control and laterally injured brains. In control brains, the 
proximal apical dendrites of CA3 pyramidals (n=10) averaged 1.24 ± 0.11 dendritic 
spines/μm, comprising 0.72 ± 0.08 pedunculated spines/μm and 0.52 ± 0.04 non-
pedunculated spines/μm. Similar to what was observed in CA1, apical dendritic spine 
density at 1hr or 24hr post-LFPI did not differ significantly from that of controls, in either 
hemisphere of CA3 (vs. control, p > 0.05; Figure 8a-c). 
As was also observed in CA1, however, LFPI caused a delayed increase in the 
spine density of apical CA3 dendrites. By 1wk post-LFPI in ipsilateral CA3, for instance, 
spine density increased 31% relative to controls (vs. control, p < 0.01; Figure 8a). 
Further analysis revealed an underlying, 33% increase in pedunculated spine density 
(vs. control, p < 0.05; Figure 8b) but no significant change in non-pedunculated spine 
density (vs. control, p > 0.05; Figure 8c), relative to controls. However, unlike what was 
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observed in CA1, the effect appeared to be limited to the ipsilateral hemisphere: in the 
contralateral CA3, spine density at 1wk post-LFPI did not differ significantly from that of 
controls (vs. control, p > 0.05; Figure 8a-c) though pedunculated spine density had 
increased 44% relative to the 24hr post-LFPI time point (24hr post-LFPI vs. 1wk post-
LFPI, p < 0.05; Figure 8b). Therefore, LFPI caused a delayed increase in the spine 
density of CA3 apical dendrites, and to a greater extent in the ipsilateral hemisphere. As 
with the neocortex and CA1, this increase in spine density could have substantial 
implications for the excitatory circuitry of the injured forebrain. 
 
On basilar dendrites in hippocampal CA3, lateral fluid percussion injury caused a 
delayed increase in spine density 
Basilar dendrites of CA3 pyramidal cells were also examined in control and 
laterally injured brains. In control brains, the proximal basilar dendrites of CA3 
pyramidals (n=12) exhibited 1.28 ± 0.09 dendritic spines/μm, which consisted of 0.73 ± 
0.05 pedunculated spines/μm and 0.55 ± 0.04 non-pedunculated spines/μm. Consistent 
with the apical dendrites in this region, the spine density of basilar dendrites at 1hr or 
24hr post-LFPI did not differ significantly from that of controls, in either hemisphere of 
CA3 (vs. control, p > 0.05; Figure 9a-c). However, these dendrites also showed a 
delayed increase in spine density, as described below. Micrographs of representative 
dendrites from ipsilateral CA3 are provided as a supplementary figure (Supplementary 
Figure 3). 
By 1wk post-LFPI, the spine density of CA3 basilar dendrites increased 
significantly above control levels in both hemispheres. In the ipsilateral CA3, for 
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example, these dendrites showed a 34% increase in total spine density, driven by a 
41% increase in pedunculated spine density (each vs. control, p < 0.01; Figure 9b). 
While non-pedunculated spine density at 1wk post-LFPI did not change significantly 
relative to controls, it did increase by 66% from 1hr post-LFPI and by 27% from 24hr 
post-LFPI (1hr post-LFPI vs. 1wk post-LFPI, p < 0.001; 24hr post-LFPI vs. 1wk post-
LFPI, p < 0.05; Figure 9c). Meanwhile, in the contralateral CA3, similar changes in spine 
density were observed: total spine density increased by 25%, driven by a 36% increase 
in pedunculated spine density, compared to controls (vs. control, p < 0.05 and p < 0.01, 
respectively; Figure 9b). 
In general, the data indicate that LFPI caused a delayed increase in basilar spine 
density in both hemispheres of CA3. As with neocortexII,III and CA1, this increase in 
spine density could indicate an increased density of excitatory synapses and therefore 
have considerable implications for hippocampal circuitry in the injured brain. 
 
On dentate granule cell dendrites, lateral fluid percussion injury caused an acute 
decrease and a delayed increase in spine density 
Granule cells, the principal cells of the dentate gyrus, receive mostly 
associational and commissural synapses on spines of their proximal dendrites [194]. 
The spine density of these dendrites in the dorsal dentate gyrus (dDG) was compared 
between control and laterally injured brains. In control brains, the proximal dendrites of 
dDG granule cells (n=27) displayed 1.43 ± 0.06 total spines/μm, as previously reported 
[199]. This spine density included 0.83 ± 0.04 pedunculated spines/μm and 0.60 ± 0.03 
non-pedunculated spines/μm. At 1hr after LFPI, the spine density of these dendrites 
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was relatively unchanged in either hemisphere, relative to controls (vs. control, p > 0.05; 
Figure 10a-c). However, LFPI did cause a loss and subsequent gain of spine density in 
dDG at later time points, as described below. Micrographs of representative dendrites 
from ipsilateral dDG are provided as a supplementary figure (Supplementary Figure 4). 
By 24hr post-LFPI, dDG showed a hemisphere-specific loss of spine density. 
Specifically, in the ipsilateral dDG, pedunculated spine density decreased 20% (vs. 
control, p < 0.05; Figure 10b) without any appreciable change in non-pedunculated 
spine density (vs. control, p > 0.05; Figure 10c), relative to controls. However, in the 
contralateral dDG, spine density at 24hr post-LFPI did not differ significantly from that of 
controls (vs. control, p > 0.05; Figure 10a-c).  
As observed in neocortexII/II, the loss of spine density in dDG was not permanent. 
In fact, by 1wk post-LFPI, spine density in the ipsilateral dDG had increased above 
control levels. In particular, total spine density increased 17% over control values (vs. 
control, p < 0.05; Figure 10a), apparently driven by an 18% rise in pedunculated spine 
density relative to controls (vs. control, p < 0.05; Figure 10b). While the non-
pedunculated spine density of these dendrites did not change relative to controls (vs. 
control, p > 0.05; Figure 10c), it did increase 20% relative to the 1hr and 24hr post-LFPI 
time points (1hr post-LFPI vs. 1wk post-LFPI, p < 0.05; 24hr post-LFPI vs., 1wk post-
LFPI; Figure 10c).  
In the contralateral dDG, spine density also increased at 1wk post-LFPI, but only 
when compared to earlier post-LFPI time points. For example, total spine density in 
contralateral dDG increased 22% from 1hr post-LFPI and 23% from 24hr post-LFPI (1hr 
post-LFPI vs. 1wk post-LFPI, p < 0.05; 24hr post-LFPI vs. 1wk post-LFPI, p < 0.05; 
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Figure 10a). Likewise, pedunculated spine density in contralateral dDG increased 26% 
from 1hr post-LFPI and 43% from 24hr post-LFPI (1hr post-LFPI vs. 1wk post-LFPI, p < 
0.05; 24hr post-LFPI vs. 1wk post-LFPI, p < 0.001; Figure 10b). However, non-
pedunculated spine density at this time point did not differ significantly from controls nor 
from earlier post-LFPI time points (vs. control, 24hr post-LFPI, or 1hr post-LFPI; p > 
0.05; Figure 10c). Overall, the data show that LFPI causes a delayed increase in the 
proximal dendritic spine density of granule cells in the ipsilateral dDG. This increase in 
spine density, like that observed in the other hippocampal subfields, may indicate 
substantial re-wiring of the hippocampus in response to lateral brain injury.  
  
FK506 administration increased dendritic spine density in uninjured neocortexII,III 
In vivo imaging has revealed a daily turnover in dendritic spine populations of the 
adult rodent brain [200,201]. If this turnover of dendritic spines is mediated by CaN, then 
inhibiting CaN could increase the density of dendritic spines. To test this hypothesis and 
reduce a potential confound to the present study, uninjured subjects were administered 
the calcineurin inhibitor, FK506 (5mg/kg; i.p.) and their brains were recovered 2hr or 
23hr later for Golgi-Cox analysis of spine density. The mean spine densities and ratioP:N 
are provided in Table 1.  
FK506 administration caused significant increases in the pedunculated spine 
density of basilar dendrites in neocortexII,III, relative to drug-naïve controls. Specifically, 
at 2hr post-injection, the pedunculated spine density of these dendrites increased 29% 
relative to drug-naïve controls (vs. drug-naïve control, p < 0.05; Figure 11b). This 
increase appeared to persist for many hours. By 23hr post-injection, pedunculated spine 
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density was increased 31% relative to drug-naïve controls, driving a significant 29% 
increase in the total spine density, relative to drug-naïve controls (vs. drug-naïve 
control, p < 0.001 and p < 0.01, respectively; Figure 11a,b). A similar effect was recently 
reported in adult mice given daily doses of FK506 [202], and another study found that 
CaN inhibition increases synaptogenesis [203]. However, these findings are beyond the 
scope of the present study. Still, to avoid a potential confound to our study, FK506-
treated, injured subjects were compared only to FK506-treated, uninjured subjects.   
 
FK506 administration prevented the loss of dendritic spine density at 24hr post-injury 
CaN activity has been implicated in the injury-induced loss of dendritic spine 
density in vitro [11] and in vivo [118,204]. To determine whether CaN activity could 
explain the loss of spine density at 24hr post-LFPI, some experimental subjects (n=3) 
were administered the CaN inhibitor, FK506 (5mg/kg; i.p) 1hr after LFPI. The timing of 
this injection was based on evidence that CaN activity increases within hours of LFPI 
[186]. Furthermore, this dosage of FK506 has been shown to block dendritic spine loss 
in a different in vivo model of brain injury [118]. Brains of FK506-treated subjects were 
harvested 24hr after LFPI and subjected to Golgi-Cox histochemistry. Some uninjured 
subjects (n=3) were used as drug controls and received a single injection of FK506 
(5mg/kg; i.p.) 23hr prior to sacrifice.  
A single, post-injury injection of FK506 completely blocked the decreases in 
spine density otherwise observed at 24hr post-LFPI. Indeed, spine density was not 
statistically different between uninjured and injured subjects treated with FK506, in any 
region examined, on either apical or basilar dendrites (each vs. control, p > 0.05; Figure 
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12). This means that FK506 preserved spine density in those regions which otherwise 
lost roughly 20% of their spine density at this time point (i.e., ipsilateral neocortexII,III and 
dDG). The data thus strongly suggest that CaN activity is necessary for the loss of spine 
density at 24hr post-LFPI. 
 
DISCUSSION 
This study demonstrates that LFPI can cause significant changes in dendritic 
spine density and that these changes are time- and brain region-specific. One major 
finding is that LFPI caused a loss of spine density on proximal dendrites in ipsilateral 
neocortexII,III and dDG. This loss of spine density was prevented by administration of 
FK506, a pharmacological inhibitor of CaN, which represents a second major finding in 
this study. Indeed, a single, post-injury dose of FK506 preserved spine density at 24hr 
post-LFPI. A third major finding is that LFPI causes a delayed, regional increases in 
spine density in both hemispheres of rat hippocampus, which is consistent with reactive 
synaptogenesis (e.g., [197,198]). Specifically, within 1wk of LFPI, spine density 
increased in CA1 and CA3 bilaterally, and in dDG ipsilaterally. The implications of each 
of these major findings are considered below.                                                       
   
Lateral fluid percussion injury decreased spine density in neocortex and dentate gyrus 
In theory, a reduction in dendritic spine density could be due to a loss of spines 
or to a lengthening of the dendrite. Though the latter possibility cannot be excluded by 
this study, it seems unlikely for three reasons: first, a shortening, rather than a 
lengthening, of pyramidal dendrites has been reported in a lateral TBI model [205]; 
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second, in vitro imaging of developing neurons suggests that dendrites grow from the 
terminal tip or branch point [206], which would not affect the medial portion that we 
sampled for spine density; third, our data indicate that LFPI differentially affects 
pedunculated and non-pedunculated spine densities. For these reasons, a loss of 
spines most likely explains the reduction in spine density we observed. Interestingly, 
this spine loss corresponds in time, region, and magnitude with a loss of synaptic 
proteins reported in a different TBI model [207]. Taken together, these findings suggest 
that lateral TBI causes synapse degeneration near the site of focal injury.  
Interestingly, the apparent loss of pedunculated spines we observed at 24hr 
post-LFPI occurred independent of any change in non-pedunculated spine density. 
There are a number of possible explanations for this phenotype-specific effect. One 
possibility relates to the mechanism of spine loss: if an excess (or lack) of synaptic 
activity caused the spine loss, only spines with synapses would be directly affected. 
Since the pedunculated phenotype is typical of synapse-bearing spines [193], this can 
explain why only pedunculated spines were lost after LFPI. 
An alternative explanation is that both spine populations decrease after LFPI, but 
only non-pedunculated spines are replenished by 24hr post-LFPI. Non-pedunculated 
spines could replenish in response to a decrease in synaptic activity after LFPI. Indeed, 
immature spines are formed in response to a pharmacological blockade of synaptic 
transmission in the hippocampus in vitro [208]; a similar effect could occur with a 
reduction in synaptic transmission, or with a loss of synapses, e.g., the 60% loss that 
occurs within days of lateral cortical contusion [209]. 
44 
 
A third possibility is that LFPI causes some pedunculated spines to shrink and 
assume a non-pedunculated morphology. Shrinkage of pedunculated spines could 
mask a loss of non-pedunculated spines. Indeed, spine shrinkage is associated with 
activation of the actin binding protein, cofilin [23].  Our companion study [186] reports 
that cofilin activation in the neocortex and hippocampus coincides with the spine loss 
we observed. For these reasons, spine shrinkage could explain why only pedunculated 
spines appeared to be affected by LFPI. Future studies using in vivo imaging and 
transgenic techniques are needed to better characterize the fate of pedunculated and 
non-pedunculated spines in this brain injury model.   
Further study is also needed to determine whether the spine loss we observed 
corresponds to a loss of synapses. Studies in which cultured neurons were exposed to 
glutamate receptor agonists [11,88] or cold [97] suggest that collapsed dendritic spines 
can maintain synaptic contacts. However, other in vitro studies show that spine collapse 
can disrupt synapses: in hippocampal slices, excessive synaptic activity leads to an 
FK506-sensitive upregulation of Snk (serum-inducible kinase), resulting in proteolysis of 
the spine stabilizing protein, SPAR (spine-associated Rap guanosine triphosphatase 
activating protein) [12]. This Snk-SPAR pathway leads to spine loss as well as 
reductions in miniature post-synaptic potentials and in the immunoreactivity of the 
critical post-synaptic protein, PSD-95 [12,145]. Interestingly, the Snk-SPAR pathway 
primarily affects pedunculated spines on proximal dendrites [12] and requires hours to 
develop [142,210]. These in vitro findings are therefore consistent with our observation 
that spine loss occurred on proximal dendrites and can explain the delay in the onset of 
spine loss after brain injury. Furthermore, our companion study found a slight loss of 
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SPAR immunoreactivity in the ipsilateral hippocampus at 18hr post-LFPI [186]. This 
finding raises the possibility that SPAR proteolysis can explain the spine loss observed 
by the present study in the ipsilateral dentate gyrus. Therefore, the potential role of this 
FK506-sensitive signaling pathway in TBI-induced spine loss is an intriguing topic for 
further study. 
 
Pharmacological inhibition of calcineurin prevented the decrease in spine density at 
24hr post-injury 
CaN is a calcium-stimulated phosphatase which mediates functional and 
structural plasticity on both sides of the synapse [23,114]. One mechanism by which 
CaN regulates post-synaptic structure involves the breakdown of the spine 
cytoskeleton. As demonstrated in vitro, CaN dephosphorylates and so activates 
Slingshot [131], a family of phosphatases which in turn activate proteins of the actin 
depolymerizing factor (ADF)/cofilin family (cofilin) [132]. Activated cofilin binds and 
breaks apart filaments of actin, enabling many forms of functional and structural 
plasticity in the neuron (for review, see [119]). For example, cofilin is responsible for the 
shrinkage of dendritic spines that accompanies the long-term depression of spine 
synapses [23].  
Our companion study reports evidence that LFPI caused significant increases in 
cofilin activity [186]. In some cases, the cofilin activation observed in our companion 
study corresponds to spine loss observed in the present study. Specifically, our 
companion study reports that the ipsilateral neocortex and hippocampus each show 
increases in cofilin activity at 24hr post-LFPI (signified by decreases in the 
46 
 
phosphorylation of the cofilin serine 3 residue; [186]). At the same time point and in the 
same forebrain regions, the present study reports a significant loss of dendritic spines. 
These parallel findings raise the possibility that cofilin activation is responsible for spine 
loss after LFPI (but see also Discussion in [186]). Other brain injury models have also 
linked cofilin activation to spine loss [118,204,211]. 
Another parallel between the present study and its companion involves the CaN 
inhibitor, FK506. Our companion study found that a single, post-injury injection of FK506 
blocked cofilin de-phosphorylation in the neocortex at 24hr post-LFPI [186]. At the same 
time point and in the same brain region, an identical treatment with FK506 prevented 
spine loss in the present study. Therefore, in the neocortex at least, the FK506-sensitive 
de-phosphorylation of cofilin corresponds to spine loss after LFPI. These findings agree 
with our previous research in a rat model of status epilepticus, in which FK506 
treatment (5mg/kg) prevented cofilin de-phosphorylation and a coinciding loss of 
dendritic spines. Preventing spine loss in these different models of brain injury could 
maintain synaptic integrity and so reduce the risk of cognitive impairment and other 
sequelae. Therefore, these results emphasize the potential of CaN as a therapeutic 
target in treating brain injury. 
 
Lateral fluid percussion injury caused a delayed overgrowth of dendritic spines in CA1, 
CA3, and dDG  
Previously published studies do not predict an increase in dendritic spine density 
following lateral brain injury. For example, in a study by Schwarzbach and colleagues 
(2006), moderate (1.4-2.1atm) lateral fluid percussion injury had no effect on the apical 
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and basilar dendritic spine densities of mouse CA1 pyramidals at 1wk post-injury [195]. 
In addition, Scheff and colleagues (2005) found that lateral cortical contusion caused a 
loss of synapses in CA1 stratum radiatum which lasted at least 60 days post-injury 
[209]. Consequently, though using a different model of TBI, we were surprised to find an 
increase in the dendritic spine density of CA1 apical dendrites (as well as in other brain 
regions) at 1wk post-LFPI.  
It is possible that the spine overgrowth we observed in CA1 occurred only on 
proximal dendrites. Unlike previously published studies, our study focused on second- 
or third-order dendrites within 30-150μm of the cell soma. Compared to distal dendrites, 
these proximal regions of CA1 pyramidal dendrites are less dense with synapses [212]. 
Proximal dendrites may therefore be a more accessible target for re-innervating axons 
following injury. Indeed, the apical dendritic field of CA1, the stratum radiatum, is re-
innervated within a week or so of lateral cortical contusion in rat [209,213]. If re-
innervating fibers connect with de novo dendritic spines, this could explain the 
increased spine density in CA1 at 1wk post-LFPI. 
Delayed increases in spine density have also been associated with experimental 
denervation [214] and ischemia. Within days of ischemic injury, for example, CA1 apical 
dendrites show an increase in spine density [196,215]. Since moderate LFPI can 
depress cerebral blood flow [216], further investigation is needed to know whether there 
is a mechanistic relationship between spine overgrowth in the ischemia and LFPI 
models. 
An overgrowth of dendritic spines may be a clue to understanding the altered 
electrophysiology of the hippocampus following lateral brain injury. An 
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electrophysiological study by Akasu and colleagues found an increase in the excitability 
of rat CA1 at 1wk after moderate LFPI (1.5-2.0atm) [217]. Other research suggests that 
this increased excitability is due to recurrent circuits formed by CA1 axon collaterals. 
Indeed, CA1 axons invade the stratum radiatum within weeks of epileptogenic brain 
injury in rat, and this corresponds to an increase in CA1 excitability [198]. It is likely that 
these CA1 axons form synapses on CA1 dendrites, since CA1 pyramidals become 
increasingly interconnected when brain injury leads to epilepsy [218]. Alternatively, the 
increased spine density in CA1 and CA3 may represent innervation by commissural or 
extra-hippocampal regions. In any case, further investigation is needed to determine 
whether reactive synaptogenesis can explain the spine overgrowth we observed. A 
better understanding of how the brain is re-wired after injury holds promise for the 
treatment of TBI-related pathologies such as cognitive impairment and post-traumatic 
epilepsy. 
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FIGURE 1 – Forebrain regions sampled for dendritic spine density. Shown is a 
micrograph of a Golgi-stained section of adult rat brain recovered 24hr after lateral fluid 
percussion injury of the left hemisphere. The approximate site of fluid percussion is 
indicated with an asterisk (*). Dendritic spine density was sampled in the shaded brain 
regions located ipsilateral and contralateral to the impact site, including layer II,III of the 
parietal neocortex (“Ctx”), the hippocampal subfields CA1 and CA3, and the dorsal leaf 
of the dentate gyrus (“dDG”). Analogous regions of uninjured brains were similarly 
assessed for spine density. Also visible in this image is where a wedge-shaped portion 
of ventral neocortex was excised prior to sectioning, to mark the ipsilateral hemisphere.  
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FIGURE 2 – Dendritic spines on a Golgi-stained pyramidal neuron from layer II,III 
of rat neocortex. A thin spine and a mushroom-shaped spine are marked, respectively, 
with a thin arrow and a thick arrow. A stubby spine and a filopodia-like spine are 
marked, respectively, with an arrowhead and a hollow arrow. Thin spines and 
mushroom-shaped spines were counted together as “pedunculated” spines, whereas 
stubby spines and filopodia-like spines were counted together as “non-pedunculated” 
spines. The arrowhead also approximates the minimum distance (30μm) from the cell 
soma beyond which dendrites were traced and spine density was sampled. Scale bar, 
10μm.   
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FIGURE 3 – Representative apical dendrites from Golgi-stained pyramidal cells in 
layer II,III neocortex. Shown are proximal dendrites (within 30-150μm of cell soma) 
from the apical arbors of Golgi-stained pyramidal cells in rat neocortex layer II,III. Panel 
A shows a control dendrite with 8.10 pedunculated spines/10μm (110% of group mean) 
and 4.05 non-pedunculated spines/10μm (88% of group mean). Panels B, C, and D 
show dendrites in the penumbral region of the focal injury. Panel B shows a dendrite at 
1hr post-LFPI, with 7.09 pedunculated spines/10μm (102% of group mean) and 4.46 
non-pedunculated spines/10μm (92% of group mean). Panel C shows a dendrite at 24hr 
post-LFPI, with 4.89 pedunculated spines/10μm (95% of group mean) and 4.14 non-
pedunculated spines/10μm (98% of group mean). Panel D shows a dendrite at 1 week 
post-LFPI, with 8.05 pedunculated spines/10μm (119% of group mean) and 4.98 non-
pedunculated spines/10μm (117% of group mean). Note that not all spines counted are 
in focus in these micrographs. Scale bar, 10μm. 
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FIGURE 4 – On apical dendrites in neocortexII,III, lateral fluid percussion injury 
caused a transient decrease in spine density. Rat brains were recovered 1hr, 24hr, 
or 1wk after moderate lateral fluid percussion injury, and subjected to Golgi-Cox 
histochemistry. Golgi-stained pyramidal neurons were selected at random from 
neocortex layer II,III (“neocortexII,III”), either adjacent to the site of injury (“ipsilateral”; 
black bars) or in an analogous region of the contralateral hemisphere (“contralateral”; 
gray bars). The density of pedunculated spines (mushroom spines and thin spines) and 
the density of non-pedunculated spines (stubby spines and filopodia-like spines) were 
each quantified on traced segments of proximal apical dendrites (nneurons > 13). In 
ipsilateral neocortexII,III, apical dendritic spine density decreased significantly by 24hr 
post-LFPI, relative to controls (A). Further analysis revealed a phenotype-specific 
change in spine density, specifically, a decrease in the density of pedunculated spines 
(B) with no appreciable change in the density of non-pedunculated spines (C). Both total 
and pedunculated spine densities recovered by 1wk post-LFPI (A,B). Meanwhile, in 
contralateral neocortexII,III, the spine density of apical dendrites did not differ significantly 
from that of controls, at any time point (B). * vs. control, p < 0.05; ** vs. control, p < 0.01 
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FIGURE 5 – On basilar dendrites in neocortexII,III, spine density fluctuated during 
recovery from lateral fluid percussion injury. Rat brains were recovered 1hr, 24hr, or 
1wk after moderate lateral fluid percussion injury and stained using a Golgi-Cox 
procedure. Golgi-stained pyramidal neurons were selected at random from neocortex 
layer II,III (“neocortexII,III”) either adjacent to the site of injury (“ipsilateral”; black bars) or 
in an analogous region of the contralateral hemisphere (“contralateral”; gray bars). 
Pedunculated spine density (mushroom spines and thin spines) and non-pedunculated 
spine density (stubby spines and filopodia-like spines) were quantified on traced 
segments of proximal basilar dendrites (nneurons > 13). The spine density of these 
dendrites did not change relative to controls, but showed significant changes across 
time points post-LFPI. For example, the total spine density of these dendrites decreased 
from 1hr to 24hr post-LFPI in ipsilateral neocortexII,III, and increased from 24hr to 1wk 
post-LFPI in bilateral neocortexII,III (A). Further analysis revealed underlying changes in 
pedunculated spine density, which decreased from 1hr to 24hr post-LFPI and increased 
from 24hr to 1wk post-LFPI, in both hemispheres of neocortexII,III (B). However, there 
were no corresponding changes in non-pedunculated spine density, except an increase 
from 1hr to 1wk post-LFPI in the contralateral neocortexII,III (C). # vs. other bracketed 
group, p < 0.05; ## vs. other bracketed group, p < 0.01; ### vs. other bracketed group, 
p < 0.001 
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FIGURE 6 - On apical dendrites in hippocampal CA1, lateral fluid percussion 
injury caused a delayed increase in spine density. Rat brains were recovered 1hr, 
24hr, or 1wk after moderate lateral fluid percussion injury and subjected to Golgi-Cox 
histochemistry. Golgi-stained pyramidal neurons were selected at random from 
ipsilateral CA1 (black bars) and from contralateral CA1 (gray bars). Pedunculated spine 
density (mushroom spines and thin spines) and non-pedunculated spine density (stubby 
spines and filopodia-like spines) were quantified on traced segments of proximal apical 
dendrites (nneurons > 13). The total spine density of these dendrites increased 
significantly at 1wk post-LFPI relative to controls, in both hemispheres of CA1 (A). 
Pedunculated spine density increased significantly at 1wk post-LFPI relative to controls 
in ipsilateral CA1, and from 24hr to 1wk post-LFPI in contralateral CA1 (B). In addition, 
ipsilateral CA1 showed a corresponding increase in non-pedunculated spine density at 
1wk post-LFPI (C). * vs. control, p < 0.05; ** vs. control, p < 0.01; *** vs. control, p < 
0.001; ## vs. other bracketed group, p < 0.01 
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FIGURE 7 – On basilar dendrites in hippocampal CA1, lateral fluid percussion 
injury caused a delayed increase in spine density. Rat brains were recovered 1hr, 
24hr, or 1wk after moderate lateral fluid percussion injury and stained using a Golgi-Cox 
procedure. Golgi-stained pyramidal neurons were selected at random from ipsilateral 
CA1 (black bars) and from contralateral CA1 (gray bars). Pedunculated spine density 
(mushroom spines and thin spines) and non-pedunculated spine density (stubby spines 
and filopodia-like spines) were quantified on traced segments of proximal basilar 
dendrites (nneurons > 12). The total spine density of these dendrites increased 
significantly at 1wk post-LFPI relative to controls, in both hemispheres of CA1 (A). 
Pedunculated spine density increased significantly from 1hr to 1wk post-LFPI and from 
24hr to 1wk post-LFPI in ipsilateral CA1, and relative to controls in contralateral CA1 
(B). However, there were no corresponding changes in the non-pedunculated spine 
density of these dendrites (C). * vs. control, p < 0.05; ## vs. other bracketed group, p < 
0.01; ### vs. other bracketed group, p < 0.001 
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FIGURE 8 – On apical dendrites in hippocampal CA3, lateral fluid percussion 
injury caused a delayed increase in spine density. Rat brains were recovered 1hr, 
24hr, or 1wk after moderate lateral fluid percussion injury and subjected to Golgi-Cox 
histochemistry. Golgi-stained pyramidal neurons were selected at random from 
ipsilateral CA3 (black bars) and from contralateral CA3 (gray bars). Pedunculated spine 
density (mushroom spines and thin spines) and non-pedunculated spine density (stubby 
spines and filopodia-like spines) were quantified on traced segments of proximal apical 
dendrites (nneurons > 10). In ipsilateral CA3, the total spine density of these dendrites 
increased significantly at 1wk post-LFPI (A), driven by a rise in pedunculated spine 
density (B), relative to controls. In contrast, contralateral CA3 showed only an increase 
in pedunculated spine density from 24hr to 1wk post-LFPI (B). In terms of non-
pedunculated spine density, the only significant change was an increase from 1hr to 
1wk post-LFPI in ipsilateral CA3 (C). * vs. control, p < 0.05; ** vs. control, p < 0.01; # vs. 
other bracketed group, p < 0.05 
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FIGURE 9 – On basilar dendrites in hippocampal CA3, lateral fluid percussion 
injury caused a delayed increase in spine density. Rat brains were recovered 1hr, 
24hr, or 1wk after moderate lateral fluid percussion injury and stained using a Golgi-Cox 
procedure. Golgi-stained pyramidal neurons were selected at random from ipsilateral 
CA3 (black bars) and from contralateral CA3 (gray bars). Pedunculated spine density 
(mushroom spines and thin spines) and non-pedunculated spine density (stubby spines 
and filopodia-like spines) were quantified on traced segments of proximal basilar 
dendrites (nneurons > 12). The total spine density of these dendrites increased 
significantly by 1wk post-LFPI relative to controls, in both hemispheres of CA3 (A). 
Further analysis revealed underlying changes in pedunculated spine density, which 
increased significantly in both hemispheres of CA3 relative to controls (B). In contrast, 
non-pedunculated spine density did not change appreciably in either hemisphere of 
CA3 relative to controls, but did increase from 1hr to 1wk post-LFPI and from 1hr to 
24hr post-LFPI in the ipsilateral CA3 (C). * vs. control, p < 0.05; ** vs. control, p < 0.01; 
# vs. other bracketed group, p < 0.05; ### vs. other bracketed group, p < 0.001 
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FIGURE 10 – On dentate granule cell dendrites, lateral fluid percussion injury 
caused an acute decrease and a delayed increase in spine density. Rat brains 
were recovered 1hr, 24hr, or 1wk after moderate lateral fluid percussion injury and 
subjected to Golgi-Cox histochemistry. Golgi-stained granule cells were selected at 
random from the dorsal leaf of the dentate gyrus (dDG) in the ipsilateral (black bars) 
and the contralateral (gray bars) hemispheres. Pedunculated spine density (mushroom 
spines and thin spines) and non-pedunculated spine density (stubby spines and 
filopodia-like spines) were quantified on traced segments of proximal dendrites (nneurons 
> 12). The total spine density of these dendrites increased by 1wk post-LFPI relative to 
controls in ipsilateral dDG, as well as from 1hr to 1wk and from 24hr to 1wk in the 
contralateral dDG (A). In terms of pedunculated spine density, ipsilateral dDG showed a 
significant decrease at 24hr post-LFPI and a significant increase at 1wk post-LFPI, 
whereas contralateral dDG showed an increase from 1hr to 1wk post-LFPI and from 
24hr to 1wk post-LFPI (B). The non-pedunculated spine density of these dendrites only 
changed appreciably in the ipsilateral dDG, where an increase was observed from 1hr 
to 1wk post-LFPI and from 24hr to 1wk post-LFPI (C). * vs. control, p < 0.05; # vs. other 
bracketed group, p < 0.05; ### vs. other bracketed group, p < 0.001 
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FIGURE 11 – FK506 administration increased dendritic spine density in uninjured 
neocortexII,III. Rat brains were recovered 2hr (black bars) or 23hr (gray bars) after 
FK506 administration (5mg/kg; i.p.), and subjected to Golgi-Cox histochemistry. Golgi-
stained principal cells were selected at random and bilaterally from the following 
forebrain regions: neocortexII,III, hippocampus CA1, hippocampal CA3, and the dorsal 
leaf of the dentate gyrus (n values are given in Table 1). Pedunculated spine density 
and non-pedunculated spine density were quantified on traced segments of proximal 
dendrites. By 2hr post-injection, FK506 administration did not significantly affect the 
total spine density of these dendrites (A) but caused a significant increase in the 
pedunculated spine density of basilar dendrites in neocortexII,III relative to controls (B). 
By 23hr post-injection, both the total spine density (A) and pedunculated spine density 
(B) of basilar dendrites in neocortexII,III were increased significantly relative to controls. 
** vs. control, p < 0.05; ** vs. control, p < 0.01; *** vs. control, p < 0.001; 
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FIGURE 12 – FK506 administration prevented a loss of dendritic spine density 
following lateral fluid percussion injury. Rats received a lateral brain injury by fluid 
percussion and were administered FK506 (5mg/kg; i.p.) 1hr later. Rat brains were 
recovered 24hr after injury and subjected to Golgi-Cox histochemistry. Golgi-stained 
principal cells were selected at random from the ipsilateral (black bars) and contralateral 
(gray bars) hemispheres of neocortexII,III (“Ctx”), hippocampus CA1, hippocampal CA3, 
and the dorsal leaf of the dentate gyrus (“DG”; n values are provided in Table 1). 
Pedunculated spine density and non-pedunculated spine density were quantified on 
proximal dendrites in these regions. Administering FK506 at 1hr post-injury preserved 
pedunculated spine density at 24hr post-LFPI on apical dendrites in ipsilateral 
neocortexII,III and on granule cell dendrites in ipsilateral dDG (B), dendrites which 
otherwise showed significant spine loss at this time point (see Figures 4b and 10b). 
Data given as percent of FK506-treated, uninjured controls. 
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SUPPLEMENTARY FIGURE 1 – Basilar dendritic spine density in ipsilateral 
neocortex
 
after lateral fluid percussion injury. Shown are proximal dendrites (within 
30-150ìm of cell soma) from the basilar arbors of Golgi-stained pyramidal cells in rat 
neocortexII,III. Panel A shows a control dendrite with 6.64 pedunculated spines/10ìm 
(103% of group mean) and 3.92 non-pedunculate spines/10ìm (92% of group mean). 
Panels B, C, and D show dendrites in the penumbral region of the focal injury. Panel B 
shows a dendrite at 1hr post-LFPI, with 7.59 pedunculated spines/10ìm (97% of group 
mean) and 5.77 non-pedunculated spines/10ìm (116% of group mean). Panel C shows 
a dendrite at 24hr post-LFPI, with 4.95 pedunculated spines/10ìm (97% of group mean) 
and 4.40 non-pedunculated spines/10ìm (104% of group mean). Panel D shows a 
dendrite at 1wk post-LFPI, with 9.69 pedunculated spines/10ìm (129% of group mean) 
and 5.09 non-pedunculated spines/10ìm (100% of group mean). Note that not all spines 
counted are in focus in the micrographs. Scale bar, 10ìm. 
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SUPPLEMENTARY FIGURE 2 – Apical dendritic spine density in ipsilateral CA1
 
after lateral fluid percussion injury. Shown are proximal dendrites (within 30-150μm 
of cell soma) from the apical arbors of Golgi-stained pyramidal cells in rat hippocampal 
CA1. Panel A shows a control dendrite with 10.00 pedunculated spines/10μm (109% of 
group mean) and 4.59 non-pedunculated spines/10μm (82% of group mean). Panel B 
shows a dendrite at 1hr post-LFPI, with 10.18 pedunculated spines/10μm (111% of 
group mean) and 5.60 non-pedunculated spines/10μm (100% of group mean). Panel C 
shows a dendrite at 24hr post-LFPI, with 7.74 pedunculated spines/10μm (84% of group 
mean) and 7.07 non-pedunculated spines/10μm (126% of group mean). Panel D shows 
a dendrite at 1wk post-LFPI, with 10.38 pedunculated spines/10μm (113% of group 
mean) and 7.55 non-pedunculated spines/10μm (135% of group mean). Note that not 
all spines counted are in focus in the micrographs. Scale bar, 10μm. 
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SUPPLEMENTARY FIGURE 3 – Basilar dendritic spine density in ipsilateral CA3
 
after lateral fluid percussion injury. Shown are proximal dendrites (within 30-150μm 
of cell soma) from the basilar arbors of Golgi-stained pyramidal cells in rat hippocampal 
CA3. Panel A shows a control dendrite with 8.56 pedunculated spines/10μm (118% of 
group mean) and 5.45 non-pedunculated spines/10μm (98% of group mean). Panel B 
shows a dendrite at 1hr post-LFPI, with 7.16 pedunculated spines/10μm (119% of group 
mean) and 3.12 non-pedunculated spines/10μm (75% of group mean). Panel C shows a 
dendrite at 24hr post-LFPI, with 8.93 pedunculated spines/10μm (139% of group mean) 
and 6.20 non-pedunculated spines/10μm (114% of group mean). Panel D shows a 
dendrite at 1wk post-LFPI, with 8.90 pedunculated spines/10μm (87% of group mean) 
and 5.93 non-pedunculated spines/10μm (86% of group mean). Note that not all spines 
counted are in focus in the micrographs. Scale bar, 10μm. 
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SUPPLEMENTARY FIGURE 4 – Dendritic spine density in ipsilateral dentate gyrus
 
after lateral fluid percussion injury. Shown are proximal dendrites (within 30-150μm 
of cell soma) of Golgi-stained granule cells in the dorsal leaf of the rat dentate gyrus. 
Panel A shows a control dendrite with 10.32 pedunculated spines/10μm (124% of group 
mean) and 5.90 non-pedunculated spines/10μm (99% of group mean). Panel B shows a 
dendrite at 1hr post-LFPI, with 7.50 pedunculated spines/10μm (97% of group mean) 
and 5.28 non-pedunculated spines/10μm (92% of group mean). Panel C shows a 
dendrite at 24hr post-LFPI, with 5.96 pedunculated spines/10μm (89% of group mean) 
and 5.57 non-pedunculated spines/10μm (98% of group mean). Panel D shows a 
dendrite at 1wk post-LFPI, with 9.51 pedunculated spines/10μm (96% of group mean) 
and 6.34 non-pedunculated spines/10μm (92% of group mean); note that spine density 
was not quantified in the beaded region of this dendrite. Also, not all spines counted are 
in focus in the micrographs. Scale bar, 10μm. 
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TABLE 1 – Spine densities and n values. 
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CHAPTER II 
MECHANISMS OF DENDRITIC SPINE REMODELING IN A RAT MODEL OF 
TRAUMATIC BRAIN INJURY 
 
INTRODUCTION 
A traumatic brain injury (TBI) occurs every 19 seconds in the United States [219] 
and is a leading cause of death and disability.  TBI typically involves both an immediate, 
mechanical destruction of tissue as well as prolonged reactive processes such as 
excitotoxicity which develop over a period of hours to days.  This secondary injury can 
affect cellular function well beyond the site of impact and so may be responsible for 
many of the long-lasting neurological deficits associated with TBI [220,221].  However, 
this secondary injury may be treatable or even preventable, given the apparent window 
for therapeutic intervention.  
Calcium-regulated systems have been implicated in the spread of neuronal 
damage following ischemia and TBI [32,35,222].  One such system involves the 
calcium-regulated phosphatase, calcineurin (CaN) [223,224,225].  CaN mediates many 
cellular responses to brain injury, including the expression of cytokines [226] and 
neuronal nitric oxide synthase [227], glial apoptosis [228] and activation [229].  CaN 
also regulates synaptic plasticity under normal conditions (e.g., [114,230]) and in 
various pathological states, including prolonged seizure [118], amyloid beta exposure 
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[231], and TBI [186].  Given its regulation by calcium and role in cellular responses to 
injury, CaN and its signaling pathways may contribute to the pathology of TBI.  Previous 
research by our laboratory found both an increase in CaN activity and its re-distribution 
to synapses in the rat forebrain after fluid percussion TBI [224,232].  More recently, we 
found that these changes coincide with a CaN-dependent loss of dendritic spines in the 
rat neocortex and hippocampus after fluid percussion TBI [233].  However, it is unclear 
how CaN is involved in this spine loss. Several signaling pathways which connect CaN 
activity to spine loss have been characterized in vitro (for review, see [183]).  One such 
pathway involves remodeling the spine’s actin-rich cytoskeleton by the actin-binding 
protein, cofilin [23,118,211].  Another pathway involves the targeted proteolysis of the 
spine-stabilizing protein, SPAR (spine-associated Rap guanosine triphosphatase 
activating protein) [12,142].  While these pathways have been demonstrated in other 
injury models, it is unclear whether they can explain the spine loss we observed in the 
TBI model [233].  Therefore, the present study examined the activity and temporal 
profile of these CaN-dependent pathways in the fluid percussion model of TBI. We 
report significant changes in CaN activity and in its downstream substrates.  Together 
with our companion paper [233], these experiments characterize cellular mechanisms 
through which TBI can cause dendritic spine loss. 
 
MATERIALS AND METHODS 
All animal use procedures were performed in strict accordance with the Guide for 
the Care and Use of Laboratory Animals described by the National Institutes of Health 
and was approved by the Virginia Commonwealth University Institutional Animal Care 
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and Use Committee.  Animal subjects received ad libitum access to food and water and 
were maintained on 12-hour light/dark cycles throughout the experiment.  A total of 105 
adult, male Sprague-Dawley rats (90 day old; 350-400g) were used in this study.   
These rats were randomly distributed among the following treatment groups: controls 
(naïve, age-matched; n=20), FK506-only (n=4), TBI-only (n=76), and TBI+FK506 (n=5). 
 
Fluid percussion injury 
The TBI and TBI+FK506 groups were surgically prepared for TBI as follows.  
First, rats were anesthetized with sodium pentobarbital l (54 mg/kg intraperitoneally; i.p.) 
or isoflurane (3% isoflurane in a carrier gas mixture of 30% N2O and 70% O2) and 
placed into a stereotactic frame.  The scalp was then incised and a 4.8-mm hole was 
made over the left hemisphere using a manual trephine centered 4mm caudal to 
bregma and -3mm lateral to the sagittal suture.  An anchor screw was inserted into the 
skull overlying the opposite hemisphere.  A modified female Luer-Loc syringe hub 
(2.6mm inside diameter) was placed over the exposed dura, affixed with a 
cyanoacrylate adhesive, and then secured with dental acrylic.  The hub was filled with 
sterile saline and the scalp was sutured closed.  On the following day, subjects were 
anesthetized with isoflurane (4min in 4% isoflurane in a carrier mixture of 30% N2O and 
70% O2) and subjected to fluid percussion of the intact dura over their left parietal 
cortex.  The fluid percussion device used in these experiments is identical to that 
described by Dixon and colleagues [187].  Immediately after fluid percussion injury, the 
Luer-Loc fitting, screw, and dental cement were removed from the skull and the scalp 
was sutured closed.  Subjects were then placed in a supine position and the time at 
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which they righted themselves was recorded.  Upon recovery of righting reflexes, 
subjects were returned to home cages and monitored daily.  At 1hr post-TBI, some rats 
(n=5; “TBI+FK506”) received a single injection of FK506 (5mg/kg; i.p.; Astellas Pharma 
Inc., Tokyo, Japan).  As a drug control group, additional age-matched Sprague-Dawley 
rats (“FK506 only”; n=4) were administered FK506 (5mg/kg; i.p.) and then sacrificed 
23hr after drug administration. 
 
Isolation and homogenization of brain regions 
Rats were briefly anesthetized with isoflurane and quickly decapitated at the 
following times after TBI: 1hr (n=7); 6hr (n=4); 12hr (n=5); 18hr (n=13); 24hr (n=18); 
24hr+FK506 (n=5); 48hr (n=4); 1wk (n=5); 2wk (n=6); and 4wk (n=5).  Age-matched 
control rats and FK506-only rats were sacrificed along with TBI rats and in the same 
manner.  Brains were rapidly dissected on an iced Petri dish to reduce postmortem 
enzyme activity.  Ipsilateral and contralateral hemispheres of neocortex and 
hippocampus were dissected whole and separately homogenized with 10 strokes (up 
and down) at 12,000 rpm using a motorized homogenizer (TRI-R Instruments, Inc., 
Rockville Center, NY).  Brain regions were homogenized in ice-cold homogenization 
buffer containing 7mM EGTA, 5mM EDTA, 1mM dithiothreitol, 0.3 mM 
phenylmethylsulfonylfluoride, and 300mM sucrose.  Neocortical hemispheres and 
hippocampal hemispheres were homogenized in 4mL and 2mL of buffer, respectively.  
Homogenates were aliquoted and stored at -80°C until use. Homogenates from the 
same animals were used for multiple experiments whenever possible. To control for 
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storage artifact in the Western analyses of phosphorylated cofilin, samples from post-
TBI animals were normalized to equivalently-stored control samples. 
 
pNPP assay of CaN activity 
CaN activity was measured using the procedure of Pallen and Wang [234], as 
optimized by Kurz et al. [224,235].  Briefly, all reaction tubes were prepared on ice and 
contained the following: 25mM MOPS (pH 7.0), 1mM DTT, 2mM p-nitrophenyl 
phosphate (pNPP) (Sigma-Aldrich; St Louis, MO, U.S.A.).  Tubes used to measure 
basal CaN activity also contained 2mM EGTA and 2mM EDTA.  Tubes used to measure 
maximal CaN activity contained the same reagents as basal reactions, with the addition 
of 2mM MnCl2.  Manganese activates CaN much more strongly than calcium in the 
pNPP assay and is therefore used to reveal changes in maximal CaN activity [224].  
Final reaction volumes were 1mL.  Prior to use, the protein concentrations of all 
homogenate samples were determined using the method of Bradford [236].  Reactions 
were initiated by the addition of 50μg/mL brain homogenate.  Reactions were incubated 
at 37°C for 30min in a shaking water bath.  Tubes were then removed from the water 
bath and placed in ice to stop the reaction.  Absorbance of the reaction mixture was 
immediately measured at 405nm in a spectrophotometer (UV-2101, Shimadzu Scientific 
Instruments, Inc., Columbia, MD).  Absorbance units were converted to nmol of pNP 
produced by comparison to a pNP concentration standard absorption curve. 
 
Western analysis 
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Brain samples were normalized using the Bradford method, resolved by sodium 
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Mini-Protean II 
system, Bio-Rad, Hercules, CA, U.S.A.), and transferred to nitrocellulose membrane 
using the Trans-blot system (Bio-Rad).  Transfer quality was confirmed by staining the 
blots with a reversible protein stain, Ponceau S (Sigma-Aldrich), according to the 
manufacturer’s instructions.  After de-staining, blots were twice immersed for 15 
minutes in blocking solution containing phosphate buffered saline (PBS, pH 7.4), 0.05% 
(v/v) polyoxyethylene sorbitan monolaurate (Tween 20), and 2.5% blotting grade dry 
milk (Bio-Rad).  Blots were then incubated overnight with the appropriate antibody in 
blocking solution at 4°C.  Antibodies were used at the following dilutions: rabbit anti-
cofilin, 1:500 (catalog #3842, Chemicon International, Temecula, CA, U.S.A.); rabbit 
anti-Ser3 phosphorylated cofilin, 1:500 (catalog #3831, Chemicon International); rabbit 
anti-PSD-95, 1:1000 (catalog #51-9600, Invitrogen, San Diego, CA, U.S.A.); goat anti-
E6TP1 (“SPAR”), 1:1000 (catalog #sc-20846, Santa Cruz Biotechnology).  Membranes 
were then washed in 0.05% Tween 20-PBS three times for 10 minutes each.  Next, the 
nitrocellulose was incubated for 45min in the appropriate horseradish peroxidase-
conjugated secondary antibody (Thermo Scientific, Waltham, MA, U.S.A.), diluted 
1:4000 in blocking solution.  The blots were then washed 3 times in PBS for 10min each 
wash. Immunoreactive bands were revealed by chemiluminescence (Pierce Femto or 
Pico Luminol Substrate, Pierce, Rockford, IL, U.S.A.) and exposed to x-ray films (Kodak 
X-OMAT) which were then developed on a Kodak X-OMAT developer.  The mean 
optical densities of immunoreactive bands were measured by computer-assisted 
densitometry (GS-800 Calibrated Densitometer, Bio-Rad) and compared to a linear 
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concentration curve as described previously [237].  In the SPAR and PSD-95 
experiments, data were normalized to whole-lane optical densities obtained from the 
same Ponceau S stained blots [238]. 
 
Statistical analysis 
Group means were statistically analyzed with GraphPad Prism 4.0 (Graph-Pad 
Software, San Diego, CA, U.S.A.).  All comparisons were made by one-way analysis of 
variance (ANOVA). Post hoc analyses were conducted with either Tukey’s test (only 
data related to Figure 19) or Dunnett’s test (all other data).  Groups were considered 
significantly different if p < 0.05.  All data are presented as group mean ± standard 
deviation. Sample sizes (n values) are shown on the figures. 
 
RESULTS 
Lateral fluid percussion TBI 
Adult male rats received a traumatic brain injury by fluid percussion of the dura 
overlying their left parietal cortex. The mean fluid percussion pressure was 2.22 ± 
0.11atm and did not differ significantly across groups (F [9,64]=1.111, p=0.3678).  A 
common correlate of injury severity is the latency between injury and the recovery of the 
righting reflex (“righting time”) [191].  In the present study, the mean righting time was 
7.00 ± 3.19min.  This mean righting time corresponds to an injury of moderate severity 
(e.g., [239]).  Righting time did not differ significantly across groups (F [9,63]=0.9287, 
p=0.5068).  Some subjects (n=3) exhibited apnea immediately following injury and were 
mechanically ventilated until spontaneous respirations resumed (mean duration, 25 ± 
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5sec).  The acute mortality rate associated with LFPI in this study was approximately 
3% (2 of 76 rats died within 7 days of LFPI and so were excluded from all other data). 
  
Lateral TBI enhanced the enzymatic activity of calcineurin 
To determine the effect of lateral TBI on CaN activity, ipsilateral and contralateral 
hemispheres of neocortex and hippocampus were dissected, separately homogenized, 
and subjected to a well-characterized pNPP assay [118,224,235,240] (see Materials 
and Methods).  Using this approach, CaN activity was measured either in the absence 
of stimulating cations (“basal CaN activity”), or in the presence of stimulating cations 
(“maximal CaN activity”).   
Lateral TBI had a significant effect on basal CaN activity in the ipsilateral 
hippocampus, when compared to analogous tissue from control animals (F 
[8,56]=5.617, p<0.0001; Figure 13A).  Post hoc analysis indicates that this effect was 
delayed, as basal CaN activity at 1hr post-TBI did not differ significantly from controls 
(p>0.05).  By 6hr post-TBI, however, basal CaN activity in this region had increased 
significantly over control levels (p<0.01).  The increase was transient, as basal CaN 
activity did not differ significantly from controls at 12hr, 18hr, or 24hr post-TBI (p>0.05, 
each time point).  Basal CaN activity increased again at 1wk post-TBI relative to 
controls (p<0.01).  This increase also appeared to be transient, as basal CaN activity at 
2wk and 4wk post-TBI did not differ significantly from controls (p>0.05, each time point). 
The contralateral hippocampus also showed a significant change in basal CaN 
activity after lateral TBI, when compared to controls (F [8,56]=5.524, p<0.0001; Figure 
13B).  Like the ipsilateral hippocampus, basal CaN activity in the contralateral 
83 
 
hippocampus was unchanged at 1hr post-TBI (p>0.05) but increased significantly by 6hr 
post-TBI, relative to controls (p<0.01).  Basal CaN activity at 12hr post-TBI was also 
significantly elevated over control levels (p<0.01).  This increase was transient, as basal 
CaN activity returned to control levels by 18hr post-TBI and remained near control 
levels at the subsequent time points (p>0.05, each time point).  Overall, lateral TBI 
caused delayed, transient increases in basal CaN activity in the ipsilateral hippocampus 
and in the contralateral hippocampus. 
The maximal enzymatic activity of CaN was also altered by lateral TBI.  In the 
ipsilateral hippocampus, for example, TBI had a significant effect on maximal CaN 
activity, relative to controls (F [8,56]=3.283, p=0.0039; Figure 13C).  The effect was 
delayed though, as maximal CaN activity at 1hr and 6hr post-TBI did not differ 
significantly from controls (p>0.05, each time point).   By 12hr post-TBI, however, 
ipsilateral hippocampus showed a significant increase in maximal CaN activity over 
control levels (p<0.05).  This increase did not persist, as maximal CaN activity was not 
significantly altered at 18hr post-TBI, nor at the later time points, relative to controls 
(p>0.05, each time point).   
The contralateral hippocampus also showed significant changes in maximal CaN 
activity after lateral TBI, compared to controls (F [8,56]=4.791, p=0.0002; Figure 13D).  
As with basal CaN activity, maximal CaN activity was unchanged at 1hr post-TBI 
(p>0.05) but increased significantly at 6hr and 12hr post-TBI, relative to controls (p<0.01 
and p<0.05, respectively).  The increase did not persist though, as maximal CaN activity 
had returned to control levels by 18hr post-TBI and remained near control levels at the 
subsequent time points (p>0.05, each time point).  Thus, lateral TBI caused delayed but 
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transient increases in maximal CaN activity in the ipsilateral hippocampus and in the 
contralateral hippocampus. 
Lateral TBI altered CaN phosphatase activity in the neocortex as well. In the 
ipsilateral neocortex, for example, lateral TBI had a significant effect on basal CaN 
activity and maximal CaN activity relative to controls (basal CaN activity, F [7,43]=5.519, 
p=0.0001, Figure 14A; maximal CaN activity, F [7,43]=3.264, p=0.0072, Figure 14C).  
The effect was delayed though, as neither basal nor maximal CaN activity differed 
significantly from controls at the acute time points, 1hr, 6hr, 12hr, and 24hr post-TBI 
(p>0.05, each time point).  By 1wk post-TBI, however, ipsilateral neocortex showed 
significant increases in both basal CaN activity and maximal CaN activity, compared to 
control levels (basal CaN activity, p<0.01, Figure 14A; maximal CaN activity, p<0.05, 
Figure 14C).  Basal and maximal CaN activity were also increased above control levels 
at 2wk post-TBI (basal CaN activity, p<0.05, Figure 14A; maximal CaN activity, p<0.01, 
Figure 14C) but returned to control levels by 4wk post-TBI (p>0.05; Figure 14A,C).   
The contralateral neocortex also underwent significant changes in basal and 
maximal CaN activity after lateral TBI, when compared to control tissue (basal CaN 
activity, F [7,43]=3.483, p=0.0048, Figure 14B; maximal CaN activity, F [7,43]=3.088, 
p=0.0100, Figure 14D).  These too were delayed changes, as neither basal nor maximal 
CaN activity differed significantly from controls at 1hr, 6hr, 12hr, 24hr, 1wk, or 2wk post-
TBI (p>0.05, each time point; Figure 14B,D). By 4wk post-TBI, both basal and maximal 
CaN activity had increased significantly above control levels (p<0.01; Figure 14B,D).  
The data thus demonstrate delayed but transient increases in CaN activity in the 
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ipsilateral neocortex, followed weeks later by an increase in CaN activity in the 
contralateral neocortex. 
 
Lateral TBI caused time- and region-dependent changes in pSer3-cofilin 
immunoreactivity 
To further characterize the TBI-induced changes in CaN activity, we examined 
the effect of TBI on cofilin, an endogenous protein which is activated downstream of 
CaN [131,241].  Cofilin is an actin-binding and -depolymerizing protein critically involved 
in both functional and structural remodeling of excitatory synapses [23,242].  CaN 
activation leads to de-phosphorylation of a key serine 3 (Ser3) residue on cofilin, 
resulting in an increase in cofilin activity [131,241].  To test whether lateral TBI affects 
cofilin Ser3 phosphorylation, ipsilateral and contralateral hemispheres of neocortex and 
hippocampus were dissected after lateral fluid percussion injury, separately 
homogenized, and subjected to Western analysis with a phospho-specific antibody 
recognizing the inactivated, serine 3-phosphorylated cofilin (pSer3-cofilin).  This 
analysis revealed apparent, time-dependent changes in pSer3-cofilin immunoreactivity 
in hippocampal and neocortical structures (Figure 15).  In both the ipsilateral and 
contralateral hippocampi, for example, pSer3-cofilin immunoreactivity appeared to 
decrease acutely, within 1hr of TBI, and remain decreased at 24hr post-TBI (Figure 
15A,B).  However, in animals allowed to recover for 1wk after injury, pSer3-cofilin 
immunoreactivity appeared to return to control levels.  A different trend was observed in 
the neocortex, where pSer3-cofilin immunoreactivity appeared to increase or remain 
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unchanged at 1hr post-TBI, but then decrease at the subsequent time points (Figure 
15C,D).   
To further investigate the apparent changes in pSer3-cofilin immunoreactivity, 
additional Westerns were performed for quantitative analysis (Figure 16).  These 
experiments confirmed that lateral TBI caused time- and region-dependent changes in 
pSer3-cofilin immunoreactivity.  For example, lateral TBI significantly altered pSer3-
cofilin immunoreactivity in the ipsilateral hippocampus, when compared to analogous 
tissue from controls (F [6,48]=7.953, p<0.0001; Figure 16A).  At 1hr post-TBI in the 
ipsilateral hippocampus, pSer3-cofilin immunoreactivity appeared to decrease relative to 
control levels, though post hoc analysis indicates that this decrease was not statistically 
significant (1hr post-TBI vs. controls, p>0.05).  Nor did pSer3-cofilin immunoreactivity at 
12hr post-TBI differ significantly from controls (p>0.05).  However, a significant 
decrease in pSer3-cofilin immunoreactivity was observed at 24hr post-TBI, relative to 
controls (p<0.05).  This decrease did not persist, as pSer3-cofilin immunoreactivity had 
returned to control levels by 1wk post-TBI (p>0.05), and was elevated above control 
levels at 2wk post-TBI (p<0.01).  Surprisingly, at 4wk post-TBI, pSer3-cofilin 
immunoreactivity again fell below control levels (p<0.05).   
The contralateral hippocampus also underwent significant changes in pSer3-
cofilin immunoreactivity after lateral TBI, relative to controls (F [6,48]=13.60, p<0.0001; 
Figure 16B).  Like the ipsilateral hippocampus, the contralateral hippocampus showed 
an acute, TBI-induced decrease in pSer3-cofilin immunoreactivity.  Specifically, at 1hr, 
12hr, and 24hr post-TBI in the contralateral hippocampus, pSer3-cofilin 
immunoreactivity was significantly below control levels (p<0.01, each time point).  As 
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observed in the ipsilateral hemisphere, pSer3-cofilin immunoreactivity returned to 
control levels by 1wk post-TBI and did not change significantly thereafter (1wk, 2wk, or 
4wk post-TBI, p>0.05).  Overall, the data demonstrate an acute, decrease in apparent 
pSer3-cofilin immunoreactivity in both hemispheres of the hippocampus.   
Lateral TBI also caused significant changes in pSer3-cofilin immunoreactivity in 
the neocortex, though these changes differed from those observed in the hippocampus.  
In the ipsilateral neocortex, TBI had a significant effect on pSer3-cofilin 
immunoreactivity, when compared to controls (F [6,47]=17.27, p<0.0001; Figure 16C).  
However, in contrast to what was observed of the hippocampal fractions, lateral TBI 
caused an initial increase in pSer3-cofilin immunoreactivity in the ipsilateral neocortex.   
Post hoc analysis shows that, at 1hr post-TBI, pSer3-cofilin immunoreactivity in the 
ipsilateral neocortex was significantly increased above control levels (p<0.01).  This 
initial increase was followed by a decrease, as pSer3-cofilin fell substantially below 
control levels by 12hr post-TBI (p<0.01).  pSer3-cofilin immunoreactivity was 
significantly decreased at all subsequent time points as well, relative to controls (24hr 
post-TBI, p<0.01; 1wk post-TBI, p<0.05; 2wk post-TBI, p<0.01; 4wk post-TBI, p<0.01).   
The contralateral neocortex also showed changes in pSer3-cofilin 
immunoreactivity after lateral TBI (F [6,47]=12.61, p<0.0001; Figure 16D), changes 
which were similar to those observed of the ipsilateral neocortex.  As in the ipsilateral 
neocortex, pSer3-cofilin immunoreactivity in the contralateral neocortex increased over 
control levels by 1hr post-TBI (p<0.01).  However, pSer3-cofilin immunoreactivity 
returned to control levels by 12hr post-TBI (p>0.05).  The downward trend continued at 
24hr post-TBI, when pSer3-cofilin immunoreactivity decreased substantially below 
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control levels (p<0.01).  The pSer3-cofilin immunoreactivity at 1wk and 2wk post-TBI 
appeared reduced when compared to controls, but not to a statistically significant extent 
(p>0.05, each time point).  At 4wk post-TBI though, pSer3-cofilin immunoreactivity was 
significantly below control levels (p<0.01), similar to what was observed of the ipsilateral 
side.  In general, lateral TBI caused acute, but transient increases in pSer3-cofilin 
immunoreactivity, followed by delayed but persistent decreases, bilaterally in the 
neocortex 
 
Lateral TBI generally caused a transient increase in total cofilin protein 
To determine whether TBI-induced changes in pSer3-cofilin immunoreactivity 
were due to quantitative changes in cofilin protein, Western analyses were repeated 
with an antibody recognizing total cofilin protein, regardless of Ser3 phosphorylation.  
This antibody was generated using the same peptide sequence as the pSer3-specific 
antibody, but without the phosphate at the Ser3 residue.  These analyses revealed 
significant changes in total cofilin immunoreactivity, though nearly all of these changes 
were increases.   
Lateral TBI significantly altered total cofilin immunoreactivity in the ipsilateral 
hippocampus relative to analogous tissue from control animals (F [6,48]=40.10, 
p<0.0001; Figure 17A).  Post hoc analysis indicates that total cofilin immunoreactivity at 
1hr and 12hr post-TBI in the ipsilateral hippocampus was significantly above control 
levels (p<0.05 and p<0.01, respectively).  The increase was transient, as total cofilin 
immunoreactivity at 24hr and 1wk post-TBI did not differ significantly from controls 
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(p>0.05, each time point).  Total cofilin immunoreactivity increased above control levels 
again, at 2wk post-TBI (p<0.01), but returned to control levels by 4wk post-TBI (p>0.05). 
The contralateral hippocampus also underwent significant changes in total cofilin 
immunoreactivity after lateral TBI, relative to controls (F [6,49]=6.342, p<0.0001; Figure 
17B).  In contrast to the ipsilateral hippocampus, acute changes in total cofilin 
immunoreactivity were not observed in the contralateral hippocampus, as total cofilin 
immunoreactivity did not differ significantly from controls at 1hr or 12hr post-TBI 
(p>0.05, each time point).  Nor did total cofilin immunoreactivity change significantly at 
24hr or 1wk post-TBI,  relative to controls (p>0.05, each time point).  As observed of the 
ipsilateral hippocampus, however, total cofilin immunoreactivity increased above control 
levels at 2wk post-TBI (p<0.01) but then returned to control levels by 4wk post-TBI 
(p>0.05).  Overall, lateral TBI caused acute and delayed increases in total cofilin 
immunoreactivity in each hemisphere of hippocampus, but no significant decrease at 
any time point tested. 
Lateral TBI altered total cofilin immunoreactivity in the neocortex as well.  In the 
ipsilateral neocortex, TBI had a significant effect on total cofilin immunoreactivity, 
compared to controls (F [6,49]=11.20, p<0.0001; Figure 17C).  In contrast to the 
hippocampal data, post hoc analysis revealed a decrease in total cofilin 
immunoreactivity in the ipsilateral neocortex at 1hr post-TBI (p<0.01).  This decrease 
was transient, as total cofilin immunoreactivity had returned to control levels by 12hr 
post-TBI (p>0.05).  Total cofilin immunoreactivity remained near control levels at 24hr 
and 1wk post-TBI (p>0.05, each time point) but then increased at 2wk post-TBI, relative 
to controls (p<0.01).  Similar to what was observed of the hippocampus, the increase at 
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2wk post-TBI did not persist, as total cofilin immunoreactivity at 4wk post-TBI in the 
ipsilateral neocortex did not differ significantly from controls (p>0.05).   
The contralateral neocortex, like the hippocampus, did not show a significant loss 
of total cofilin immunoreactivity after lateral TBI, at any time point tested.  However, TBI 
did have a significant effect on total cofilin immunoreactivity in the contralateral 
neocortex relative to controls (F [6,49]=5.228, p=0.0003; Figure 17D).  In contrast the 
ipsilateral neocortex, total cofilin immunoreactivity at 1hr post-TBI in the contralateral 
neocortex did not differ significantly from controls (p>0.05).   Nor was there a significant 
change in total cofilin immunoreactivity at 12hr post-TBI, relative to controls (p>0.05).  
At 24hr post-TBI, however, total cofilin immunoreactivity increased significantly above 
control levels (p<0.01).  This increase did not last, as total cofilin immunoreactivity had 
returned to control levels by 1wk post-TBI (p>0.05) and did not differ significantly from 
controls at 2wk or 4wk post-TBI (p>0.05).  In general, lateral TBI caused delayed but 
transient increases in total cofilin immunoreactivity in each hemisphere of neocortex, but 
a decrease only at 1hr post-TBI in the ipsilateral hemisphere. 
 
Lateral TBI resulted in time- and region-specific changes in the percentage of Ser3 
phosphorylated cofilin 
To correct for TBI-induced changes in cofilin protein expression, pSer3-cofilin 
immunoreactivity data were normalized to total cofilin immunoreactivity data for each 
tissue sample.  This yielded a ratio of pSer3-cofilin to total cofilin (“p/t cofilin”) for each 
animal, allowing us to determine whether TBI affected the proportion of Ser3-
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phosphorylated cofilin.  Statistical analysis of these data revealed significant changes in 
p/t cofilin after lateral TBI, as detailed below. 
Lateral TBI significantly altered p/t cofilin in the ipsilateral hippocampus, when 
compared to controls (F [6,47]=10.71, p<0.0001; Figure 18A).  Post hoc analysis 
indicates that p/t cofilin was significantly decreased at 1hr, 12hr, and 24hr post-TBI, 
relative to controls (p<0.01, each time point).  This decrease did not persist, as p/t cofilin 
at 1wk and 2wk post-TBI did not differ significantly from controls (p>0.05, each time 
point).  At 4wk post-TBI, however, p/t cofilin again decreased below control levels 
(p<0.01).   
The contralateral hippocampus also underwent significant changes in p/t cofilin 
after lateral TBI, relative to controls (F [6,48]=16.76, p<0.0001; Figure 18B).  Like the 
ipsilateral hippocampus, contralateral hippocampus showed acute and delayed 
decreases in p/t cofilin.  At 1hr, 12hr, and 24hr post-TBI in the contralateral 
hippocampus, for example, p/t cofilin was substantially below control levels (p<0.01, 
each time point).  The decrease appeared to be transient, as p/t cofilin did not differ 
significantly from controls at 1wk post-TBI (p>0.05).  However, p/t cofilin decreased 
again by 2wk post-TBI (p<0.01), relative to controls, before returning to control levels by 
4wk post-TBI (p>0.05).  Overall, lateral TBI resulted in significant alterations in p/t cofilin 
in both the ipsilateral and the contralateral hippocampus. 
Lateral TBI altered p/t cofilin immunoreactivity in the neocortex as well.  In the 
ipsilateral neocortex, for instance, TBI had a significant effect on p/t cofilin, compared to 
controls (F [6,47]=28.98, p<0.0001; Figure 18C).  Post hoc analysis shows that p/t 
cofilin was increased above control levels at 1hr post-TBI (p<0.01).  This increase in p/t 
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cofilin was followed by decreases at 12hr and 24hr post-TBI, relative to controls (p<0.05 
and p<0.01, respectively).  By 1wk post-TBI, p/t cofilin had recovered to control levels 
(p>0.05).  However, additional decreases in p/t cofilin were observed at 2wk and 4wk 
post-TBI, relative to controls (p<0.01, each time point).   
The contralateral neocortex also showed significant changes in p/t cofilin after 
lateral TBI, relative to controls (F [6,47]=17.37, p<0.0001; Figure 18D).  As in the 
ipsilateral neocortex, p/t cofilin at 1hr post-TBI in the contralateral neocortex was 
significantly above control levels (p<0.01).  This increase was transient though, as p/t 
cofilin had returned to control levels by 12hr post-TBI (p>0.05).  The downward trend 
continued at 24hr post-TBI, when p/t cofilin decreased substantially below control levels 
(p<0.01).  Similar decreases in p/t cofilin were observed at all subsequent time points, 
24hr, 1wk, 2wk, and 4wk post-TBI, relative to controls (p<0.01, each time point).  In 
general, both the ipsilateral and contralateral hemispheres of neocortex showed acute 
but transient increases in p/t cofilin, followed by delayed but apparently persistent 
decreases in p/t cofilin, after lateral TBI. 
 
Post-TBI treatment with FK506 prevented cofilin de-phosphorylation in neocortex but 
not hippocampus 
In vitro studies have shown that CaN negatively regulates the phosphorylation of 
the cofilin Ser3 residue [241], which could explain how pSer3-cofilin immunoreactivity 
decreased after TBI in the absence of any overt loss of cofilin protein (see Figures 3 
and 4).  To test whether CaN caused the apparent de-phosphorylation of cofilin after 
TBI, we administered a selective CaN inhibitor, FK506 (5mg/kg, i.p.) to rats at 1hr post-
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TBI and sacrificed them at 24hr post-TBI (“TBI+FK506”).  To control for drug effects, an 
age-matched group of uninjured rats (n=5) were also injected with FK506 (5mg/kg, i.p.) 
and then sacrificed 23hr post-injection (“FK506-only”).  Whole hemispheres of 
neocortex and hippocampus were dissected, separately homogenized, and subjected to 
Western analysis with a phospho-specific antibody recognizing Ser3-phosphorylated 
cofilin.  Data were then compared across the following groups, using one-way ANOVA 
and Tukey’s post hoc test: controls, FK506-only, TBI-only, and TBI+FK506.  These 
analyses indicate that FK506 treatment had region-specific effects on pSer3-cofilin 
immunoreactivity after lateral TBI.   
In the ipsilateral hippocampus, for example, pSer3-cofilin immunoreactivity 
differed significantly between the treated groups and controls (F [3,34]=20.97, p<0.001; 
Figure 19A).  Post hoc comparisons revealed a significant reduction in pSer3-cofilin 
immunoreactivity in the TBI+FK506 group relative to either the FK506-only group 
(p<0.001) or controls (p<0.001).  In addition, pSer3-cofilin immunoreactivity did not differ 
significantly between the TBI-only and FK506 groups (p>0.05).   
Like the ipsilateral hippocampus, pSer3-cofilin immunoreactivity in the 
contralateral hippocampus differed significantly between the treated groups and controls 
(F [3,32]=36.24, p<0.0001; Figure 19B).  Also like the ipsilateral hippocampus, the 
contralateral hippocampus showed a significant loss of pSer3-cofilin immunoreactivity in 
the FK506+TBI relative to the FK506-only and control groups (p<0.001, each), but no 
significant difference between the FK506+TBI and TBI-only groups (p>0.05).  The data 
thus suggest that the FK506 treatment failed to prevent the 24hr post-TBI loss of pSer3-
cofilin immunoreactivity in either hemisphere of hippocampus. 
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The ipsilateral neocortex also showed significant differences in pSer3-cofilin 
immunoreactivity between the control and treated groups (F [3,33]=10.35, p<0.0001; 
Figure 19C).  In contrast to the hippocampus, however, pSer3-cofilin immunoreactivity 
in the ipsilateral neocortex did not differ significantly between the TBI+FK506 group and 
the FK506-only group (p>0.05), nor between the TBI+FK506 group and controls 
(p>0.05).  In addition, pSer3-cofilin immunoreactivity in the FK506+TBI group was 
increased substantially over that of the TBI-only group (p<0.001).  This increase in 
pSer3-cofilin immunoreactivity was not likely due to an increase in cofilin protein 
expression, as one-way ANOVA found no significant difference in total cofilin 
immunoreactivity between the control and treated groups (control, n=20, 100 ± 15% of 
control; FK506-only, n=4, 97 ± 37% of control; TBI-only, n=10, 113 ± 26% of control; 
TBI+FK506, n=5, 92 ± 27% of control; F [3,35]=1.320, p=0.2835).   
Like the ipsilateral neocortex, pSer3-cofilin immunoreactivity in the contralateral 
neocortex differed significantly between the control and treated groups (F [3,33]=4.109, 
p=0.0139; Figure 19D).  Also like the ipsilateral side, there was no significant difference 
in pSer3-cofilin immunoreactivity between the TBI+FK506 group and the control group 
(p>0.05), or between the TBI+FK506 group and the FK506-only groups (p>0.05).  
Again, however, there was a significant increase in pSer3-cofilin immunoreactivity in the 
TBI+FK506 group relative to the TBI-only group (p<0.05) which did not appear to be 
due to an increase in cofilin protein (total cofilin immunoreactivity: control, n=20, 100 ± 
14% of control; FK506-only, n=4, 102 ± 32% of control; TBI-only, n=10, 200 ± 108% of 
control; TBI+FK506, n=5, 118 ± 42% of control; F [3,35]=6.893, p=0.0009; TBI-only vs. 
FK506+TBI, p>0.05).  The data thus strongly suggest that the FK506 treatment 
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prevented the 24hr post-TBI loss of pSer3-cofilin immunoreactivity in both the ipsilateral 
QHRFRUWH[ and contralateral QHRFRUWH[. 
 
Lateral TBI caused a decrease in PSD-95 immunoreactivity 
Pathological activation of CaN and cofilin are associated with the degeneration of 
excitatory synapses in vitro [12,23,211].  To test whether synapse degeneration 
occurred in our TBI model, Western blots were used to measure the immunoreactivity of 
a post-synaptic marker protein, PSD-95, in neocortical and hippocampal homogenates 
obtained 18hr, 24hr, and 48hr after lateral fluid percussion injury.  As described below, 
TBI caused a significant loss of PSD-95 immunoreactivity in ipsilateral neocortex and 
bilateral hippocampus.   
Lateral TBI had a significant effect on PSD-95 immunoreactivity in the ipsilateral 
hippocampus, when compared to analogous tissue from control animals (F 
[3,13]=13.75, p=0.0003; Figure 20A).  Post hoc analysis indicates that PSD-95 
immunoreactivity at 18hr, 24hr, and 48hr post-TBI in the ipsilateral hippocampus was 
significantly below control levels (p<0.01, p<0.05, and p<0.01, respectively).  The 
contralateral hippocampus also showed significant changes in PSD-95 immunoreactivity 
after lateral TBI, relative to controls (F [3,13]=6.890, p=0.0051; Figure 20B).  As in the 
ipsilateral hippocampus, PSD-95 immunoreactivity in the contralateral hippocampus 
decreased below control levels at 18hr and 24hr post-TBI (p<0.05 and p<0.01, 
respectively). Unlike the ipsilateral hippocampus, however, PSD-95 immunoreactivity in 
the contralateral hippocampus returned to control levels by 48hr post-TBI (p>0.05).  
96 
 
Overall, lateral TBI caused an acute loss of PSD-95 immunoreactivity bilaterally in the 
hippocampus, though the loss appeared to persist longer in the ipsilateral hemisphere. 
Lateral TBI also affected PSD-95 immunoreactivity in the ipsilateral neocortex, 
when compared to controls (F [3,14]=8.328, p=0.002; Figure 20C).  Post hoc analysis 
revealed a significant loss of PSD-95 immunoreactivity in the ipsilateral neocortex at 
18hr and 24hr post-TBI, relative to controls (p<0.01 and p<0.05, respectively).  This loss 
did not persist though, as PSD-95 immunoreactivity at 48hr post-TBI did not differ 
significantly from controls (p>0.05).  Unlike the ipsilateral neocortex, the contralateral 
neocortex showed no significant change in PSD-95 immunoreactivity after TBI, when 
compared to controls (F [3,13]=2.921, p=0.0739; Figure 20D).  The data thus 
demonstrate an acute but transient loss of PSD-95 immunoreactivity in the ipsilateral 
neocortex after lateral TBI. 
 
Effect of lateral TBI on SPAR immunoreactivity 
Injury to hippocampal neurons in vitro can cause a CaN-dependent induction of 
serum-induced kinase (Snk), resulting in increased proteolysis of SPAR, a protein which 
is critical to post-synaptic stability [12,145,210].  To determine whether SPAR 
proteolysis occurred after lateral TBI, SPAR immunoreactivity was measured using 
Western blots of neocortical and hippocampal homogenates obtained 18hr, 24hr, and 
48hr after lateral fluid percussion injury.  No significant change in SPAR 
immunoreactivity was detected in either hemisphere of neocortex or hippocampus, at 
any post-TBI time point tested, relative to controls (ipsilateral hippocampus, F 
[3,14]=3.134, p=0.0593; contralateral hippocampus, F [3,13]=0.8802, p=0.4767; 
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ipsilateral neocortex, F [3,14]=0.3530, p=0.7877; contralateral neocortex, F 
[3,13]=2.850, p=0.0784; Figure 21).  The data therefore suggest that SPAR proteolysis 
is unlikely to be a mechanism behind the dendritic spine loss observed in neocortex and 
dentate gyrus at 24hr post-TBI [233]. 
 
DISCUSSION 
The present study examined the effects of lateral fluid percussion on CaN activity 
and CaN-dependent signaling in the rat forebrain.  An in vitro assay revealed significant, 
time-dependent changes in CaN phosphatase activity in the hippocampus and 
neocortex after lateral TBI. Changes in CaN activity were further characterized by 
Western analyses.  These analyses measured the effect of lateral TBI on two signaling 
pathways through which CaN regulates the stability of dendritic spines.  The results 
implicate cellular pathways through which lateral TBI could alter dendritic spine stability.  
Together with its companion study [233], the present study demonstrates a specific 
cellular mechanism through which lateral TBI can cause a loss of dendritic spines.  This 
spine loss may be clinically relevant, if it alters inter-neuronal communication and so 
contributes to cognitive impairment.   
Analogous to what our group observed in midline TBI model [224,232], lateral 
TBI resulted in a delayed, transient change in CaN phosphatase activity in the 
hippocampus and neocortex.  The increase in CaN activity could be explained by an 
acute increase in CaN protein, as has been reported in a different model of lateral TBI 
[243].  An alternative hypothesis is that CaN activity is enhanced through some post-
translational modification of the enzyme – e.g., a partial proteolytic cleavage which 
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disinhibits its phosphatase activity [244], as has been proposed in models of central 
fluid percussion injury [224] and status epilepticus [118,235].  Recently, D’Amelio and 
colleagues reported evidence of a caspase-3 cleaved, constitutively active fragment of 
CaN in a mouse model of Alzheimer’s disease [245].  Enhancement of CaN activity in 
this manner would agree with our findings from the midline TBI model, wherein no 
change in CaN holoenzyme expression was observed [224].  However, it is noteworthy 
that the changes in CaN activity induced by lateral TBI were not as long-lasting as those 
induced by midline TBI.  Specifically, the increase in CaN activity lasted for hours after 
lateral TBI but for weeks after midline TBI [224]. 
CaN activity can also influenced by endogenous factors, such as Ca2+ binding, 
that cannot be measured by our in vitro assay.  These endogenous changes in CaN 
activity can, however, be measured by the downstream effects on CaN substrates.  The 
present study therefore examined a downstream substrate of CaN, cofilin.  CaN activity 
leads to de-phosphorylation of a key Ser3 residue on cofilin [131], and the removal of 
this Ser3 phosphate enables cofilin to bind and de-polymerize actin [246].  The 
breakdown of actin filaments by cofilin is critical to synaptic plasticity and a number of 
other cellular processes (reviewed in [247]).  Therefore, this choice of substrate allowed 
us not only to indirectly measure CaN activity, but to directly assess the cellular 
consequences of CaN activity.     
The present study found that lateral TBI caused time- and region-dependent 
changes in pSer3-cofilin immunoreactivity in both the ipsilateral and contralateral 
hemispheres of hippocampus and neocortex.  These changes could be due to changes 
in cofilin protein expression or Ser3 phosphorylation, or both.  While total cofilin 
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immunoreactivity did change at some post-TBI time points, relative to controls, only 
once did it correspond to a change in pSer3-cofilin immunoreactivity (i.e., at 2wk post-
TBI in the ipsilateral hippocampus, pSer3-cofilin increased and total cofilin increased).  
It is therefore reasonable to conclude that all of the decreases in pSer3-cofilin 
immunoreactivity we observed were due to decreased Ser3 phosphorylation and not 
due to decreased cofilin protein expression. Likewise, all but one of the increases in 
pSer3-cofilin immunoreactivity appeared to be due to increased Ser3 phosphorylation, 
not to increased cofilin protein expression.  A noteworthy example is the loss of pSer3-
cofilin which occurred bilaterally in the neocortex at 24hr post-TBI.  This loss cannot be 
attributed alone to a decrease in cofilin protein, because total cofilin immunoreactivity 
was unchanged in the ipsilateral neocortex at 24hr post-TBI, and actually increased in 
the contralateral neocortex at this time point, relative to controls.  Therefore, the loss of 
pSer3-cofilin most likely represents Ser3 de-phosphorylation.  Previous studies have 
shown that this de-phosphorylation can occur downstream of CaN activity [131].  
Though our in vitro assay found no significant change in CaN phosphatase activity at 
24hr post-TBI, it is possible that some endogenous (e.g., Ca2+-mediated) increase in 
CaN activity led to the cofilin de-phosphorylation we observed.  Consistent with this 
possibility, the present study found that the CaN inhibitor, FK506, administered 1hr 
post-TBI, prevented the loss of pSer3-cofilin immunoreactivity bilaterally in the 
neocortex at 24hr post-TBI.  The data thus suggest that a TBI-induced increase in CaN 
activity leads to cofilin de-phosphorylation in the neocortex at 24hr post-TBI.   
The results of the present study strongly suggest that TBI causes cofilin de-
phosphorylation bilaterally in the rat forebrain.  The resulting increase in cofilin activity 
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could degrade the actin-rich cytoskeleton of dendritic spines, causing the spines to 
shrink or collapse [23,118,211].  Since dendritic spines form most of the excitatory 
synapses in the brain, their collapse may physically de-stabilize and disrupt synapses.  
Indeed, lateral TBI is associated with synapse degeneration, evident in the loss of 
synaptic proteins reported in previous studies [207,248] and the loss of PSD-95 
immunoreactivity observed in the present study.  Thus, a pathological increase in cofilin 
activity may result in not only a loss of dendritic spines, but a loss of spine synapses 
[211]. 
Interestingly, the apparent de-phosphorylation of cofilin observed in the present 
study coincides with a loss of dendritic spines reported in our companion study [233].  
Specifically, the ipsilateral neocortex at 24hr post-TBI shows both cofilin de-
phosphorylation (Figure 15) and spine loss [233], and both of which are prevented by a 
1hr post-TBI administration of FK506.  These studies, along with the evidence from 
other models (e.g., [23,118,211]), thus implicate cofilin de-phosphorylation as a 
mechanism of dendritic spine loss in the neocortex (Figure 22, “Cofilin Pathway”).  
Surprisingly, the same FK506 treatment failed to block cofilin de-phosphorylation 
in the hippocampus.  We suspect that different timing or mechanisms are involved in 
cofilin de-phosphorylation in the hippocampus.  For example, CaN may have been 
activated in the hippocampus earlier than in the neocortex after lateral TBI.  Indeed, 
cofilin was significantly de-phosphorylated at 1hr post-TBI in the hippocampus, though it 
is unclear from the present study whether this de-phosphorylation is CaN-dependent.  
However, if CaN is responsible for this acute de-phosphorylation of cofilin, then FK506 
may need to be administered earlier than 1hr post-TBI to fully prevent CaN activation in 
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the hippocampus.  By 1hr post-TBI, CaN may have already conveyed the signal to de-
phosphorylate cofilin, or may have been cleaved into a catalytically active fragment 
which resists inhibition by FK506 [249].   
Though FK506 administration failed to block cofilin de-phosphorylation in the 
hippocampus, it fully prevented a concurrent loss of dendritic spines in the dentate 
gyrus [233].  One possible explanation is that FK506 inhibits CaN to varying degrees 
across the subfields of the hippocampus, perhaps due to differential expression of 
FK506’s partner in inhibiting CaN, FKBP12 [250].  A more plausible explanation is that a 
different mechanism underlies spine loss in the hippocampus, a mechanism which is 
CaN-dependent but cofilin-independent.  The present study considered one such 
mechanism: the proteolysis of SPAR.  SPAR is a post-synaptic protein which stabilizes 
dendritic spines in hippocampal neurons [141] (Figure 22, “SPAR Pathway“).  In 
cultured hippocampal neurons, excitotoxic injury triggers a CaN-dependent increase in 
Snk protein, resulting in an increased proteolysis of SPAR and a corresponding loss of 
dendritic spines [12].  In contrast to these in vitro findings, however, the present study 
detected no significant change in SPAR immunoreactivity at 18hr, 24hr, or 48hr post-
TBI in the hippocampus, nor in the neocortex.  One could conclude then that SPAR 
proteolysis did not occur after lateral TBI and so is not a major mechanism of spine loss 
in this model.  However, our data cannot exclude the possibility that SPAR proteolysis 
occurred focally - e.g., within the dentate gyrus, the only hippocampal subfield which 
showed spine loss [233].  Such a spatially-limited change in SPAR protein would not 
likely be detected in a Western analysis of a whole hippocampal hemisphere. Future 
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studies using immunohistochemistry or micro-dissection could detect changes in SPAR 
protein with better spatial resolution. 
Considering the findings of the present study and its companion [233], we 
hypothesize that different, CaN-dependent mechanisms underlie spine loss in the 
neocortex and dentate gyrus following lateral TBI.  In the neocortex, CaN may cause 
spine loss through activation (de-phosphorylation) of cofilin, whereas in the dentate 
gyrus, CaN may cause spine loss through a cofilin-independent pathway.  These 
studies do not, however, exclude the possibility of other CaN-dependent mechanisms of 
spine loss in this model.  Further investigation is needed to definitively characterize the 
mechanisms of spine loss following lateral TBI. 
Another interesting parallel between the present study and its companion is 
found at the 1wk post-TBI time point.  By 1wk post-TBI in the present study, cofilin 
phosphorylation had returned to control levels bilaterally in the hippocampus.  This 
recovery represented a substantial increase in cofilin phosphorylation relative to the 
preceding time point.  At the same 1wk post-TBI time point, our companion study found 
an increase in dendritic spine density bilaterally in the hippocampus [233].  The increase 
in cofilin phosphorylation and spine density may be related, as the 
phosphorylation/inactivation of cofilin would favor the cytoskeletal expansion necessary 
for spine growth.  Therefore, the increase in cofilin phosphorylation during recovery from 
TBI may play a role in the increase in spine density.    
The present study and its companion [233] identify potential mechanisms of 
dendritic remodeling in the traumatically-injured forebrain.  This remodeling could 
disrupt neuronal circuits, or facilitate aberrant re-wiring, and so contribute to cognitive 
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impairment and other TBI sequelae.  CaN inhibition may help to prevent these sequelae 
by preserving synaptic circuits following TBI, and so could be a new option for treating a 
widespread medical problem that currently has few treatment options.  
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FIGURE 13 - Lateral TBI enhanced calcineurin phosphatase activity in the 
hippocampus.  Hippocampal tissue was isolated from adult rats at specific times after 
lateral fluid percussion injury, homogenized, and subjected to an in vitro assay of CaN 
enzymatic activity (see Materials and Methods).  CaN activity was measured either in 
the absence of stimulating cations (“basal CaN activity”), or in the presence of 
stimulating cations (“maximal CaN activity”).  In the ipsilateral hippocampus, these 
experiments revealed increases in basal CaN activity at 6hr and 1wk post-TBI, relative 
to controls (A).  Similarly, in the contralateral hippocampus, increases in basal CaN 
activity were detected at 6hr and 12hr post-TBI, relative to controls (B).  Lateral TBI also 
affected the maximal activity of CaN, causing increases at 12hr post-TBI in the 
ipsilateral hippocampus (C) and at 6hr and 12hr post-TBI in the contralateral 
hippocampus (D), compared to controls.  All comparisons were made by one-way 
ANOVA with Dunnett’s post hoc test. *p<0.05, **p<0.01 
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FIGURE 14 - Lateral TBI enhanced calcineurin phosphatase activity in the 
neocortex.  Neocortical tissue was isolated from adult rats at specific times after lateral 
fluid percussion injury, homogenized, and subjected to an in vitro assay of CaN 
enzymatic activity (see Materials and Methods).  CaN activity was measured either in 
the absence (“basal CaN activity”) or presence (“maximal CaN activity”) of stimulating 
cations.  In the ipsilateral neocortex, basal CaN activity increased significantly above 
control levels by 1wk and 2wk post-TBI (A).  The contralateral neocortex also showed 
an increase in basal CaN activity, but weeks later, at 4wk post-TBI, compared to 
controls (B).  The maximal activity of CaN also changed after lateral TBI, increasing 
significantly over control levels at 1wk and 2wk post-TBI in the ipsilateral neocortex (C), 
and at 4wk post-TBI in the contralateral neocortex (D).  All comparisons were made by 
one-way ANOVA with Dunnett’s post hoc test. *p<0.05, **p<0.01 
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FIGURE 15 - Lateral TBI caused apparent changes in pSer3-cofilin 
immunoreactivity.  Western analysis was performed on crude homogenates of whole 
ipsilateral and contralateral hemispheres of hippocampus and neocortex dissected from 
adult rats 1hr, 24hr, 1wk, or 2wk after lateral TBI, and from age-matched control rats.  
The immunoreactivity of Ser3 phosphorylated cofilin (pSer3-cofilin) was detected with a 
phospho-specific antibody.  Results suggest that the hippocampus and neocortex 
underwent time- and region-dependent changes in pSer3-immunoreactivity after lateral 
TBI.  In both the ipsilateral and contralateral hippocampi, for example, pSer3-cofilin 
immunoreactivity appeared to decrease below control levels by 1hr post-TBI and remain 
decreased at 24hr post-TBI (A,B).  However, by 1wk post-TBI, pSer3-cofilin 
immunoreactivity appeared to have increased to control levels or beyond.  A different 
trend was observed in the neocortex, where pSer3-cofilin immunoreactivity seemed to 
initially increase (C) or remain unchanged (D) at 1hr post-TBI, but then decrease at later 
time points (C,D).   
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FIGURE 16 - Lateral TBI caused time- and region-dependent changes in pSer3-
cofilin immunoreactivity.  Ipsilateral and contralateral hemispheres of hippocampus 
and neocortex were dissected from post-TBI rats and their age-matched controls, 
separately homogenized, and subjected to immunoblotting with antibodies recognizing 
the serine 3 phosphorylated form of cofilin (pSer3-cofilin).  Results indicate significant 
changes in pSer3-cofilin immunoreactivity following lateral TBI, relative to controls. In 
the ipsilateral hippocampus, for example, pSer3-cofilin decreased significantly at 24hr 
post-TBI, increased at 2wk post-TBI, but then decreased again at 4wk post-TBI, relative 
to controls (A). The contralateral hippocampus also underwent an acute decrease in 
pSer3-cofilin immunoreactivity, at 1hr, 12hr, and 24hr post-TBI, compared to controls 
(B).  The neocortex showed a different pattern of changes in pSer3-cofilin 
immunoreactivity, with an increase at 1hr post-TBI followed by decreases at subsequent 
time points, in both the ipsilateral neocortex (C) and contralateral neocortex (D), relative 
to controls. Specifically, pSer3-cofilin immunoreactivity decreased below control levels 
at 12hr post-TBI and all later time points in the ipsilateral neocortex (C), and at 24hr and 
4wk post-TBI in the contralateral neocortex (D).  All comparisons were made by one-
way ANOVA with Dunnett’s post hoc test. *p<0.05, **p<0.01 
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FIGURE 17 - Lateral TBI generally caused a transient increase in total cofilin 
immunoreactivity.  Western analyses were repeated using an antibody recognizing 
cofilin regardless of Ser3 phosphorylation status (“total cofilin”).  Analyses revealed 
time- and region-dependent changes in total cofilin immunoreactivity, relative to 
controls.  In the ipsilateral hippocampus, for example, total cofilin immunoreactivity 
increased at 1hr, 12hr, and 2wk post-TBI, relative to controls (A). In the contralateral 
hippocampus, total cofilin immunoreactivity also increased above control levels, but only 
weeks later, at 2wk post-TBI (B). Unlike all other brain regions tested, the ipsilateral 
neocortex decreased in total cofilin immunoreactivity, at 1hr post-TBI, relative to 
controls. However, total cofilin immunoreactivity returned to control levels by 12hr post-
TBI, and then increased above control levels weeks later, at 2wk post-TBI (C). The 
contralateral neocortex underwent a delayed increase in total cofilin immunoreactivity, 
at 24hr post-TBI, relative to controls (D).  All comparisons were made by one-way 
ANOVA with Dunnett’s post hoc test.  *p<0.05, **p<0.01 
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FIGURE 18 - Lateral TBI caused time- and region-dependent changes in the 
proportion of Ser3-phosphorylated cofilin.  To determine whether TBI affected the 
proportion of Ser3 phosphorylated cofilin, pSer3-cofilin immunoreactivity data were 
normalized to total cofilin immunoreactivity data for each sample, yielding a ratio of 
pSer3-cofilin to total cofilin (“p/t cofilin”).  Analysis of these data identified time- and 
region-dependent changes in p/t cofilin.   In the ipsilateral hippocampus, for example, p/t 
cofilin was significantly below control levels at 1hr, 12hr, and 24hr post-TBI, and again 
at 4wk post-TBI (A). In the contralateral hippocampus, a similar reduction in p/t cofilin 
was observed at 1hr, 12hr, and 24hr post-TBI, and then at 2wk post-TBI, relative to 
controls (B). The ipsilateral neocortex showed an increase in p/t cofilin at 1hr post-TBI, 
followed by decreases in p/t cofilin at 12hr, 24hr, 2wk and 4wk post-TBI, relative to 
controls (C).  A similar pattern was observed in the contralateral neocortex, where p/t 
cofilin was significantly above control levels at 1hr post-TBI but then dropped below 
control levels at 24hr, 1wk, 2wk, and 4wk post-TBI (D).  All comparisons were made by 
one-way ANOVA with Dunnett’s post hoc test. *p<0.05, **p<0.01 
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FIGURE 19 – A 1hr post-TBI administration of FK506 prevented the 24hr post-TBI 
loss of pSer3-cofilin immunoreactivity in the neocortex.  Adult rats received either 
lateral fluid percussion TBI alone (“TBI only,”), TBI followed by a 1hr post-TBI injection 
of FK506 (5mg/kg; i.p.; “TBI+FK506”), FK506 injection but no TBI (“FK506 only”), or no 
treatment (“control”).  Treated groups were sacrificed at 24hr post-TBI (or 23hr post-
injection), along with equivalently-aged control rats.  Ipsilateral and contralateral 
hemispheres of hippocampus and neocortex were dissected, separately homogenized, 
and subjected to immunoblotting with antibodies recognizing either the serine 3-
phosphorylated cofilin (pSer3-cofilin).  Statistical analysis identified region-specific 
effects of FK506 treatment on pSer3-cofilin phosphorylation. For example, FK506 
treatment did not prevent the loss of pSer3-cofilin at 24hr post-TBI, in either the 
ipsilateral hippocampus (A) or contralateral hippocampus (B).  In the neocortex, 
however, FK506 treatment completely blocked the loss of pSer3-cofilin at 24hr post-TBI 
in both the ipsilateral (C) and contralateral (D) hemispheres. All comparisons were 
made by one-way ANOVA with Tukey’s post hoc test.  *p<0.05 vs. controls; **p<0.01 
vs. controls; ***p<0.001 vs. controls; # p<0.05 vs. other bracketed group; ## p<0.01 vs. 
other bracketed group; ### p<0.001 vs. other bracketed group 
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FIGURE 20 - Lateral TBI caused a loss of PSD-95 immunoreactivity.  Ipsilateral and 
contralateral hemispheres of hippocampus and neocortex were dissected from adult 
rats at 18hr, 24hr, and 48hr after lateral fluid percussion TBI, separately homogenized, 
and subjected to immunoblotting with antibody recognizing the post-synaptic protein, 
PSD-95.  Lateral TBI caused a significant loss of PSD-95 immunoreactivity at 18hr, 
24hr, and 48hr post-TBI in the ipsilateral hippocampus (A) and at 18hr and 24hr post-
TBI in the contralateral hippocampus (B), relative to controls.  In the ipsilateral 
neocortex, PSD-95 immunoreactivity also decreased significantly below control levels, 
at 18hr and 24hr post-TBI (C). In the contralateral neocortex, however, PSD-95 
immunoreactivity did not differ significantly from controls, at any time point tested (D).  .  
All comparisons were made by one-way ANOVA with Dunnett’s post-hoc test.   *p < 
0.05; **p < 0.01; n.s., no significant differences   
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FIGURE 21 – Effect of lateral TBI on SPAR immunoreactivity.  Ipsilateral and 
contralateral hemispheres of hippocampus and neocortex were dissected from adult 
rats at 18hr, 24hr, and 48hr after lateral fluid percussion TBI, separately homogenized, 
and subjected to immunoblotting with an antibody recognizing SPAR.  No change in 
SPAR immunoreactivity was detected at any time point tested, in the ipsilateral 
hippocampus (A), contralateral hippocampus (B), ipsilateral neocortex (C), or 
contralateral neocortex (D), relative to controls.  All comparisons were made by one-
way ANOVA with Dunnett’s post hoc test.  n.s., no significant differences   
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FIGURE 22 – Calcineurin-dependent mechanisms by which brain injury could 
cause dendritic spine collapse.  Brain injury can cause an increase in the activity of 
the calcium-sensitive phosphatase, calcineurin (CaN).  CaN-dependent signaling can 
then lead to dendritic spine collapse through regionally-distinct signaling pathways.  In 
the neocortex, for example, CaN activity may lead to a rapid de-
phosphorylation/activation of the actin-depolymerizing protein, cofilin.  Excessive cofilin 
activity could disrupt the spine’s actin-rich cytoskeleton, resulting in spine shrinkage or 
de-stabilization [23].  In the hippocampus, however, a different mechanism may be 
involved - a mechanism involving CaN but not cofilin.  For example, an injury-induced 
increase in CaN activity can lead to a transcriptional up-regulation of Snk (serum-
inducible kinase), ultimately resulting in the targeted proteolysis of a spine-stabilizing 
protein, SPAR (spine-associated Rap guanosine triphosphatase activating protein) [12]. 
SPAR loss is associated with degeneration of post-synaptic function and structure, 
including spine loss [12,141,145]. Therefore, cofilin activation and SPAR proteolysis 
represent different mechanisms by which CaN may cause spine loss.  Evidence from 
the present study favors cofilin activation as a regional mechanism of spine loss after 
TBI but does not rule out focal involvement of SPAR proteolysis.   
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CHAPTER III 
TRAUMATIC BRAIN INJURY CAUSES A TACROLIMUS-SENSITIVE INCREASE IN 
NON-CONVULSIVE SEIZURES IN A RAT MODEL OF POST-TRAUMATIC EPILEPSY 
 
INTRODUCTION 
 Every 16 minutes in the U.S., a traumatic brain injury (TBI) occurs which results 
in chronic, recurrent seizures [160,163].  This form of acquired epilepsy, known as post-
traumatic epilepsy, is often refractory to medications or surgery [168,169] and so can be 
a lifelong disability for the victim and a financial burden which extends to their 
community.  An ideal therapy would prevent or limit the development of post-traumatic 
epilepsy, but no such therapy has yet been found  [171].  A better understanding of how 
the injured brain becomes epileptic, a process called epileptogenesis, should reveal 
novel opportunities for preventing post-traumatic epilepsy. 
 Epileptogenesis is thought to begin within minutes to hours after brain injury 
[176,177], though the underlying mechanisms are still unknown.  One hypothesis is that 
a pathological increase in intracellular calcium triggers molecular changes which 
culminate in neuronal hyperexcitability [33,251].  Calcium-sensitive enzymes which 
regulate neuronal excitability may thus play a critical role in epileptogenesis.  Indeed, 
animal models of acquired epilepsy have implicated a calcium-sensitive phosphatase, 
calcineurin [251,252,253,254].  Recent research by our lab suggests that calcineurin 
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may also be involved in the epileptogenesis after TBI.  In a study of lateral fluid 
percussion TBI in rats, a well-characterized model of post-traumatic epilepsy [173,255], 
we identified an acute post-injury increase in calcineurin activity [186].  This increase 
could facilitate epileptogenesis through the dysregulation of hyperpolarizing cyclic 
nucleotide-gated (HCN) channels [254] or voltage-gated potassium channels (KV2.1) 
[256].  An increase in calcineurin activity may also alter excitatory synaptic circuits by 
destabilizing dendritic spines [11,12,118,204,211,233], potentially creating opportunities 
for maladaptive plasticity [78].  The increase in calcineurin activity we observed after 
TBI could therefore be an early but critical step in epileptogenesis.   
 The present study characterized the importance of calcineurin activity in a rat 
model of post-traumatic epilepsy.  We administered the calcineurin inhibitor, Tacrolimus 
(FK506), to adult rats 1 hour after lateral fluid percussion TBI and then monitored 
spontaneous seizure activity 5 weeks or 33 weeks later.  The results indicate a 
significant disease-modifying effect of Tacrolimus in this model of post-traumatic 
epilepsy.  
 
MATERIALS AND METHODS 
Animal Use and Housing Conditions 
 All animal care and use complied with the Guide for the Care and Use of 
Laboratory Animals described by the National Institutes of Health and was approved in 
advance by the Virginia Commonwealth University Institutional Animal Care and Use 
Committee.  Animals received ad libitum access to food and water and were kept in 
temperature- and humidity-controlled housing on 12 hour light/dark cycles throughout 
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the experiment.  The present study involved a total of 49 male, Sprague-Dawley rats 
acquired as adults (90 day old) and randomly assigned to treatment groups in two 
experiments.  Experiment 1 assessed spontaneous seizure activity at 33 weeks post-
TBI and involved the following treatment groups: controls (naïve, age-matched rats; 
n=7), sham TBI (n=3), TBI Only (n=10), and TBI+TAC (n=14).  Experiment 2 examined 
spontaneous seizure activity at 5 weeks post-TBI in different rats assigned to the same 
treatment groups: control (naïve, age-matched rats; n=4), TBI Only (n=5), and TBI+TAC 
(n=6). 
 
Lateral Fluid Percussion Injury 
 The procedure for lateral fluid percussion injury has been described previously 
[186,233] and was identical for Experiments 1 and 2.  All rats except controls were each 
anesthetized with 3% isoflurane in a carrier gas mixture of 30% N2O and 70% O2 and 
placed into a stereotactic frame.  A 5mm circular craniotomy was made over the left 
hemisphere using a manual trephine centered between Lambda and Bregma 
(approximately -4.4mm Bregma), and midway between the sagittal suture and the 
lateral ridge.  A modified syringe hub was placed over the craniotomy, affixed to the 
skull with a cyanoacrylate adhesive, and then secured with dental acrylic.  The hub was 
filled with sterile saline and the scalp was sutured closed over the hub.  On the following 
day, the same rats were anesthetized with isoflurane (4min of 4% isoflurane in a carrier 
mixture of 30% N2O and 70% O2) and subjected to fluid percussion of the intact dura 
over their left parietal cortex.  Sham TBI rats received the same dose of isoflurane but 
no fluid percussion.  The fluid percussion device used in Experiment 1 is identical to that 
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described by Dixon and colleagues (Dixon et al., 1987).  A newer model of this device 
was used in Experiment 2.  Fluid percussion pressure was measured at the time of fluid 
impact, by an external pressure transducer adjacent to the hub.  The Luer-Loc fitting, 
screw, and dental cement were removed from the skull and the scalp was sutured 
closed immediately after fluid percussion injury (or, in sham TBI rats, immediately after 
discontinuation of isoflurane anesthesia).  If apnea occurred immediately following TBI, 
rats were mechanically ventilated with room air until spontaneous respiration resumed.  
Immediately following injury, rats were placed in a supine position and the time at which 
they righted themselves was recorded.  Body temperature was maintained for at least 1 
hour after injury by placement on a heating pad set to “low.”  Rats were then returned to 
their home cages and monitored daily.  Some rats (TBI+TAC) received a single injection 
of Tacrolimus (5mg/kg; intraperitoneal, i.p.; Astellas Pharma Inc., Tokyo, Japan) 1 hour 
after TBI.  
 
Video-Electrocorticography  
 Each rat was anesthetized with 3% isoflurane in a carrier gas mixture of 30% 
N2O and 70% O2.  The scalp was then incised and reflected, and surgical steel screws 
with Teflon-coated leads (1.6mm long shafts, 10mm long leads; Plastics One, Norfolk, 
VA, U.S.A.) were implanted over the frontal cortex (3.5mm anterior to Bregma, +/- 
2.5mm lateral to midline), the right parietal cortex (2.0mm posterior to Bregma, +2.5mm 
lateral to midline) and the left parietal/occipital cortex (8.0mm posterior to Bregma, -
2.5mm lateral to midline).  To protect underlying brain tissue, electrode screws were 
inserted into the skull to a depth of no more than 0.8mm (i.e., half of the electrode screw 
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length).  Next, the tips of each electrode lead were inserted into a plastic electrode 
platform (Plastics One), the entire headset was then secured in place with dental 
acrylic, and the scalp was sutured closed around the base of the headset.  Rats were 
then allowed to recover for at least 3 days prior to EEG recording, after which they were 
lightly sedated with isoflurane (i.e., to the point of slowing reflexes) and connected to a 
video-ECoG system (BMSI 5000, Nicolet, Middleton, WI, U.S.A.).  A bipolar montage 
was used, with individual traces representing the voltage difference between (from top 
trace to bottom) the two frontal leads, the two ipsilateral leads, the two contralateral 
leads, and the two posterior leads.  In Experiment 1, video-ECoG was recorded for at 
least 12 hours per rat.  In Experiment 2, video-ECoG was recorded daily, or every other 
day, until at least 40 hours were recorded in total per rat.  To ensure the quality of video 
data for behavioral analysis, recordings were scheduled so that at least two-thirds of 
video would be recorded during light hours. 
 
Analysis of Spontaneous Seizures (Experiments 1 and 2) 
 Video-ECoG data in Experiment 1 were analyzed offline by three identically-
trained reviewers, one of whom was blinded to treatment groups.  In Experiment 2, all 
video-ECoG data were analyzed offline by a single reviewer who was blinded to 
treatment groups.  All ECoG traces were visually reviewed for electrographic seizures, 
defined as paroxysmal, rhythmic trains of spikes, waves, or spike-waves with amplitude 
at least double that of baseline (i.e., the 3-second epoch preceding the event) and a 
duration of 5 seconds or longer.  The duration of ECoG discharge was interpreted as 
seizure duration.  To characterize ECoG power distribution, spectral analysis with 
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Insight II software was performed on a representative sample of seizures (200Hz 
sampling of ≥3 second epochs; Persyst Corporation, Prescott, AZ).  To estimate the 
average frequency of seizures (seizures per hour) for each rat, the number of seizures 
observed on video-ECoG was divided by the number of video-ECoG hours reviewed.  
Seizure behavior was scored by comparison to a modified Racine scale [257]: sudden 
freezing was scored as a “0,” facial twitching as a “1,” head bobbing as a “2,” forelimb 
clonus as a “3,” rearing as a “4,” and falling or jumping as a “5.”  Seizures with a Racine 
score of 0 to 2 were considered “non-convulsive,” whereas those with a Racine score of 
3 to 5 were identified as “convulsive.”  Seizures were characterized as “non-convulsive” 
(Racine stage 0 to 2) or “convulsive” (Racine stage 3 to 5) according to the 
corresponding behavior. 
 
Ethosuximide and fos-Phenytoin Challenges (Experiment 1) 
 A subset of rats in Experiment 1 was used for additional experiments involving 
conventional anti-seizure medications.  Any epileptic, post-TBI rats with a functioning 
ECoG headset were included in these experiments, regardless of treatment group.  
These rats were administered a single dose of either ethosuximide (“ETX”; 25mg/kg; 
i.p.; Sigma Aldrich, St. Louis, MO, U.S.A.) or fos-phenytoin (“fPHT;” 40mg/kg; i.p. APP 
Pharmaceuticals, LLC, Schaumburg, IL, U.S.A.) while being monitored with video-
ECoG.  At least 2 hours of video-ECoG were recorded prior to drug administration, and 
at least another 2.5 hours were recorded thereafter.  A reviewer blind to the time of drug 
administration then visually reviewed ECoG traces for electrographic seizures (see 
criteria above).  Seizure frequency (seizures/hour) and duration were calculated for the 
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2 hour period preceding drug administration and for a 2 hour period beginning 30 
minutes after drug administration, to allow time for drug absorption.  All pre- and post-
drug data were normalized to pre-drug data for each rat.  To characterize time-
dependent changes in seizure frequency, seizure frequency was also calculated for 30 
minute segments of each video-ECoG recording.  To control for hourly fluctuations in 
seizure frequency which were not related to drug administration, analyses were 
repeated on previously recorded video-ECoG of the same rats, in which the recording 
conditions were the same except that no drugs were administered. 
 
Histology and Analysis of Neocortical Volume (Experiments 1 and 2) 
 Rats were deeply anesthetized with a euthanasia cocktail (390mg/kg of 
pentobarbital, 50mg/kg of phenytoin; i.p.) and then transcardially perfused with room-
temperature 0.9% saline followed by phosphate-buffered 4% paraformaldehyde 
(Pease’s fixative).  Brains were extracted whole and then immersed in Pease’s fixative 
overnight at 4ºC.  Brains were examined grossly for evidence of electrode injury, 
typically appearing as a small (<1mm) brown lesion on the surface of the neocortex 
underlying an electrode.  Any rats showing such injury were excluded from all analyses.  
Brains were blocked to remove tissue rostral to Bregma and caudal to Lambda.  Tissue 
blocks were then sectioned in the coronal plane by vibratome (Leica, Wetzler, 
Germany).  Sections were cut slowly and at a thickness of 75μm to minimize fraying and 
folding of peri-lesional tissue.  Beginning at the hippocampal commissure (-0.8mm 
Bregma), every eighth section was retained until 9 sections were collected per brain (1-
in-8 series, 600μm intervals; last section at -5.6mm Bregma).  This range permitted 
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analysis of tissue located 3.6mm rostral and 1.2mm caudal to the site of fluid percussion 
impact.  Slide-mounted sections were stained with thionine, dehydrated in ethanol, 
cleared in xylene, and coverslipped with Permount (Thermo Scientific).  Sections were 
then imaged through a macro lens (0.5x) on a light microscope (Nikon Eclipse E800M).  
Images were opened in ImageJ [258], which was then used to trace the borders of the 
ipsilateral and contralateral neocortex and measure the enclosed area.  The area of the 
ipsilateral neocortex was then divided by that of the contralateral neocortex, yielding a 
ratio (“RatioCx”) for each brain section [259].  An analogous procedure was used to 
calculate a ratio of the hippocampal hemispheres (RatioHp).  Regional boundaries and 
distances from Bregma were defined according to a stereotaxic atlas [188].    
 
Statistical Analysis 
 The normality of data distribution was assessed by Shapiro Wilk test (α=0.05).  
Normal data were compared by paired Student’s t test, unpaired Student’s t test, or one-
way analysis of variance (ANOVA) with Tukey’s post hoc test (for paired, single, or 
multiple comparisons, respectively), including the following: FPI pressure, subject age, 
post-TBI time, and pre vs. post-fPHT seizure frequency and duration.  Non-normal data 
were compared by Wilcoxon matched-pairs signed rank test, Mann Whitney test, or 
Kruskall-Wallis test with a post hoc Mann Whitney test (for paired, single, or multiple 
comparisons, respectively),  including the following: righting reflex latency; seizure 
frequency; seizure duration; total seizure time; pre- vs. post-ETX seizure frequency; 
RatioCx; RatioHp.  Acute mortality rate, prevalence of seizures, and prevalence of 
thalamic calcifications were compared across groups using a Chi-square test.  
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Spearman’s test was used to assess the correlation between seizure frequency and 
each histological measure (RatioCx, RatioHp, and thalamic calcifications).  When 
testing for a correlation between seizure frequency and thalamic calcifications, each rat 
was scored as a “1” or “0” depending on the presence or absence of calcifications, 
respectively.  All statistical analyses were performed with an alpha level of 0.05, using 
GraphPad Prism (version 5.0; GraphPad Software, La Jolla, CA, U.S.A.).  Data are 
reported as mean ± standard deviation (SD) in the text but are illustrated as mean ± 
standard error of the mean (SEM) in the figures.  N values represent the number of rats, 
unless stated otherwise. 
 
RESULTS 
 The present study used a total of 49 male, Sprague-Dawley rats acquired as 
adults (90 day old) and randomly assigned to treatment groups in two experiments.  
Rats were subjected to traumatic brain injury (TBI) by lateral fluid percussion and then 
monitored for spontaneous seizure activity at either 33 weeks post-TBI (Experiment 1) 
or 5 weeks post-TBI (Experiment 2).   
 
Mortality and Severity of Lateral Fluid Percussion Injury 
 To ensure that TBI severity was comparable between Experiments 1 and 2, we 
examined two correlates of TBI severity, the latency to recovery of righting reflex after 
TBI (“righting time”) and the acute mortality rate (i.e., within 7 days of TBI).  Overall, the 
average righting time was 9.1 ± 3.8 minutes and the average mortality rate was 14%.  
Neither righting time nor acute mortality rate differed significantly between experiments 
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(righting time, p=0.4599; acute mortality rate, χ2 [5]=3.461, p=0.6293), thus indicating 
that TBI severity was equivalent between the two experiments. 
 EXPERIMENT 1 – Adult, male Sprague-Dawley rats (n=34; 14 ± 1 weeks old) 
were administered lateral fluid percussion TBI or a sham injury (n=3), or were kept as 
age-matched controls (n=7).  At 1 hour post-TBI, rats received either a single dose of 
the calcineurin inhibitor, Tacrolimus (5mg/kg; i.p.; “TBI+TAC”; n=14) or no injection (“TBI 
Only”; n=10).  Age at the time of TBI (or sham) did not differ significantly among 
treatment groups (F [2,16]=0.4307, p=0.6574; Table 1).  Three rats died within 7 days of 
TBI (acute mortality rate, 13%), including one rat humanely sacrificed due to severe 
motor impairment.  Acute mortality rate varied across treatment groups but not to a 
statistically significant extent (mortality rates by treatment: TBI Only, 20%; TBI+TAC, 
7%; χ2 [2]=0.8816, p=0.6435).  The rats which died acutely after TBI were excluded 
from all analyses, as were the additional two rats that died after 7 days post-TBI but 
before data collection.  Three of the surviving rats (TBI+TAC group) exhibited apnea 
immediately following TBI and were mechanically ventilated with room air until 
spontaneous respirations resumed (mean duration of ventilation, 1.8 ± 1.1 minutes).  
Fluid percussion pressure (surviving rats) and righting time (all rats) were measured as 
correlates of injury severity.  Among the rats surviving TBI and used for video-ECoG 
analysis, fluid percussion pressure averaged 2.7 ± 0.1 atmospheres and righting time 
averaged 9.5 ± 4.2 minutes (Table 1).  Neither fluid percussion pressure nor righting 
time differed significantly between TBI Only and TBI+TAC rats (fluid percussion 
pressure, t [15]=1.495, p=0.1558; righting time, p=0.5622), which demonstrates that TBI 
severity was equivalent between these groups.   
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 EXPERIMENT 2 – Adult, male Sprague-Dawley rats (n=15; 14 ± 1 weeks old) 
were administered lateral fluid percussion TBI, followed 1 hour later by either 
Tacrolimus (n=6; TBI+TAC) or no injection (n=5; TBI Only).  Uninjured littermates were 
kept as age-matched controls (n=4; Control).  Two rats in the TBI+TAC group died 
within 7 days of TBI (acute mortality rate, 33%) and so were excluded from analysis.  All 
other rats survived until completion of the experiment.  Overall, the acute mortality rate 
associated with TBI in Experiment 2 was 18%.  Fluid percussion pressure and acute 
mortality were again used to approximate injury severity.  The mean fluid percussion 
pressure among surviving rats was 2.36 ± 0.04 atmospheres, and the mean righting 
time was 8.3 ± 2.8 minutes (Table 1).  Neither injury measure differed significantly 
between TBI Only and TBI+TAC rats (fluid percussion pressure, t [7]=1.562, p=0.1622; 
righting time, p=0.9048), indicating that the severity of TBI was equivalent between 
these groups. 
 
Video-Electrocorticography Revealed Two Distinct Types of Late Post-Traumatic 
Seizures (Experiment 1) 
 We used simultaneous video-ECoG to monitor spontaneous seizure activity at 33 
± 5 weeks after TBI or sham, or at the equivalent age in control rats (Figure 1A,B).  One 
rat (sham TBI) was excluded from analysis due to a surgical injury of the neocortex 
which occurred during implantation of the ECoG electrodes.  Age at time of video-ECoG 
did not differ significantly among treatment groups (F [3,22]=2.539; p=0.0827; Table 1).  
On average, video-ECoG was recorded over the course of 8 ± 7 days for a total of 51 ± 
15 hours per rat (Table 1).  In one case the ECoG headset detached from a rat after 
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only two days of recording, limiting that rat’s ECoG record to 12.4 hours.  We confirmed 
electrode depth by examining the neocortex post-mortem.  Two rats (TBI Only and 
TBI+TAC) were each found to have a small (<1mm) neocortical lesion at an electrode 
site and so were excluded from all analyses.  The remaining 1,315 hours of ECoG data 
were visually reviewed for electrographic seizures, defined as paroxysmal, rhythmic 
trains of spikes, waves, or spike-waves, lasting 5 seconds or longer and with an 
amplitude at least double that of baseline ECoG activity.   
 All rats exhibited arrhythmic, low-amplitude ECoG activity during awake behavior 
(Figure 1C).  In sharp contrast to this baseline activity were observed two distinct types 
of electrical seizures.  One seizure type appeared on the ECoG as a burst of high-
voltage spikes, followed by low-voltage fast activity which evolved into high-voltage 
spikes and waves (Figure 1D,E).  Spectral analysis of these seizures showed dominant 
power in the delta (<4Hz) and theta (4 to 8Hz) ranges (Figure 1E).  Analysis of the 
corresponding video revealed a tonic contraction followed by forelimb clonus, rearing, 
and falling (i.e., progression from Racine stage 3 to 5) – we therefore classified these 
events as “convulsive seizures.”  Previous studies of lateral fluid percussion TBI have 
reported similar seizures [173,259].   
 The present study identified convulsive seizures in two rats (TBI+TAC) during 
video-ECoG recording months after TBI.  These seizures occurred at a rate of 0.05 ± 
0.04 per hour and lasted an average of 95 ± 14 seconds (n=5 seizures; range 78 – 110 
seconds).  A third rat (TBI Only) exhibited a convulsive seizure prior to video-ECoG, at 
13 weeks post-TBI, but no additional seizures during video-ECoG.  Overall, only 5 
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convulsive seizures were recorded, rarity which precluded further analysis of these 
seizures. 
 The second type of seizure we observed was distinct in terms of electrographic 
appearance, spectral profile, and behavioral correlate.  This type of seizure appeared 
on the ECoG as a rhythmic train of spike-waves, beginning abruptly or building-up 
rapidly across all four ECoG leads, and lasting for tens of seconds (Figure 1F).  These 
discharges had a spike frequency of 6 to 8Hz, peak spectral power in the theta (4 to 
8Hz) and beta (12 to 18Hz) ranges (Figure 1G), and could be interrupted by alerting 
stimuli such as sudden changes in lighting or noise (data not shown).  The 
corresponding video showed subtle but stereotyped changes in behavior, ranging from 
behavioral arrest (or immobility) to head bobbing (Racine stage 0 to 2) - we termed 
these events “non-convulsive seizures.”  Similar seizures have been described in 
studies of adult rats following lateral [255] or parasagittal fluid percussion TBI 
[172,255,260] or neonatal hypoxic injury [261]. 
 We identified spontaneous, non-convulsive seizures at 33 weeks post-TBI in 
94% rats (16 of 17), prevalence similar to that observed months after parasagittal fluid 
percussion TBI [172,260].  One rat (TBI Only) did not exhibit any non-convulsive 
seizures on video-ECoG, only a single convulsive seizure which occurred prior to video-
ECoG recording (see above).  The two other rats with convulsive seizures also 
exhibited non-convulsive seizures, though convulsive and non-convulsive seizures were 
never observed on the same day in the same rat.  A total of 3,279 non-convulsive 
seizures were identified in the video-ECoG record of TBI rats.  
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 Previous ECoG studies have reported idiopathic seizure activity in uninjured 
Sprague-Dawley rats, typically beginning around 7-8 months of age (e.g., [172,260]).  
Accordingly, the present study identified non-convulsive seizures in 3 of 7 control rats 
and 2 of 2 sham TBI rats (average age, 10 ± 2 months).  The seizures in control and 
sham TBI rats were similar electrographically, characterized by a generalized onset, a 
spike-wave morphology, and peak spectral power in the theta and beta ranges (Figure 
2A).  The corresponding video showed behavioral freezing (or immobility) lasting at 
least as long as the electrographic discharge.   
 
TBI and Age Each Increased the Frequency and Duration of Non-Convulsive Seizures 
 The non-convulsive seizures of age-matched control and sham TBI rats 
resembled those of TBI rats (Figure 2A-C).  We therefore compared 
treatment groups in terms of seizure prevalence, frequency, or duration.  Prevalence 
was calculated as the percentage of rats observed to have at least 1 seizure during 
video-ECoG monitoring.  Non-convulsive seizures appeared to be more prevalent in TBI 
Only rats (83%) than in control and sham TBI rats (56%, combined), though the 
difference was not statistically significant (χ2 [1]=0.8365, p=0.3604).   
 We also compared the frequency of non-convulsive seizures across groups 
(Figure 2D).  Data from control and sham TBI rats were pooled for this analysis, since 
these groups did not differ significantly in seizure frequency (control, 2.1 ± 2.5 seizures 
per hour; Sham TBI, 0.4 ± 0.1 seizures per hour; t [3]=0.9146, p=0.4279).  Controls and 
sham TBI rats together exhibited 1.4 ± 1.9 non-convulsive seizures per hour (n=243 
seizures).  The frequency of non-convulsive seizures was 5-fold higher in TBI Only rats 
137 
 
than in controls/shams (TBI Only rats, 7.0 ± 3.6 non-convulsive seizures per hour; 
n=1,713 seizures; TBI Only vs. controls/shams, t [8]=3.075, p=0.0152).   
 We then analyzed the duration of non-convulsive seizures (Figure 2E).  Data 
from control and sham TBI rats were again pooled, since seizure duration did not differ 
significantly between these groups (control, 7 ± 1 seconds; sham TBI, 6 ± 0 seconds; t 
[3]=1.656, p=0.1963).  The mean duration of non-convulsive seizures in controls/shams 
was 6.8 ± 1.2 seconds.  The durations of non-convulsive seizures in TBI Only rats was 
twice as long as in controls/shams (13.6 ± 11.6 seconds; t [8]=2.887, p=0.0203; Figure 
2E).  In addition, the longest non-convulsive seizure recorded in controls/shams was 15 
seconds, but in TBI Only rats was 181 seconds.   
 An increase in seizure frequency and duration could mean that more time per 
hour is spent in a seizure state.  To test this possibility, we multiplied the averages of 
seizure frequency and seizure duration for each rat.  This analysis indicated that TBI 
Only rats averaged ten-fold more time per hour in a seizure state than did 
controls/shams (p=0.0159; Figure 2F).  Thus, non-convulsive seizures in TBI Only rats 
were significantly more frequent and longer-lasting than in controls/shams. 
 Previous ECoG studies have shown that idiopathic seizures become more 
frequent with age in Sprague-Dawley rats (e.g., [260]).  To confirm this in the present 
study, we performed video-ECoG monitoring on uninjured rats that were 5 months older 
than the controls/shams (older rats, n=2, 12 video-ECoG hours per rat).  The older rats 
exhibited spontaneous seizures which were electrographically and behaviorally similar 
to those of the age-matched controls/shams (data not shown).  However, seizure 
frequency differed significantly between the older and younger rats (p=0.0206).  
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Specifically, the older rats exhibited 9.7 ± 0.4 seizures per hour (n=232 seizures), a 7-
fold increase in frequency over that of controls/shams (p<0.05; Dunn’s post hoc test).  
Interestingly, seizure frequency in older rats was comparable to that of TBI Only rats 
(p>0.05).   
 Older rats also differed from the younger rats in terms of seizure duration 
(p=0.0168).  Specifically, the idiopathic seizures of older rats lasted 24.5 ± 4.0 seconds 
on average (range, 5 – 129 seconds), significantly longer than those of the younger 
controls/shams (p<0.05; Dunn’s).  However, seizure duration did not differ significantly 
between the older rats and the TBI Only rats (p>0.05; Dunn’s).  The preliminary data 
thus indicate that idiopathic seizures increase in frequency and duration with age, and 
suggest that TBI may accelerate this process. 
 
Tacrolimus Administered at One Hour Post-TBI Reduced the Frequency of Non-
Convulsive Seizures Months Later 
 Our lab recently demonstrated that calcineurin activity in the rat cortex increases 
within hours of lateral fluid percussion TBI [186], suggesting that calcineurin may be 
involved in post-traumatic epileptogenesis.  We therefore administered a calcineurin 
inhibitor, Tacrolimus (5mg/kg; i.p.; TBI+TAC; n=12) to rats 1 hour after lateral fluid 
percussion TBI and then monitored the rats by video-ECoG alongside their untreated 
counterparts (TBI Only) at 33 ± 5 weeks post-TBI.  As mentioned above, 1 TBI+TAC rat 
was excluded from analysis due to a small (<1mm) neocortical lesion at an electrode 
site.  Data from the remaining TBI+TAC rats (n=11) are summarized below. 
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Like the TBI Only rats, TBI+TAC rats exhibited spontaneous non-convulsive seizures 
months after lateral TBI (Figure 3A).  The prevalence of these seizures did not differ 
significantly between TBI+TAC rats and TBI Only rats (100% and 83%, respectively; 
χ2[1]=1.948, p=0.1628).  We then compared TBI groups in terms of seizure frequency 
and duration.  This analysis indicated that non-convulsive seizures were significantly 
less frequent in the TBI+TAC group than in the TBI Only group (p=0.0414; Figure 3B).  
However, seizure duration did not differ significantly between the TBI groups (p=0.2127; 
Figure 3C).  Multiplying seizure frequency by seizure duration for each rat revealed that 
TBI+TAC rats averaged significantly less seizure time per hour than did TBI Only rats 
(p=0.0414; Figure 3D).  The data overall indicate that administering Tacrolimus at 1 
hour post-TBI reduced the frequency of spontaneous non-convulsive seizures months 
later. 
 Differences in seizure frequency between groups could be explained by 
differences in the light/dark dependency of seizures.  For example, since most video-
ECoG was recorded during light hours, seizure frequency could be underestimated if 
more seizures occurred during the dark hours.  Plotting seizure onset times on a Raster 
did not suggest any light/dark dependence (Figure 4A), and seizure frequency did not 
differ significantly between light hours and dark hours of ECoG recording (for each 
treatment group, p>0.05 for light vs. dark seizure frequency; paired Student’s t test; 
Figure 4B). 
 Review of the Uaster plots also revealed a clustering pattern to the non-
convulsive seizures, especially in the brain injured rats (Figure 4A).  To confirm the 
apparent clustering, we averaged the time between seizures for each rat and then 
140 
 
compared group means (Figure 4C).  A binned analysis indicated that about 50% of 
non-convulsive seizures occurred within seconds of one another in the TBI Only and 
TBI+TAC rats.  In the controls/shams however, only about 25% of non-convulsive 
seizures occurred within seconds of one another.  The apparent increase in seizure 
clustering in TBI rats could be due to an increase in seizure frequency.  However, 
seizure frequency did not differ significantly between the TBI+TAC and controls/shams 
(p>0.05), though seizures tended to cluster more in the TBI+TAC rats (Figure 4C).  The 
data thus suggest that TBI enhances clustering of non-convulsive seizures, independent 
of the change in seizure frequency.     
 Nearly one-third of the ECoG data in Experiment 1 were reviewed blind to 
treatment group (28% overall; by treatment group, 0% control/sham, 34% TBI Only, and 
43% TBI+TAC).  The remaining data were reviewed without blinding and so may have 
been subject to experimenter bias. To control for this potential confound, we tested 
whether blinding affected seizure identification in the ECoG reviewers. Three ECoG 
recordings (~18 ECoG hours total) were analyzed independently by two reviewers, one 
of whom was blinded to treatment group.  The blinded reviewer counted 8.0 ± 5.3 
seizures per recording, whereas the unblinded reviewer counted 8.3 ± 4.6 seizures per 
recording.  Paired analysis confirmed that seizure counts did not differ significantly 
between the blinded and unblinded reviews (p=0.7728; Wilcoxon).  The data suggest 
that blinding ECoG reviewers to treatment group in the present study did not confound 
seizure identification. 
 
141 
 
Ethosuximide and fos-Phenytoin Differentially Affected the Frequency of Spontaneous 
Non-Convulsive Seizures 
 The conventional anti-seizure medication, ethosuximide (ETX), LV 
effective against multiple types of spontaneous non-convulsive seizures in rat models.  
For example, a single dose of ETX (50mg/kg; i.p.) can reduce both the frequency of 
absence seizures in a genetic model [262] and the frequency of partial seizures in an 
iron-induced neocortical injury model [263].  To determine whether ETX had a similar 
effect on non-convulsive seizures in the present study, we administered ETX (50mg/kg; 
i.p.) to a subset of epileptic rats (n=6) during video-ECoG.  This testing took place 1 
week after the rats were monitored for spontaneous seizure activity.  To ensure that a 
decrease in seizure frequency could be detected, we only included rats which had 
exhibited a high frequency of non-convulsive seizures (≥ 5 seizures/hr; n=6 rats).   
 We assessed seizure frequency and duration during the 2-hour period 
immediately preceding ETX administration (“pre-ETX period”) and for the 2-hour period 
beginning 30 minutes after ETX administration (“post-ETX period”).  During the pre-ETX 
period, rats averaged 7.0 ± 9.3 non-convulsive seizures per hour, lasting 14.3 ± 10.8 
seconds.  Compared to the pre-ETX period, seizure frequency decreased by 92% in the 
post-ETX period (p=0.0313, Wilcoxon; Figure 5A,D).  The decrease in seizure 
frequency was equivalent between TBI rats and uninjured rats (TBI rats, 96 ± 8% 
decrease; older, uninjured rats, 83 ± 24% decrease; t [4]=1.082; p=0.3402).  We did not 
compare seizure duration between the pre-ETX and post-ETX periods, because only 1 
rat exhibited seizures during the post-ETX period (post-ETX seizure duration, 10.1 ± 3.5 
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seconds).  The data overall suggest that ETX reduces the frequency of spontaneous 
non-convulsive seizures.  
 We then treated a different group of epileptic rats (n=4) with another anti-seizure 
medication, fos-phenytoin (fPHT; 40mg phenytoin equivalents/kg; i.p.), the pro-drug 
form of phenytoin.  In contrast to ETX, phenytoin has shown contrary effects in rat 
models of non-convulsive seizures.  Phenytoin can aggravate absence seizures in 
genetic models [264,265] at doses which inhibit partial seizures during electrical [266] or 
chemical kindling [267].  The present study used fPHT instead of phenytoin, because 
fPHT is more reliably absorbed when administered intraperitoneally but has shown 
similar pharmacokinetics and dose-equivalent efficacy in a rat model of partial seizures 
[268].  Rats in the present study were administered fPHT 9 ± 6 weeks after monitoring 
for spontaneous seizure activity.  To ensure that bi-directional changes in seizure 
frequency could be detected, we only included rats which exhibited a moderate 
frequency of non-convulsive seizures (≈ 2/hr; n=4 rats) at 33 weeks post-TBI.   
 We measured seizure frequency and duration in the 2-hour period immediately 
preceding fPHT administration (“pre-fPHT period”) and in the 2-hour period beginning 
30 minutes after fPHT administration (“post-fPHT period”).  One rat exhibited no 
seizures during the pre- or post-fPHT periods.  All other rats showed non-convulsive 
seizures during both periods, averaging 1.6 ± 1.3 seizures per hour in the pre-fPHT 
period, and 6.1 ± 3.3 seizures per hour in the post-fPHT period (Figure 5B,D).  Despite 
the nearly 4-fold increase in seizure frequency, a paired analysis found no significant 
difference in seizure frequency between the pre- and post-fPHT periods (t [4]=2.423, 
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p=0.0725).  Nor did seizure duration change significantly after fPHT treatment (pre-
fPHT, 9.7 ± 6.4 seconds; post-fPHT, 8.9 ± 5.5 seconds; t [4]=0.5512, p=0.6108).   
 The changes in seizure frequency following ETX and fPHT treatment could 
represent either normal fluctuations or drug effects.  To FRPSDUHWKHVHSRVVLELOLWLHV, we 
reviewed previous ECoG of the rats later used in the ETX and fPHT experiments.  The 
recording conditions for these ECoG were the same as in the ETX and fPHT 
experiments, except that no drug was administered.  We assessed non-convulsive 
seizure frequency in 2-hour periods which were analogous to the pre- and post-drug 
periods in the ETX and fPHT experiments.  A paired analysis found no significant 
difference in seizure frequency between the first and second 2-hour periods, either 
among the rats later treated with ETX or among those later treated with fPHT (p=0.4615 
and 0.2785, respectively; Wilcoxon; Figure 5C,D).  Therefore, the changes in seizure 
frequency following administration of ETX and fPHT most likely represent drug effects. 
 
Tacrolimus Did Not Protect against Cortical Atrophy or Thalamic Calcifications following 
TBI (Experiment 1) 
 Lateral fluid percussion TBI causes progressive degeneration of ipsilateral cortex 
over the course of a year [269], and the degeneration of certain cortical regions 
correlates with the incidence of late spontaneous seizures [259].  Therefore, to 
determine the location and extent of cortical degeneration in the present study, we 
sacrificed the rats of Experiment 1 at 43 ± 8 weeks post-TBI (or sham) and processed 
them for histology, along with age-matched controls.  Groups did not differ significantly 
either in age at sacrifice or in time between TBI and sacrifice (age at sacrifice, F 
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[2,20]=1.438, p=0.2610; time between TBI and sacrifice, F [2,14]=0.1998, p=0.8212; 
Table 1).  Gross examination of fixed brains from TBI rats revealed an opaque lesion, 
1mm or more in diameter, at or just ventral to the site of fluid percussion impact.  We 
collected coronal sections at 0.6mm intervals between 0.8mm and 5.6mm caudal to 
Bregma, stained the sections with thionine and examined them by light microscopy 
(Figure 6A,B).  Most TBI brains showed at least 1 opaquely-stained lesion in the 
ipsilateral thalamus (Figure 6C and inset in Figure 6B).  We interpreted these lesions as 
thalamic calcifications, based on similar findings in previous studies of fluid percussion 
TBI [172,259].  Thalamic calcifications were identified in nearly all TBI rats but never in 
control rats (Figure 6C).  However, the prevalence of these calcifications did not differ 
significantly between TBI Only and TBI+TAC rats (χ2 [1]=0.7804; p=0.3770; Figure 6C).  
Nor did the presence of calcifications correlate with seizure frequency, either within or 
across groups (p>0.05).  The data therefore suggest that thalamic calcifications were 
not related to the frequency of non-convulsive seizures after lateral TBI. 
 Initial examinations also suggested atrophy of the ipsilateral neocortex in all TBI 
rats.  To quantify the apparent atrophy, we used ImageJ to trace the ipsilateral and 
contralateral neocortex in micrographs and then measure the area enclosed by the 
tracing (Figure 6B).  The traced area of the ipsilateral (left) neocortex was then divided 
by that of the contralateral (right) neocortex in each brain section, yielding a ratio of the 
two hemispheres (“RatioCx”) [259].  This analysis revealed significant differences in 
RatioCx among the treatment groups, as described below.  
 NEOCORTEX - The RatioCx in control brains was consistent along the rostro-
caudal axis, averaging 0.98 ± 0.01 when measured from -0.8mm through -5.6mm 
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Bregma (Figure 6D).  Cross-comparison of the mean RatioCx revealed significant 
differences among treatment groups (mean RatioCx, p=0.0022; Figure 6D2).  Post hoc 
analysis indicated, for example, that the RatioCx was significantly decreased in TBI 
Only rats relative to controls (p=0.0043).  The RatioCx in TBI+TAC rats was also 
decreased from control levels (p=0.0002).  The decrease in RatioCx in TBI+TAC rats 
appeared to be comparable to that of TBI Only rats, as the TBI groups did not differ 
significantly from one another (p=0.6787).  RatioCx decreased most likely due to 
atrophy of the ipsilateral neocortex, since the area of the contralateral neocortex did not 
differ significantly across treatment groups (control, 10.6 ± 1.4 arbitrary units, A.U.; TBI 
Only, 9.9 ± 0.3 A.U.; TBI+TAC, 10.4 ± 0.9 A.U.; p=0.3228, Kruskal-Wallis) [259].  The 
data thus demonstrate substantial atrophy of the ipsilateral neocortex by 43 weeks post-
TBI, and agree with previous findings that Tacrolimus does not prevent neocortical 
atrophy following TBI [270,271]. 
 Previous research has shown that the risk of spontaneous seizures increases 
with the severity of neocortical atrophy following lateral fluid percussion TBI [259].  We 
therefore used linear correlation to test whether seizure frequency and neocortical 
atrophy were related.  However, mean RatioCx did not correlate with the frequency of 
non-convulsive seizures, either within TBI groups or when all TBI groups were 
combined (each, p>0.05).  The data thus suggest that neocortical atrophy is not related 
to non-convulsive seizure frequency after lateral TBI. 
 We did not perform correlational analysis on convulsive seizure data due to lack 
of data.  It is worth noting, however, that the two rats exhibiting convulsive seizures on 
video-ECoG also had the most severe neocortical atrophy (i.e., first and second lowest 
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mean RatioCx among all rats).  Quantitative analysis revealed that the RatioCx was 
significantly decreased in these two rats, when compared to the TBI rats in which no 
convulsive seizures were observed (t [13]=4.563, p=0.0005).  The data therefore 
support previous research showing a correlation between neocortical atrophy and 
convulsive seizures after lateral TBI [259]. 
 HIPPOCAMPUS – We also assessed atrophy in the hippocampus, since 
previous research has linked hippocampal asymmetry related to the incidence of late 
non-convulsive seizures after fluid percussion TBI [260].  In the present study, we 
estimated hippocampal atrophy by tracing the ipsilateral and contralateral hippocampi, 
measuring the enclosed areas (Figure 6B), and then calculating a ratio of ipsilateral to 
contralateral area (“RatioHp”).  Analysis of RatioHp was limited to Bregma levels -
3.2mm through -5.6mm for two reasons.  First, hippocampal gray matter was not 
present in the sections representing -0.8mm and -1.4mm Bregma.  Second, the rostral 
end of the hippocampus appeared to have shifted caudally after TBI, confounding the 
RatioHp in those sections (Figure 6E).   
 RatioHp in controls was consistent along the rostro-caudal axis, averaging 1.03 ± 
0.03 when measured from Bregma levels -3.2mm to -5.6mm (Figure 6E).  As with 
RatioCx,  RatioHp differed significantly among treatment groups (mean RatioHp, 
p=0.0028; Figure 6E2).  In particular, RatioHp in TBI Only rats was significantly 
decreased relative to controls (p=0.0087).  TBI+TAC rats also showed a loss of RatioHp 
when compared to controls (p=0.0005), but not when compared to TBI Only rats 
(p=0.3710).  As with RatioCx, RatioHp most likely decreased due to changes in the 
ipsilateral hippocampus, since the area of the contralateral hippocampus did not differ 
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significantly across treatment groups (control, 4.6 ± 0.4 arbitrary units, A.U.; TBI Only, 
4.2 ± 0.4 A.U.; TBI+TAC, 4.6 ± 0.7 A.U.; p=0.3646, Kruskal-Wallis).  Overall, the data 
suggest that the ipsilateral hippocampus underwent a significant change in volume 
and/or shape by 43 weeks post-TBI.  While this change is consistent with previous 
reports of hippocampal asymmetry after fluid percussion injury [260], it did not appear to 
be related to the expression of non-convulsive seizures, since RatioHp did not correlate 
with non-convulsive seizure frequency (within or across the TBI groups, p>0.05). 
 
Seizures Were Not Observed at 5 Weeks Post-TBI (Experiment 2) 
 Spontaneous non-convulsive seizuresFDQ begin a few weeks after lateral 
fluid percussion TBI and increase in both frequency and severity over months [255].  To 
characterize the timing of seizure development in the present study, we subjected a 
different set of rats to lateral fluid percussion TBI and then monitored spontaneous 
seizure activity by video-ECoG 5 weeks later (Experiment 2; Figure 7A).  The severity of 
TBI in Experiment 2 was equivalent to that in Experiment 1 (see Results above), and 
the treatment groups were also the same - rats received either a single dose of 
Tacrolimus (5mg/kg; i.p.; “TBI+TAC”; n=4) or no injection (“TBI Only”; n=5) at 1 hour 
post-TBI.  At 5 weeks post-TBI, injured rats and their uninjured littermates (n=4) were 
monitored by simultaneous video-ECoG.  Video-ECoG was recorded 12 ± 1 hours per 
rat, beginning in the morning and completed the same day.  A trained observer who was 
blinded to treatment group then visually reviewed video-ECoG data offline for evidence 
of seizure activity. 
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 Low-voltage, arrhythmic electrographic activity was observed during awake 
behavior in all rats.  In contrast to the baseline ECoG activity were observed paroxysmal 
discharges lasting less than 5 seconds.  These epileptiform discharges were observed 
occasionally (<1/hr) in all TBI rats (Figure 7B) and in one control rat (Figure 7C).  
However, epileptiform activity lasting longer than 5 seconds was not observed in any 
rat.  The data thus confirms previous reports that seizure prevalence and/or frequency 
increases over months following fluid percussion TBI [172,255,260]. 
 
DISCUSSION 
 The present study describes several major findings related to the long-term 
electrographic and anatomical consequences of lateral TBI.  For example, video-ECoG 
revealed two distinct types of spontaneous seizures in adult rats months after TBI.  
These seizure types included convulsive seizures which were infrequent but lasted for 
minutes, and non-convulsive seizures which were frequent but lasted tens of seconds 
on average.  A subset of age-matched, uninjured rats exhibited idiopathic seizures, and 
these idiopathic seizures were electrographically and behaviorally similar to the non-
convulsive seizures seen months after TBI.  However, the idiopathic seizures were far 
less frequent and shorter lasting than the non-convulsive seizures of TBI rats.  
Interestingly, administering a calcineurin inhibitor, Tacrolimus (TBI+TAC) at 1 hour post-
TBI significantly decreased the frequency of non-convulsive seizures months later but 
did not protect against cortical atrophy or thalamic calcifications.  A second video-ECoG 
experiment performed at 5 weeks post-TBI revealed epileptiform discharges but no 
149 
 
seizures, suggesting that both the convulsive and non-convulsive seizures have a 
delayed onset. The context and implications of the major findings are discussed below.  
 Studies of post-traumatic epilepsy in human patients and rodent models suggest 
that epileptogenesis begins within minutes to hours of TBI [176,177].  Our previous 
research identified an increase calcineurin activity in the minutes to hours following 
lateral fluid percussion TBI [186].  This increase in calcineurin activity could be an early 
but critical event in the development of post-traumatic epilepsy, as has been proposed 
in other models of acquired epilepsy (reviewed in [251]).  Consistent with this possibility, 
the present study demonstrated that administering a calcineurin inhibitor, Tacrolimus, 1 
hour after TBI reduced the frequency of spontaneous non-convulsive seizures months 
later.  This finding may shed light on the timing and mechanisms by which non-
convulsive seizures develop after TBI, as it reveals a Tacrolimus-sensitive mechanism 
which is engaged acutely after TBI.  Though only a single dose of Tacrolimus was 
administered in the present study, previous studies suggest that brain levels can remain 
stable for days [272].  It is therefore possible that Tacrolimus inhibited calcineurin 
activity for days after TBI, potentially blocking the increase in calcineurin activity our lab 
previously identified in this model [186].  Importantly, these findings suggest that 
pharmacological intervention at a clinically-relevant time point can alter the course of 
epilepsy development after TBI. 
 Further research is needed to characterize the role of calcineurin in 
epileptogenesis.  One possibility is that a pathological increase in calcineurin activity 
leads to the dysregulation of hyperpolarization-activated cation (HCN) channels [254].  
Calcineurin has been shown to downregulate gating of HCN channels, resulting in 
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neuronal hyperexcitability [254], and a reduction in HCN channel expression in rat 
cortex is associated with epileptogenesis after status epilepticus [273,274].  HCN 
channelopathy may also explain the spontaneous non-convulsive seizures observed in 
the present study.  HCN channels are downregulated in subthalamic nuclei in the 
tottering mouse, a genetic model of spontaneous non-convulsive seizures [275].  In 
addition, mice lacking a subtype of HCN channels (HCN2) also exhibit spontaneous 
non-convulsive seizures [276].  It is therefore possible that TBI induces (or exacerbates) 
the development of spontaneous non-convulsive seizures through a calcineurin-
dependent dysregulation of HCN channels, and that this process begins within hours or 
days of TBI.   
 Calcineurin may also mediate epileptogenesis through its effects on the immune 
system or in synaptic circuits.  For example, calcineurin mediates pro-inflammatory 
signaling by interleukin-1β and tumor necrosis factor-α, and these signaling pathways 
have been strongly implicated in epileptogenesis [226,277,278,279].  An alternative but 
not exclusive possibility is that calcineurin facilitates epileptogenesis by destabilizing 
dendritic spines.  Various injury models have shown that drugs which inhibit calcineurin 
activity also block the loss of dendritic spines after injury, including the spine loss we 
observed in the neocortex and dentate gyrus after lateral TBI [11,12,118,233].  Since 
dendritic spines bear the majority of excitatory synapses in the adult cortex [5], a 
widespread and persistent loss of spines could equate to deafferentation.  
Deafferentation can induce epileptiform activity in the neocortex [280,281,282], 
potentially through a homeostatic increase in network excitability [283].  In addition, 
studies of human epileptic tissue have found that spine loss in the dentate gyrus 
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correlates with an abnormal prolonging of excitatory post-synaptic responses [284,285], 
which could support seizure activity. 
 Previous studies of the lateral fluid percussion model have reported either 
convulsive seizures or non-convulsive seizures in the months following TBI [173,255].  
For example, Kharatishvili and colleagues (2006) described infrequent but long-lasting 
convulsive seizures in up to 50% of rats after TBI, but did not note any non-convulsive 
seizures [173].  In contrast, a study by Curia et al. (2011) found frequent but short-
lasting non-convulsive seizures in nearly all rats after TBI, but did not note any 
convulsive seizures [255].  The present study is thus the first (to our knowledge) in 
which both types of seizures were identified after TBI, and in the same rats.  
Methodological differences could explain the discrepant findings in previous studies.  
For example, adolescent rats (1 month old) like those used in the Curia et al. (2011) 
study may be less likely to develop convulsive seizures after fluid percussion TBI than 
the adult rats used in the present study and in the Kharatishvili et al. (2006).  Age-
dependency is characteristic of other models of acquired epilepsy – for example, rats 
younger than 25 days are less likely to develop spontaneous convulsive seizures 
following experimental status epilepticus [286,287].  
 While the post-traumatic seizures observed in the present study resemble those 
seen in previous studies, questions remain about the nature of the non-convulsive 
seizures.  Specifically, it is unclear whether these seizures represent an acquired form 
of partial epilepsy [288], or an exacerbated form of idiopathic, absence-like epilepsy 
[289,290].  Previous studies have reported that the non-convulsive seizures are focal in 
origin [172], involve limbic regions, and can be electrographically differentiated from 
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idiopathic seizures on the basis of waveform and localization [260].  Subsequent 
research also determined that the non-convulsive seizures were insensitive to the anti-
seizure drug, carisbamate [291], at dosages above those which suppress absence 
seizures in rat models [292] (but see also [293]).  Overall, the evidence from previous 
studies suggests that the non-convulsive seizures are partial seizures, like those 
frequently seen in human post-traumatic epilepsy [166,288].  The non-convulsive 
seizures in the present study, however, more closely resembled absence seizures.  For 
example, the seizures we observed typically had a generalized onset, spike-wave 
morphology, and dominant spectral power in the theta and beta ranges.  These 
electrographic features are typical of absence seizures in rats [294].  Also, the non-
convulsive seizures we observed could be interrupted by sensory stimulation, 
suppressed by ETX, and exacerbated by fos-phenytoin - also characteristic of absence 
seizures [262,264,265,295]  (but see also [263,296,297]).  However, further 
investigation is needed to confirm that the non-convulsive seizures we observed months 
after TBI were absence seizures.   
 Studies of other rat models suggest that brain injury can cause or exacerbate 
absence-like seizures in rats.  For example, focal thrombolytic damage to rat neocortex 
has been shown to impair the excitability of thalamic reticular neurons [298], cells which 
normally inhibit thalamocortical circuits implicated in involved in absence seizures [299].  
More diffuse brain injuries may also give rise to absence seizures.  For example, rats 
develop absence-like seizures weeks to months after pilocarpine-induced status 
epilepticus [300,301] .  For example, Francois and colleagues (2011) found that 
administering adult male Sprague-Dawley rats the anti-seizure drug, carisbamate (90 or 
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120mg/kg), after pilocarpine-induced status epilepticus reduced by half the number of 
rats developing late convulsive seizures [300].  These rats instead developed frequent, 
non-convulsive seizures which were not observed in rats with convulsive seizures, and 
which were electrographically, behaviorally, and pharmacologically similar to absence 
seizures [300].  Though the authors note that a third of age-matched controls also 
showed absence-like seizures, the seizures in post-SE rats were nearly ten-fold more 
frequent than in controls [300].  Likewise in the present study, non-convulsive seizures 
in brain injured rats study were similar in phenotype to idiopathic seizures, but were 
significantly more frequent and longer lasting.  Together these studies suggest that 
brain injury can increase the frequency of absence-like seizures in adult rats [290]. 
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TABLE 2 – TBI Severity, Age, and Video-ECoG Duration.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Values represent mean ± standard deviation. 
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FIGURE 23 – Video-Electrocorticography Revealed Two Distinct Types of Late 
Post-Traumatic Seizures.  Adult, male Sprague-Dawley rats were subjected to lateral 
fluid percussion TBI or sham TBI and then monitored for spontaneous seizure activity 
33 ± 5 weeks later, alongside age-matched uninjured controls.  A)  Timeline of 
Experiment 1.  B)  Placement of fluid percussion impact (FPI) and epidural electrodes 
for electrocorticography (ECoG).  C)  Arrhythmic, low-voltage ECoG activity typical of 
awake behavior in all rats, shown as bipolar montage.  D)  Representative ECoG of 
convulsive (tonic-clonic) seizures observed months after TBI.  E)  On left, enlarged 
ECoG trace showing irregular spike-and-wave waveform of convulsive seizures. On 
right, spectral analysis of a 3 second epoch showing typical distribution of power during 
a convulsive seizure.  F)  Representative example of ECoG of non-convulsive seizure.  
G)  On left, enlarged ECoG trace revealing spike-wave waveform of non-convulsive 
seizures.  On right, spectral analysis of a 3 second epoch showing typical distribution of 
power during a non-convulsive seizure.  All scale bars, 0.4mV by 3sec. 
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FIGURE 24 – Late Post-Traumatic Seizures Could Be Distinguished from 
Idiopathic Seizures by Frequency and Duration.  Video-ECoG was performed on 
male Sprague-Dawley rats 33 weeks after lateral fluid percussion TBI (“TBI Only”) or 
sham (“Sham TBI”), or at the equivalent age in uninjured littermates (“Control”).  A – C) 
Representative ECoG and spectral profiles of non-convulsive seizures in an uninjured 
control rat, a Sham TBI rat, and a TBI Only rat.  D, E)  Non-convulsive seizures were 
significantly more frequent and longer lasting in TBI Only rats than in controls/shams.  
F) TBI Only rats spent on average significantly more time in a non-convulsive seizure 
than did controls/shams.  Circles and bars on graphs denote individual means and 
group means, respectively.  Means compared by Kruskal-Wallis test with post hoc Mann 
Whitney tests.  Scale bars, 0.4mV by 2 seconds. *, p<0.05 
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FIGURE 25 – Administering Tacrolimus Acutely after TBI Decreased the 
Frequency of Late Non-Convulsive Seizures.  Rats were administered a calcineurin 
inhibitor, Tacrolimus (5mg/kg; i.p.; “TBI+TAC”) or no injection (“TBI Only”) 1 hour after 
lateral fluid percussion TBI, and then monitored by video-ECoG approximately 33 
weeks later.  A) A typical non-convulsive seizure in a TBI+TAC rat and its spectral 
profile. B)  TBI+TAC rats exhibited significantly fewer non-convulsive seizures per hour 
than did TBI Only rats.  C) The average duration of non-convulsive seizures did not 
differ significantly between TBI+TAC and TBI Only rats.  D)  TBI+TAC rats averaged 
significantly less time per hour in a non-convulsive seizure than did TBI Only rats.  
Circles and bars on graphs denote individual means and group means, respectively.  
Means compared by Kruskal-Wallis test with post hoc Mann Whitney tests.  All scale 
bars, 0.4mV by 2 seconds. * p<0.05 
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FIGURE 26 – TBI Increased the Clustering of Non-Convulsive Seizures.  Adult, 
male Sprague-Dawley rats were administered lateral fluid percussion TBI followed by 
Tacrolimus (“TBI+TAC”) or no injection (“TBI Only”), and then were monitored for 
spontaneous seizure activity months later, along with age-matched uninjured 
(“Controls”) and Sham TBI rats.  A)  Raster plot with hashes (|) marking the onset times 
of spontaneous non-convulsive seizures during typical 10 hour video-ECoG recordings 
of Sham TBI, TBI Only, and TBI+TAC rats.  B)  Seizure frequency did not differ 
significantly between light and dark phases (paired Student’s t tests).  C)  Binned 
analysis revealed that a majority of non-convulsive seizures occurred within seconds of 
one another in TBI Only rats and TBI+TAC rats, but not in controls/shams. 
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FIGURE 27 – Ethosuximide and fos-Phenytoin Differentially Affected the 
Frequency of Non-Convulsive Seizures.  Non-convulsive seizures were 
pharmacologically characterized by administering conventional anti-seizure medications 
to epileptic rats during video-ECoG recording.  Rats exhibiting a high frequency of non-
convulsive seizures (≥5/hr; n=6) were administered a single dose of ethosuximide 
(“ETX,” 50mg/kg, i.p), whereas rats exhibiting a moderate seizure frequency (≈2/hr; 
n=4) were administered fos-phenytoin (“fPHT,” 40mg phenytoin equivalents/kg, i.p.).  A)  
ETX treatment was associated with a significant decrease in the frequency of non-
convulsive seizures.  B)  fPHT treatment appeared to increase the frequency of non-
convulsive seizures, but not to a statistically significant extent.  C)  Changes in seizure 
frequency after ETX or fPHT treatment likely represent drug effects, since seizure 
frequency did not fluctuate significantly in previously-recorded, drug-free recordings of 
the same rats (rats later administered ETX, orange; rats later administered fPHT, blue).  
D)  Temporal profile showing changes in seizure frequency which began soon after drug 
administration (vertical dotted line) and which were not observed when no drug was 
administered.  ETX data compared by Wilcoxon matched-pairs signed rank test. fPHT 
data compared by paired Student’s t-tests.  All data presented as mean ± standard error 
of the mean (S.E.M.).  * p<0.05 
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FIGURE 28 – TBI Caused Thalamic Calcifications and Cortical Atrophy.  Rats were 
sacrificed and processed for thionine histology after completion of video-ECoG, 
approximately 42 ± 9 weeks after lateral fluid percussion TBI, or at an equivalent age in 
uninjured controls.  A) Illustration indicating where sections were collected relative to 
the site of fluid percussion impact (FPI).  B) Low-magnification (0.5x) light micrographs 
of representative, thionine-stained sections from -3.8mm Bregma, and the 
corresponding traces of neocortex and hippocampus which were used for measuring 
area (in black).  Inset indicates a thalamic calcification; a smaller calcification can also 
be seen in the TBI+TAC image.  C) Thalamic calcification from (B, inset) shown at 5x 
and 10x magnification, and a graph of the percentage of rats having at least 1 thalamic 
calcification.  D) TBI Only and TBI+TAC rats showed significant but comparable 
decreases in RatioCx when assessed at each Bregma level (D1) and when averaged 
across Bregma levels (D2).  E) TBI Only and TBI+TAC rats showed significant but 
comparable decreases in RatioCx when assessed at the rostral Bregma levels (E1) and 
when averaged from Bregma -3.2mm to -5.6mm (E2).  The decrease in RatioHp in the 
rostral sections (Bregma -2.0mm and -2.6mm) appeared to be due to shrinkage of the 
hippocampus along the rostro-caudal axis; the affected sections were therefore 
excluded from the mean RatioHp.  Means compared by Kruskal-Wallis test with post 
hoc Mann Whitney tests.  Scale bar, 0.5mm.  *p<0.05 vs. control, **p<0.01 vs. control, 
***p<0.001 vs. control 
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FIGURE 29 – No Seizures Were Observed at 5 Weeks Post-TBI.  Adult, male 
Sprague-Dawley rats were subjected to lateral fluid percussion TBI, followed 1 hour 
later by administration of Tacrolimus (5mg/kg; i.p.; “TBI+TAC”; n=4) or no injection (“TBI 
Only”; n=5), and then were video-ECoG monitored at 5 weeks post-TBI along with 
uninjured littermates (“Control;” n=4).  A) Timeline of Experiment 2.  B)  Examples of 
paroxysmal electrographic discharges lasting <5 seconds from two different TBI Only 
rats.  Similar phenomena were observed occasionally (<1/hr) in all TBI rats and were 
interpreted as epileptiform discharges.  C)  An example of the epileptiform activity 
exhibited by one control rat.  All scale bars, 0.4mV by 3 seconds. 
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DISCUSSION 
 
 The present study characterized the biochemical, histological, and electrographic 
consequences of lateral traumatic brain injury (TBI) in a rat model.  Chapter I 
demonstrated an acute post-TBI loss of dendritic spines from principal cells of the 
ipsilateral neocortex and bilateral dentate gyrus.  Administering the calcineurin inhibitor, 
Tacrolimus (FK506), 1 hour after TBI prevented this spine loss.  Chapter II then 
characterized the role of calcineurin in TBI-induced spine loss.  Western blots revealed 
evidence of an acute post-TBI increase in the cortical activity of cofilin, an actin-
depolymerizing protein which had been previously implicated in dendritic spine loss 
[23,211,241].  Administering Tacrolimus 1 hour after TBI prevented the apparent 
activation of cofilin in the neocortex.  In addition, enzymatic assays showed an acute 
post-TBI increase in calcineurin activity in the hippocampus.  Chapter III then assessed 
the long-term consequences of an acute post-TBI increase in calcineurin activity. 
Specifically, rats were administered a calcineurin inhibitor, Tacrolimus (FK506), at 1 
hour post-TBI and then monitored for spontaneous seizure activity months later.  This 
acute treatment with Tacrolimus reduced the frequency of late non-convulsive seizures 
months later.  The results presented in these chapters together demonstrate that a 
calcineurin inhibitor, Tacrolimus, can mitigate two significant consequences of lateral 
TBI, an acute loss of dendritic spines and the delayed development of non-convulsive 
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seizures.  However, It remains unclear whether the spine loss and seizure development 
are related phenomena.  The spine loss and seizure development may be two 
independent outcomes of a Tacrolimus-sensitive event.  Alternatively, spine loss may 
be an early but critical event in epileptogenesis, as has been hypothesized previously 
[78].  The remainder of this discussion considers the evidence for a causal relationship 
between spine loss and epileptogenesis. 
 Could the spine loss observed in Chapter I somehow give rise to the late 
spontaneous seizures seen in Chapter III?  Evidence for this possibility comes from a 
different model of epileptogenesis, the “cortical undercut” model.  In one version of this 
model, adult rat neocortex is partially but chronically isolated through mechanical 
lesions of the cortical white matter [302].  After an electrographically silent period of 
days to weeks, the undercut cortex begins to show recurrent epileptiform activity 
[280,303].  Studies of this model have identified potential mechanisms of 
epileptogenesis.  One mechanism may be the formation of new excitatory circuits, as 
epileptogenesis coincides with axonal sprouting and an increase in connectivity among 
layer V neurons [304,305].  Furthermore, blocking synaptic activity acutely after cortical 
undercut can prevent both the axonal sprouting and the development of epileptiform 
activity [306,307,308].  These studies collectively suggest that an up-regulation of 
excitatory synapses in the undercut neocortex may give rise to epilepsy. 
 How could the undercut injury lead to an up-regulation of excitatory synapses? 
One possibility is that the deafferentation triggers a compensatory increase in the 
strength or number of excitatory synapses [283].  For example, de novo intracortical 
connections may develop to replace the severed, extracortical ones [305].  However, 
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replacing extracortical connections with intracortical ones could dramatically alter 
network dynamics, potentially resulting in hyper-excitable or hyper-synchronous circuits 
[283].  Deafferentation could also cause hyper-excitability in the absence of 
synaptogenesis, by triggering a homeostatic increase in the sensitivity of surviving 
connections [309].  Regardless of the underlying mechanism, these studies show that 
deafferentation can trigger an up-regulation of excitatory synapses, potentially resulting 
in epilepsy. 
 The changes in spine density we observed after lateral TBI may reflect synaptic 
re-wiring like that observed in the cortical undercut model [305].  In the cortical undercut 
model, injury causes a deafferentation of neocortical pyramidal cells and a consequent 
up-regulation of excitatory synapses.  In the lateral TBI model, we observed an acute 
loss and subsequent regrowth of dendritic spines, which could equate to deafferentation 
and re-afferentation, respectively.  Though spine regrowth may signify circuit restoration 
rather than alteration, we also observed an abnormal increase in spine density in the 
hippocampus 1 week post-TBI, which suggests de novo synaptogenesis.  Lateral TBI 
and cortical undercut therefore may both induce epilepsy through a common 
mechanism: a compensatory but maladaptive elaboration of excitatory synapses. It is 
important to note that, in the present study, spine loss and regrowth were observed on 
layer II/III pyramidal neurons, whereas the cortical undercut studies focused on layer V 
pyramidals [302,304,305].  Still, deafferentation has been shown to cause an increase 
in dendritic spine density on layer II/III pyramidals [310], which suggests that 
connectivity in layer II/III is also subject to homeostatic regulation.  A loss of dendritic 
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spines in layer II/III could therefore trigger compensatory changes in neuronal networks, 
and so facilitate epileptogenesis in our TBI model. 
 While our data raise the possibility that spine loss is involved in post-traumatic 
epileptogenesis, many related questions remain unanswered.  For example, do the 
changes in dendritic spine density we observed after TBI truly represent changes in 
synaptic circuitry?  This question could be answered with combination of anatomical 
and physiological techniques.  Anatomical techniques, such as array tomography and 
electron microscopy, could be used to correlate spine density with synapse density after 
TBI.  If these methods detect a change in synapse density, the functional consequences 
could then be assessed by electrophysiology and/or functional imaging.  For example, 
synaptic activity could be measured within fluorescently-labeled neurons showing an 
increase in spine density.  These experiments would reveal whether the spine 
overgrowth at 1 week post-TBI represents an excess of excitatory synapses.  Also, 
paired intracellular recordings or functional imaging could be used to test whether local 
connectivity is enhanced after TBI as it is after cortical undercut [305].  An increase in 
synaptic activity or local connectivity would confirm that TBI alters synaptic circuits, 
consistent with the changes in dendritic spine density described in Chapter I.  
 Another important question concerns whether synaptic re-wiring is necessary for 
post-traumatic epilepsy.  Studies of the cortical undercut model suggest that newly-
formed excitatory circuits give rise to epileptiform activity [311].  Do similar circuits form 
after lateral fluid percussion TBI?  If so, are these circuits responsible for the late 
spontaneous seizures described in Chapter III?  Excitatory synaptogenesis has been 
observed after lateral TBI [209], which could explain the regrowth (and overgrowth) of 
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dendritic spines shown in Chapter I.  However, it is unclear whether this synaptogenesis 
is adaptive or maladaptive (i.e., epileptogenic). To test whether synaptogenesis is 
epileptogenic, rats could be treated after TBI with an inhibitor of synaptogenesis and 
then monitored for spontaneous seizures months later.  For example, the anti-epileptic 
drug Gabapentin has been shown to inhibit excitatory synaptogenesis during 
development [312] and may similarly interfere with reactive synaptogenesis in the adult 
brain [311].  Interestingly, epileptogenesis in the cortical undercut model is delayed 
when rats are treated with Gabapentin after the undercut [311].  Another drug, the 
experimental Rac1 inhibitor NSC23766, may also block excitatory synaptogenesis in the 
adult brain, as it has been shown to prevent spine overgrowth a mouse model of spinal 
cord injury [313]. 
 In conclusion, the present study reveals a role for the calcium-sensitive 
phosphatase, calcineurin, in TBI pathology.  Administering a calcineurin inhibitor to rats 
at 1 hour post-TBI prevented the subsequent loss of dendritic spines from principal 
cortical cells, likely through downstream inhibition of the actin-depolymerizing protein, 
cofilin.  The same drug treatment also prevented a TBI-induced increase in non-
convulsive seizures.  These findings further our understanding of the mechanisms by 
which TBI can alter neural circuitry, and emphasize the potential for calcineurin as a 
therapeutic target in the treatment of TBI. 
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